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1. Summary 
 
Urinary tract infection (UTI) is one of the most serious health problems worldwide. It 
accounts for a million hospital visits annually in the United States. Among the many 
uropathogenic bacteria, uropathogenic Escherichia coli (UPEC) is the most common 
causative agent of UTI. However, not all E. coli that inhabit the urinary tract can cause 
UTI. Some of them thrive for long periods of time in the urinary bladder without causing 
overt symptoms of infection. This carrier state is called asymptomatic bacteriuria (ABU). 
 
E. coli ABU isolates can live in the host without inducing host response due to deletions, 
insertions and point mutations in the genome leading to the attenuation of virulence 
genes. They therefore behave in the same way as commensals. Since bacteria that inhabit 
the urinary tract are said to originate from the lower intestinal tract and ABU behave in a 
similar way as commensals, this study compared various phenotypic and genotypic 
characteristics of ABU and commensal E. coli fecal isolates. The two groups did not 
show a strict clustering with regards to phylogenetic lineage since there appears to be 
overlaps in their distribution in some clonal complexes. In addition, it was observed that 
the UPEC virulence genes were more frequently inactivated in ABU than in fecal 
isolates. Hence, ABU tend to have less functional virulence traits compared to the fecal 
isolates. 
 
The ABU model organism E. coli 83972 which is known not only for its commensal 
behavior in the urinary bladder but its ability to outcompete other bacteria in the urinary 
tract is currently being used as prophylactic treatment in patients who have recurrent 
episodes of UTI at the University Hospital in Lund, Sweden. The pilot studies showed 
that upon deliberate long-term colonization of the patients with E. coli 83972, they 
become protected from symptomatic UTI.  
 
In this study, the phenotypic and genotypic characteristics of eight re-isolates taken from 
initially asymptomatically colonized patients enrolled in the deliberate colonization study 
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who reported an episode of symptoms during the colonization period were investigated. 
Two out of the eight re-isolates were proven to be a result of super infection by another 
uropathogen. Six re-isolates, on the other hand, were E. coli 83972. The urine re-isolates 
confirmed to be E. coli 83972 were phenotypically heterogeneous in that they varied in 
colony size as well as in swarming motility. Four of these re-isolates were 
morphologically homogenous and similar to the parent isolate E. coli 83972 whereas one 
of them appeared phenotypically heterogenous as a mixture of smaller and normal-sized 
colonies. Still another re-isolate phenotypically resembled small colony variants. 
Meanwhile, three of the six re-isolates did not differ from the parent isolate with regards 
to motility. On the other hand, three exhibited a markedly increased motility compared to 
the parent isolate. Transcriptome analysis demonstrated the upregulation of a cascade of 
genes involved in flagellar expression and biosynthesis in one of the three motile re-
isolates. However, upon further investigation, it was found out that the expression of 
flagella had no effect on bacterial adhesion to host cells in vitro as well as to the 
induction of host inflammatory markers. Thus, this implies that the increased motility in 
the re-isolates is used by the bacteria as a fitness factor for its benefit and not as a 
virulence factor. In addition, among the various deregulated genes, it was observed that 
gene regulation tends to be host-specific in that there is no common pattern as to which 
genes are deregulated in the re-isolates. Taken together, results of this study therefore 
suggest that the use of E. coli 83972 for prophylactic treatment of symptomatic UTI 
remains to be very promising.   
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1. Zusammenfassung 
 
Harnwegsinfektionen (HWI) sind weltweit ein ernstes Gesundheitsproblem, auf welches 
allein in den USA jährlich ca. eine Million Krankenhausbesuche entfallen. Innerhalb der 
Gruppe uropathogener Bakterien stellen die uropathogenen Escherichia coli (UPEC) die 
wichtigsten Verursacher akuter Harnwegserkrankungen dar. Interessanterweise führen 
nicht alle E. coli Varianten, die den Harnweg besiedeln, zwangsläufig zu HWI. Einige 
von ihnen sind in der Lage, die Harnblase über einen langen Zeitraum zu kolonisieren 
ohne Symptome einer HWI auszulösen. Dieses Phänomen wird als asymptomatische 
Bakteriurie (ABU) bezeichnet. 
 
Die Eigenschaft von E. coli ABU-Isolaten innerhalb des Wirtsorganismus leben zu 
können, ohne eine deutliche Wirtsabwehrreaktion hervorzurufen, ist unter anderem 
bedingt durch Deletionen, Insertionen und Punktmutationen im bakteriellen Genom und 
der daraus resultierenden Inaktivierung einiger Virulenzgene. Ihre Lebensweise ist daher 
mit der kommensaler Organismen vergleichbar. Da die den Harnweg besiedelnden 
Bakterien mit hoher Wahrscheinlichkeit ihren Ursprung im unteren Darmtrakt haben und 
sich die ABU-Isolate ähnlich der Kommensalen verhalten, wurden in dieser Arbeit 
zahlreiche phäno- und genotypische Charakteristika von ABU-Isolaten mit denen 
kommensaler E. coli-Fäkalisolate verglichen. Für diese beiden Gruppen konnte 
hinsichtlich ihrer phylogenetischen Abstammung keine strikte Clusterbildung festgestellt 
werden, da ihre Verteilung in einigen klonalen Komplexen Überlappungen aufwies. Es 
zeigte sich jedoch, dass die UPEC-Virulenzgene in den ABU-Isolaten häufiger inaktiviert 
vorlagen als in den Fäkalisolaten. Demzufolge scheinen die ABU-Isolate weniger 
funktionale Virulenzeigenschaften zu besitzen als die Fäkalisolate. 
 
Der Modell-ABU Stamm E. coli 83972 ist sowohl für sein kommensales Verhalten in der 
menschlichen Blase bekannt, als auch für seine Fähigkeit, andere Bakterien aus dem 
Harntrakt zu verdrängen. Er wird gegenwärtig am Universitätsklinikum in Lund 
(Schweden) als prophylaktisches Therapeutikum bei der Behandlung von Patienten mit 
rezidivierenden HWI eingesetzt. In Pilotstudien konnte gezeigt werden, dass eine 
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vorsätzliche Langzeit-Kolonisierung von Patienten mit  E. coli 83972 zum Schutz vor 
symptomatischen HWI führt. 
 
In der vorliegenden Arbeit wurden die phäno- und genotypischen Charakteristika von 
acht Patienten-Reisolaten dieser Langzeitstudie untersucht. Die Reisolate wurden aus 
zunächst asymptomatisch kolonisierten Patienten isoliert, die allerdings im Verlauf der 
Langzeit-Kolonisierung über eine Reihe von Symptomen klagten. Zwei dieser acht 
Reisolate waren nachweislich das Resultat einer Superinfektion mit einem anderen 
uropathogenen Bakterium. Die restlichen sechs Reisolate konnten jedoch als E. coli 
83972 identifiziert werden. Für diese sechs Reisolate war eine phänotypische 
Heterogenität zu beobachten, die sich zum einen in variierender Koloniegröße, zum 
anderen in unterschiedlichem Schwärmverhalten zeigte: Vier der Reisolate entsprachen 
morphologisch dem Ausgangsstamm E. coli 83972, wohingegen ein Reisolat 
phänotypisch abweichend als Mischung von kleineren und normal-großen Kolonien in 
Erscheinung trat. Ein weiteres Reisolat ähnelte phänotypisch sogenannten „Small Colony 
Variants“. Das Schwärmverhalten betreffend unterschieden sich indessen drei der sechs 
Reisolate vom Ausgangsstamm. Sie zeigten im Vergleich eine erhöhte Motilität. In einem 
dieser drei motilen Reisolate konnte mittels Transkriptomanalyse die hochregulierte 
Expression einer Reihe von Genen, welche für die Flagellenexpression und -biosynthese 
verantwortlich sind, aufgezeigt werden. Weiterführende in vitro-Untersuchungen ergaben 
jedoch, dass diese erhöhte Flagellenexpression weder einen verstärkenden Effekt auf die 
bakterielle Adhäsion an die Wirtszellen hat, noch in der Wirtszelle die Bildung von 
Entzündungsmarkern induziert. Dieses Ergebnis impliziert, dass die erhöhte Motilität der 
Reisolate als Fitnessfaktor und nicht als Virulenzfaktor zu betrachten ist.  
Ferner führte die genauere Analyse der deregulierten Gene zu der Annahme, dass die 
Genregulation in den Reisolaten wirtsspezifisch ist, da sich kein übereinstimmendes 
Muster bezüglich der Deregulation abzeichnete. 
 
Unter Berücksichtigung aller Ergebnisse dieser Studie lässt sich abschließend sagen, dass 
die Verwendung des E. coli Stammes 83972 als prophylaktisches Therapeutikum bei der 
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Behandlung von symptomatischen HWI weiterhin als sehr vielversprechend angesehen 
werden kann. 
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2. Introduction 
 
2.1. Urinary Tract Infection 
 
Urinary tract infection (UTI) is a serious health problem that affects millions of people 
worldwide (Stamm and Norrby, 2001). It is known to be the most common bacterial 
infection. In fact, UTI accounts for millions of clinical visits and hospitalizations 
annually.  
 
UTI is more common in women, with almost half of all women incurring one episode of 
UTI during their lifetime (Foxman, 2002; Guyer et al., 2001). Among all UTI-causing 
organisms, Escherichia coli remains to be the most predominant (Croxen and Finlay, 
2010; Ronald, 2002; Guyer et al., 2001). Moreover, uropathogenic E. coli (UPEC) is 
responsible for 70-90 % of the estimated 150 million UTIs diagnosed annually in the 
United States (Stamm and Norrby, 2001).  
Three clinical types of UTI exist. Cystitis is confined to the urinary bladder. It is 
characterized by dysuria, urgency, frequency of urination, and sometimes suprapubic 
pain. Acute cystitis should not be accompanied by acute phase reactants or cytokines in 
the serum, but there is pyuria (i.e. leukocytes in the urine), and IL-6 and IL-8 levels in 
urine may be elevated (Svanborg and Godaly, 1997). 
On the other hand, the more serious condition, acute pyelonephritis, ascends to the 
kidneys (Pace, 2000). It is accompanied by fever, flank pain, and general malaise. 
Investigation in the laboratory shows presence of pyuria, elevated acute phase reactants 
in serum (C reactive protein [CRP], erythrocyte sedimentation rate [ESR]), elevated 
levels of cytokines in serum and urine, and later increased levels of antibacterial IgA 
antibodies in urine and serum (Svanborg and Godaly, 1997). It is a severe systemic 
infection usually caused by UPEC clones with virulence genes clustered on pathogenicity 
islands (Mabbett et al., 2008).  
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Figure 1. Differences between UPEC and ABU. (a) Fully virulent UPEC possess virulence 
factors while (b) ABU have become attenuated due to gene mutations and gene loss (adapted from 
Svanborg et al., 2006).  
A third type, known as asymptomatic bacteriuria (ABU), resembles commensalism due 
to its ability to thrive in the urinary bladder without causing symptoms in the host. 
(Mabbett et al., 2008). 
2.2. Asymptomatic bacteriuria  strain 83972 
 
A certain proportion of apparently healthy individuals have bacteria in their urine in the 
absence of any clinical symptoms. This is called asymptomatic bacteriuria (ABU). ABU 
is characterized by the presence of 105 CFU/ml of one type of bacteria in a culture of 
clean voided midstream urine isolated from an individual without symptoms of a urinary 
tract infection or fever (Costerton et al., 1995). ABU is commonly detected only at 
screening because it is not accompanied by any of the symptoms seen for acute 
pyelonephritis and acute cystitis (Figure 1). The laboratory findings vary. In addition, the 
patients may have low level cytokine responses and leukocytes in urine, or they may have 
no host response to infection. (Svanborg and Godaly, 1997). ABU may be found in 2.7 % 
of women aged between 15 and 24 years and increases to 20 to 50 % in women above an 
age of 80 years. In men the prevalence of ABU is considerably lower, but increases to 6 
to 20 % above the age of 80 years (Stein and Fünfstück, 2000).  
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The most studied Escherichia coli asymptomatic bacteriuria isolate is ABU E. coli isolate 
83972, which was first discovered to have colonized a young Swedish school girl for 
three years (Lindberg et al. 1978). It has several outstanding characteristics that sparked 
the interest of clinical researchers. It has the ability to persist in the human bladder for 
extended periods without provoking host response (Mabbett et al., 2008). This is due to 
the fact that its virulence-associated adhesin genes have become attenuated giving rise to 
poor immune detection by the host. It also has the capability to outcompete other bacteria 
in the urinary tract (Klemm et al., 2006).  ABU thus represents a successful adaptation, 
because the bacteria can persist without competition in a niche with a rich nutrient 
source, often for several years (Svanborg et al. 2006). With these characteristics, E. coli 
83972 is being used in deliberate colonization studies for prophylactic purposes in 
patients with recurrent urinary tract infection (Wullt et al., 2001, Sunden et al., 2006, 
2010).  
 
2.3. Uropathogenic and Commensal Escherichia coli 
 
UPECs differ from non-pathogenic E coli variants by the presence of virulence factors 
which contribute to their ability to cause disease (Blum-Oehler et al., 2002). They acquire 
traits that distinguish them from commensal E. coli strains. Characteristically, UPEC 
strains produce alpha/hemolysin and cytotoxic necrotizing factor 1, P fimbriae, 
aerobactin, exhibit serum resistance, and are encapsulated (Tóth et al., 2000). UPECs 
have clustered sets of virulence genes, termed pathogenicity islands (PAI). PAIs are 
heterogenous pieces of DNA characterized by an unusual genetic organization, 
comprising virulence genes, mobility and regulatory genes or pseudogenes as well as 
genes or open reading frames with unknown functions (Hacker et al., 1997).  
 
As a commensal, E. coli inhabits the intestines and feces of warm-blooded animals and 
reptiles. It is the predominant aerobic organism in the vertebrate gut. As in any 
commensal relationship, E. coli commensals derive nutrients from the host. In turn, they 
can prevent host colonization by pathogens by inducing colonization resistance in the 
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host. They are able to do this by production of bacteriocins and through other 
mechanisms (Tenaillon et al., 2010).  
 
2.4. Virulence Factors of Uropathogenic Escherichia coli 
 
2.4.1. Adhesins 
 
The ability to adhere to a wide variety of biotic and abiotic surfaces is a feature which 
can promote bacterial survival and is one of the key virulence functions of many 
pathogens. Adhesion is mediated by distinct surface structures called adhesins (Gerlach 
and Hensel, 2007). For the invading bacterium, the ability to sense the host tissue 
depends on an adhesin protein at the tip of the pilus (Lund et al., 1987; Hultgren et al., 
1989).  
 
Adhesins are required for colonization of host mucosal tissues such as the urinary tract 
and establishment of the infectious process. In addition, adhesins and their cellular 
receptors also play an important function during subsequent stages of the infectious 
processes, such as during the formation of intracellular bacterial reservoirs for subsequent 
infection cycles, induction of cell signaling and induction of the innate immune response 
(Bouguénec, 2005). Most commensal and pathogenic bacteria interacting with eukaryotic 
hosts express adhesive molecules on their surfaces that promote interaction with host cell 
receptors or with soluble macromolecules. Although bacterial attachment to epithelial 
cells may be beneficial for bacterial colonization, adhesion may come at a cost because 
bacterial attachment can also stimulate immune cell infiltration, activation, and 
phagocytosis, which facilitate bacterial clearing (Kline et al., 2009). UPEC strains have 
been shown to express a number of different fimbrial adhesins including P, F1C, S, M, 
Dr and type 1 fimbriae (Bahrani-Mougeot et al., 2002). 
 
In the urinary tract, adherence is considered a virulence trait. It has been proposed to play 
a critical role for the establishment of bacteriuria. Among the many adhesins, P fimbriae 
have the strongest association with acute disease severity, being present in at least 90 % 
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of acute pyelonephritis but only 20 % of ABU. In contrast, type 1 fimbriae can be 
expressed by more than 90 % of both commensal and uropathogenic E coli.  The disease 
association of other adhesin genes, on the other hand, is less studied (Bergsten et al., 
2005).  
 
2.4.2. Flagella 
 
Flagella are filamentous appendages required for bacterial chemotaxis and motility. They 
are rotary structures driven from a motor at the base, with the filament acting as a 
propeller. The flagellum consists of three major substructures: the filament, the hook and 
the basal body. The filament is typically about 20 nm in diameter and usually consists of 
thousands of copies of a single protein called flagellin. Less commonly the filament is 
composed of several different flagellins. (Shapiro, 1995; Bardy et al., 2003). The 
polymerized sub-units of flagellin in E coli are encoded by fliC. In UPEC, the mutation 
of fliC can lead to loss of flagellation and motility (Lane et al., 2007).  
 
Flagellin signaling at the epithelium stimulates production of cytokines and chemokines 
responsible for the recruitment of immune cells to the site of pathogen entry. In addition, 
expression of TLR5 by immune cells such as polymorphonuclear neutrophils, natural 
killer (NK) cells, and monocytes and macrophages permits further amplification of the 
innate immune response (Honko and Mizel, 2005). A study by Ivison et al. (2010) 
showed that bacterial flagellin triggers inflammation in mammalian cells via TLR5 and 
that release of the chemokine IL-8 in response to flagellin involves NF-κB, p38 MAP 
kinase, and phosphatidylinositol 3-kinase (PI3K). 
 
Apart from their functions in motility, flagella also contribute to efficient colonization of 
the urinary tract (Lane et al., 2007). In fact, the flagella of enteropathogenic E. coli 
mediate adhesion to epithelial cells in vitro (Girón et al., 2002). In addition, flagella, 
specifically the flagellin, could stimulate interleukin-8 (IL-8) production in T84 bladder 
cells (Zhou et al., 2003). In fact, it causes IL-8 release from several epithelial cell lines 
(Khan et al., 2004). 
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2.4.3. Extracellular Polysaccharides 
 
Bacterial cell surface polysaccharides, such as lipopolysaccharides (LPS) and capsular 
polysaccharides (CPS), are important in processes critical for bacterial pathogenicity such 
as bacterium–host interactions, resistance to serum-mediated killing, and regulation of the 
host immune response (Robbins et al., 1980; Moxon and Kroll, 1990). Expression of CPS 
and LPS in part dictates the pathogenic potential of Gram-negative bacteria. Moreover, 
LPS and groups 2 and 3 CPS play major roles in the pathogenesis of infection. Capsules 
and LPS are considered as virulence factors that protect E. coli against various host 
bactericidal defenses (Russo, 2002).  
 
LPS is a unique glycolipid found in the outer membrane of Gram-negative bacteria. It is 
made up of lipid A, a core oligosaccharide region and a serotype- specific O antigen 
(Russo, 2002). LPS enhances inflammatory response due to its effects on cytokine 
synthesis. In addition, it is involved in the resistance of the pathogen to the killing effect 
of the host serum (Emődy, 2003).  
 
Capsular polysaccharides, on the other hand, are linear polymers of repeating 
carbohydrate subunits that sometimes also include a prominent amino acid or lipid 
component. They coat the cell, interfering with O antigen detection and protecting the 
cell from host defense mechanisms (Johnson, 1991).  Capsules provide protection against 
phagocytic engulfment and complement bactericidal effect in the host. Moreover, certain 
capsular types such as K1 and K5 show a mimicry to tissue components which prevents 
humoral immune response by the infected host (Emődy, 2003). In E. coli Nissle 1917, the 
K5 capsule expressed on the cell surface was found to be able to be important in 
mediating interactions with intestinal epithelial cells as well as induction of chemokine 
gene expression (Hafez et al., 2009). In addition, the K5 capsule was also found to 
stimulate expression of Toll-Like Receptor (TLR) 5, CD14, MyD88 and TRIF together 
with the induction of Interleukin-8 expression in epithelia cells (Hafez et al., 2010). 
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2.4.4. Toxins 
 
Toxins are exported virulence factors among UPEC of which the most important is α-
hemolysin (Smith, 1963). Alpha-hemolysin is a pore-forming toxin targeting not only 
erythrocytes but also leukocytes as well as endothelial and renal epithelial cells (Keane et 
al., 1987). Another UPEC toxin is the cytotoxic necrotizing factor 1 (CNF1) which 
interferes with polymorphonuclear phagocytosis and evokes apoptotic death of bladder 
epithelial cells (Caprioli et al., 1987; Fiorentini et al., 1997). In addition, the cytolethal 
distending toxin (CDT) was also detected among UPEC. This toxin causes apoptosis of 
host cells (Lai et al., 2000). 
 
2.5. Bacteria and Host Immune Response  
 
The immune system detects and eliminates invading pathogenic microorganisms by 
discriminating between self and non-self. In mammals the immune system can be divided 
into two branches: “innate immunity” and “adaptive immunity” (Takeda et al., 2003) 
(Figure 2). The first line of defense against infectious diseases is the innate immune 
response. This is mediated by white blood cells, cells that phagocytose and kill the 
pathogens, and those that synthesize inflammatory mediators and cytokines (Aderem and 
Ulevitch, 2000).  
 
The innate host response reflects the reactivity of mucosal sites to microbial attack. 
Commensal organisms often fail to evoke this response; thus, the mucosal barrier remains 
inert to these microbes and to their secreted products, and a state of asymptomatic 
carriage is established. The pathogens, in contrast, are equipped to break the inertia of the 
mucosal barrier by triggering a host response (Bergsten et al., 2004). 
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Figure 2. Innate immune response involves (1) activation of antigen-presenting cells (APCs) 
through recognition of pathogens or pathogen-associated molecular patterns (PAMPs) by receptors 
such as toll-like receptors (TLRs). (2) This leads to the production of inflammatory cytokines and 
expression of co-stimulatory molecules on the cell surface. Adaptive immune response involves (3) 
presentation of antigens on APCs to T lymphocytes by major histoocmpatibility complex (MHC). (4) 
Activated T lymphocytes become further differentiated to effector T lymphocytes by stimulation with 
cytokines. (Adapted from http://research4.dfci.harvard.edu/innate/innate.html).  
 
 
 
 
 
 
 
 
 
 
 
 
 
2.5.1. Interleukin-6 (IL-6) 
 
Mucosal surfaces are primary sites of encounter between bacteria and the human host. 
Mucosal response to microbial challenge includes the production of cytokines. (Agace et 
al., 1993). IL-6 is a part of the human mucosal response to Gram-negative UTIs (Hedges 
et al., 1991). It is a cytokine produced by a variety of cells and acts on a wide range of 
tissues, exerting growth-inducing, growth-inhibitory and differentiation-inducing effects, 
depending on the nature of the target cells (Hirano et al., 1990). Deliberate colonization 
of the human urinary tract with E. coli stimulated the secretion of IL-6 into the urine 
without concomitant elevation of the serum IL-6 levels. It is suggested that urinary IL-6 
is of local origin and that mucosal cells were activated directly by bacteria to produce 
cytokines (Hedges et al., 1991; Hedges et al., 1992). Moreover, IL-6 is also demonstrated 
to be activated as part of lipopolysaccharide-induced mucosal and systemic responses to 
Gram-negative bacterial infections (de Man et al., 1989). 
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IL-6 functions in several different ways. It activates hepatocytes to secrete acute-phase 
reactants, stimulates mucosal B lymphocytes, and acts as an endogenous pyrogen 
(Hedges et al., 1992). Additional functions of IL-6 are listed in Table 1. 
 
   Table 1. Various functions of IL-6 (Adapted from Hirano et al., 1990) 
 Function Cell/Process 
Induction B-cell differentiation 
Acute phase proteins in liver cells 
IL-2 and IL-2 receptor expression 
Myeloid leukemic cell lines differentiation to   
    macrophages 
Maturation of megakaryocytes as a thrombopoietic  
    factor 
Mesangial cell growth 
Neural differentiation of PC12 (pheochromocytoma)  
    cells 
Keratinocyte growth 
Growth Promotion Myeloma/plasmacytoma/hybridoma cells 
Proliferation and Differentiation T cells| 
Cell Growth Inhibition Myeloid leukemic cell lines 
Enhancement IL-3-induced multipotential colony cell formation in  
    hematopoietic stem cells 
 
In 1992, Hedges et al. compared urine and serum concentrations of IL-6 in women with 
acute pyelonephritis or asymptomatic bacteriuria. They found out that IL-6 activity was 
elevated in urine samples from most bacteriuric women, regardless of the severity of 
infection. However, elevated IL-6 serum levels occurred only in patients with acute 
pyelonephritis. The spread of IL-6 to the circulation in patients with acute pyelonephritis 
may contribute to the elevation of fever and C-reactive protein characteristic of the 
disease. 
2.5.2. Interleukin-8 (IL-8) 
 
Infection or injury of the body results in inflammation. A hallmark of this response is the 
recruitment of neutrophils from the blood to the injured tissue. This process is directed by 
chemotactic polypeptides of 8–14 kDa, so-called chemokines. About 40 human 
chemokines are known today (Zlotnik and Yoshie, 2000). The founding member of the 
C-X-C subfamily of chemokines is interleukin-8 (IL-8) (Baggiolini and Lewis, 1992; 
Wolff et al., 1998; Utgaard et al., 1998; Hoffmann et al., 2002). 
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IL-8 localizes intracellularly in the Golgi apparatus (Wolff et al., 1998). It is produced in 
several tissues by phagocytes and mesenchymal cells upon infection, inflammation, 
ischemia, trauma, among others. It activates integrin-mediated adhesion of neutrophils at 
the site of infection (Baggiolini and Lewis, 1992; Utgaard et al., 1998). In addition, it acts 
as a chemotactic factor for T-cell subsets and basophils enabling neutrophils to release 
lysosomal enzymes, undergo a respiratory burst and degranulate (Tullus et al., 1994). 
One of the most remarkable properties of IL-8 is the variation of its expression levels. In 
healthy tissues, IL-8 is barely detectable, but it is rapidly induced by ten- to 100-fold in 
response to proinflammatory cytokines such as tumor necrosis factor or IL-1, bacterial or 
viral products, and cellular stress (Hoffmann et al., 2002). 
 
2.5.3. TLR5 
 
Toll-like receptors (TLRs) are the receptors of the innate immune system. These 
receptors recognize antigen patterns (like LPS in Gram-negative bacteria) (Utgaard et al., 
1998). They are expressed by a variety of primary cells and cell lines that participate in 
innate and adaptive immune responses (Honko and Mizel, 2005). They are type I 
transmembrane receptors which recognize conserved molecular patterns of microbial 
origin. Extracellular surface TLRs including TLR2, TLR4, and TLR5 recognize bacterial 
lipoproteins, lipopolysaccharide (LPS), and flagellin, respectively. On the other hand, 
endosomal TLRs such as TLR3, TLR7 ⁄ 8, and TLR9 sense dsRNA, ssRNA, and CpG 
motif from bacterial and viral DNA (Akira et al., 2006). Activation of TLRs by specific 
ligands leads to activation of NF-κB, mitogen-activated protein kinases or interferon 
regulatory factors via myeloid differentiation factor 88 (MyD88)-dependent and MyD88-
independent (Toll/Interleukin-1 receptor domain-containing adaptor protein inducing 
interferon b-dependent) pathways. This in turn produces proinflammatory cytokines or 
type I interferons (Akira et al., 2006; Lee and Kim, 2007).  
 
TLR5 is responsible for the detection of flagellin, the major protein constituent of 
bacterial flagella. It specifically recognizes the constant flagellin domain D1, which is 
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relatively conserved among different species (Hayashi et al., 2001). TLR5 is expressed 
by epithelial cells, monocytes, and immature dendritic cells.  
 
2.6. Bacterial Adaptation at the Genomic Level 
 
Bacteria have to live and survive under continuously changing environmental conditions 
and are therefore compelled to adapt to them (Ziebuhr et al., 1999). In the process, they 
acquire new traits that lead to the development of new bacterial variants. These bacterial 
variants may become a new generation of pathogens that arose from former non-
pathogens. 
 
The rate of adaptation remains controversial to date and probably diverse. However, 
evolution among organisms could be classified as either “microevolution”, when it is 
very rapid, i.e. taking place within days or weeks, yet already resulting to new variants, or 
“macroevolution”, when the process proceeds over longer periods of time, leading to the 
development of new variants of organisms, new species and sometimes even to the 
emergence of new genera (Barrick et al., 2009; Ziebuhr et al., 1999). 
  
Virulence of pathogenic organisms depends mostly on the various genetic changes that 
occur within the organism. These changes may be acquired as an adaptation to the host 
environment to enable the organism to become more fit to live and survive. These 
changes lead to genome evolution of the organism. Genome evolution pertains to both 
acquisition and loss of genetic information. Several mechanisms are involved in DNA 
uptake and reduction of genomic content. Both could result from mutations or horizontal 
gene transfer (Donnenberg, 2002).  
 
Point mutations, genetic rearrangements and horizontal gene transfer are major driving 
forces of bacterial evolution (Schubert et al., 2009). Point mutations can be generated by 
slipped-strand mispairing, resulting in expression or non-expression of particular genes 
(Leathart and Gally, 1998). On the other hand, genetic rearrangements may result from 
deletions in the bacterial chromosome which could play a major role during bacterial 
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pathogenesis as well as insertion of so-called insertion sequence (IS) elements. IS 
elements are small mobile DNA units that encode features necessary for their own 
mobilization (Ziebuhr et al., 1999). Since point mutations and genetic rearrangements 
only lead to slow evolutionary development, they are most likely unable to create novel 
genetic determinants. In contrast, during horizontal gene transfer, substantial amounts of 
DNA are introduced into and deleted from the chromosome effectively changing the life 
style of the bacterial species. When transfer of large DNA elements including plasmids, 
phages and genomic islands (i.e. PAIs) occur, it could lead to a new bacterial pathotype 
since the incorporation of a PAI can transform a normally benign organism into a 
pathogen. (Schubert et al., 2009). 
 
Aside from the modification of structural and regulatory genes, antimicrobial resistance 
can also result from insertions, deletions and point mutations in the genome (Musser, 
1995). Specific resistance exhibits clear associations with virulence genes (Boerlin et al., 
2005). Both virulence factors and resistance determinants are subject to intrastrain 
genetic and phenotypic variation (Ziebuhr et al., 1999). 
 
Bacterial adaptation to novel environments is dependent on the rate of genetic variation 
and on how selection acts on the genetic variation formed (Nilsson, 2005). Therefore, as 
the environment changes, the organism tries to cope up with the changes in order to be fit 
for survival. 
 
2.7. Aims of the Study 
 
Phenotypic and genotypic characterization of bacterial isolates that have been re-isolated 
from in vivo growth conditions leads to a better understanding of the way they interact 
with their host and their immediate environment and how this may affect genome 
plasticity. Although the model ABU isolate 83972 is well characterized, other ABU 
isolates remain uncharacterized. Thus, this study aimed to describe the geno- and 
phenotypic traits of a collection of ABU isolates from Lund, Sweden in the context of 
asymptomatic colonization of the bladder and host-bacterium interaction. In addition, due 
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to the general commensal-like behavior of ABU with regards to interaction with the host, 
it was also of interest to compare them to commensals, in this case, fecal isolates from 
healthy carriers without any history of urinary tract infection. 
 
One specific aim of this study was to determine on the genomic level the molecular 
mechanisms involved in the evolution of ABU isolates and thus characterize bacterial 
factors involved in host-bacterium interaction and bacterial adaptation to growth in the 
urinary bladder. Furthermore, even if E. coli 83972 is successfully being used as 
prophylactic treatment for recurrent UTI in Lund, Sweden, the fitness of the strain for this 
purpose should be further and carefully investigated. Rarely has there been any report of 
symptomatic episodes among patients who are stably colonized with ABU isolate 83972. 
However, there had been few among them who complained of symptom experience 
during E. coli 83972 colonization. Therefore, this study also aimed to compare E. coli 
83972 re-isolates from patients who experienced symptoms and look at the possible 
reasons why they occurred.   
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3. Materials 
All materials used in this study are listed below. 
3.1. Strains 
 
Table 2. Bacterial strains used in this study. 
Stra in Descr iption Reference  
CFT073 Clinical isolate from pyelonephritis, O6:K2:H7 (Mobley et al., 1990) 
E. coli MG1655 F-, γ-, ilvG, rfb-50 rph-1 (Blattner et al., 1997) 
E. coli Nissle 1917 Probiotic Escherichia coli strain, O6:K5:H7 (Nissle, 1918) 
SW102 λ pir Recombineering strain EL250 gal +, λ pir lysogen (Warming et al., 2005) 
83972 Asymptomatic bacteriuria isolate (Lindberg and Winberg, 1976) 
74 ABU Isolates (1963-2037) Asymptomatic bacteriuria isolates (Svanborg C, Lund) 
39 fecal isolates (2038-2076) Asymptomatic bacteriuria isolates (Svanborg C, Lund) 
BU05 17629 83972 strain derivate – human 
colonization study, symptomatic 
(Wullt B, Lund) 
BU05 42290 83972 strain derivate – human 
colonization study, symptomatic 
(Wullt B, Lund) 
BU04 50907 83972 strain derivate – human 
colonization study, symptomatic 
(Wullt B, Lund) 
BU04 40368 83972 strain derivate – human 
colonization study, symptomatic 
(Wullt B, Lund) 
BU04 41631 83972 strain derivate – human 
colonization study, symptomatic 
(Wullt B, Lund) 
BU04 63630 83972 strain derivate – human 
colonization study, symptomatic 
(Wullt B, Lund) 
BU04 64941 83972 strain derivate – human 
colonization study, symptomatic 
(Wullt B, Lund) 
BU04 68088 83972 strain derivate – human 
colonization study, symptomatic 
(Wullt B, Lund) 
BU05 35364 83972 strain derivate – human 
colonization study, symptomatic 
(Wullt B, Lund) 
FIM 636 83972 strain derivate – human 
colonization study, symptomatic 
(Wullt B, Lund) 
BU05 13813 (AS) 83972 strain derivate – human 
colonization study, 
asymptomatic 
(Wullt B, Lund) 
83972∆fliC 83972 fliC deletion mutant This study 
83972∆papGX::CFT073papGX_cat 83972 papGX deletion mutant 
complemented with functional 
papGX 
This study 
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3.2. Oligonucleotides 
Oligonucleotides were purchased from Eurofins MWG Operon (Ebersberg, Germany).  
 
Table 3. Oligonucleotides used in this study. 
Primer Name Sequence (5´→3´) 
 
Application 
 
Length (bp) 
ES3_for 
 
agt cat acc taa atg aat aac tgt aat 
tac gga agt gat ttc tga tga aag tgt 
agg ctg gag ctg ctt 
deletion of papGX from 
83972 
 
69 
 
ES4_rev 
 
ctt ttg cct gaa gct atc cgg cat act 
cag gca ttt cac gct tta tga cat atg 
aat atc ctc ctt agt tcc ta 
deletion of papGX from 
83972 
 
74 
 
pKD3_papG_for 
 
cct ttt tgc gtg gcc agt gcc aag ctt 
gca tgc aga ttg cag cat tac aca tga 
aaa aat ggt tcc cag ctt tg 
pKD3 recombination of 
papGX 
 
74 
 
pKD3_papX_rev 
 
gaa agt ata gga act tcg aag cag 
ctc cag cct aca caa tcg ctc aag 
aca ctt tat gag ctg aca tca tca ag 
pKD3 recombination of 
papGX 
 
74 
 
F13 
 
gtc ata ccc aaa tga ata act gta att 
acg gaa gtg att tct gat gaa aaa atg 
gtt ccc agc ttt gtt a 
recombination of 
papGX from CFT073 
into 83972 
 
73 
 
F14b 
 
ttc ttt tgc ctg aag cta tcc ggc ata 
ctc agg cat ttc acg ctt cat ggt cca 
tat gaa tat cct cct tag ttc c 
recombination of 
papGX from CFT073 
into 83972 
 
76 
 
CFT_papG_for 
 
ttc tga tga aaa aat ggt tcc c 
 
screening and 
sequencing, papGX-cat 
fusion construct 
22 
 
papG_revOP 
 
tca tga gca gcg ttg ctg aac c 
 
screening and 
sequencing, papGX-cat  
construct 
22 
 
CFTpapXrev 
 
gag ctg aca tca tca aca tcc gcc screening and 
sequencing, papGX 
24 
CFTpapXmid 
 
ggg tct ttg ttt ttt tgg tgt ct screening and 
sequencing, papGX 
25 
papX rev 
 
ggt tta tga gct gac atc atc aag 
 
screening and 
sequencing, papGX 
24 
papX_for_seq 
 
ctg atg cgc gct tgt aca ca 
 
screening and 
sequencing, papGX 
20 
papEFf 
 
gca aca gca acg ctg gtt gca tca t 
 
screening and 
sequencing, papGX 
25 
c2 
 
gat ctt ccg tca cag gta gg 
 
screening and 
sequencing, papGX 
20 
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Table 3.- Continued 
Primer Name Sequence (5´→3´) 
 
Application 
 
Length (bp) 
c1 
 
tta tac gca agg cga caa gg 
 
screening and 
sequencing, papGX 
20 
cat3 
 
cat atg aat atc ctc ctt agt tcc ta 
 
screening and 
sequencing, papGX 
26 
cat5 
 
gtg tag gct gga gct gct 
 
screening and 
sequencing, papGX 
18 
F1 
 
agc cat cga caa att ggt cgt a 
 
screening and 
sequencing, papGX 
22 
F3 
 
tca agc tgc tga gac cag gtg g 
 
screening and 
sequencing, papGX 
22 
F2 
 
gtc ttg caa tct ccc ctt ccg t 
 
screening and 
sequencing, papGX 
22 
F5 
 
gca gat taa cat cag ggg aaa t 
 
screening and 
sequencing, papGX 
22 
F6 
 
gtc gct gta ctg gct gat gtg c 
 
screening and 
sequencing, papGX 
22 
F7 
 
cag aaa tca ctt ccg taa tta c 
 
screening and 
sequencing, papGX 
22 
Flic_DW_cat-
ff 
 
cgc agc gca tca ggc aat ttg gcg ttg 
ccg tca gtc tca gtt aat cag gtg tgt 
agg ctg gag ctg ctt 
deletion of fliC from 
83972 
 
69 
 
Flic_DW_cat-
rev 
 
gac ggg tgg aaa ccc aaa acg taa 
tca acg act tgc aat ata gga taa cgc 
ata tga ata tcc tcc tta gtt cct a 
deletion of fliC from 
83973 
 
76 
 
fliC_Ktr_ff 
 
ccg ttt ctg cag ggt ttt ta 
 
screening, fliC deletion 
from 83972 
20 
 
fliC_Ktr_rev 
 
ata ctt gcc atg cga ttt cc 
 
screening, fliC deletion 
from 83972 
20 
 
chuA_for gaa agc tgc gca tcg cgt tg 
 
qRT-PCR 20 
chuA_rev aat ggt gaa acc gcg ccg aa 
 
qRT-PCR 20 
papA_for tgt tga tgc tcc atg cag ca qRT-PCR 20 
papA_rev acc aga aac cct tgg acc ac 
 
qRT-PCR 20 
fliA_for  cga gcg tgg aac ttg acg a 
 
qRT-PCR 19 
fliA_rev  cgc tac ctc agt ttc cgt gg 
 
qRT-PCR 20 
rfaG_for  ccg ctt tct ctg gca gac tg 
 
qRT-PCR 20 
rfaG_rev ctg ctg gaa gcg ata act gca 
 
qRT-PCR 21 
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Table 3.- Continued 
Primer Name Sequence (5´→3´) 
 
Application 
 
Length (bp) 
narI_for cgtc atc ccc aac acc agg qRT-PCR 18 
narI_rev gtg caa cga cta ccg gag c 
 
qRT-PCR 19 
frmA_for tgc att tgc tcc cgg taa acc 
 
qRT-PCR 21 
frmA_rev gca ctc tgc ggt gta aag c qRT-PCR 19 
rrnB_for aac tga gac acg gtc cag act qRT-PCR 21 
rrnB_rev tta acg ctt gca ccc tcc gt qRT-PCR 20 
IL6_for  gca ctg gca gaa aac aac ct qRT-PCR 20 
IL6_rev tca aac tcc aaa aga cca gtg a qRT-PCR 22 
IL8_for cca aca cag aaa tta ttg taa agc qRT-PCR 24 
IL8_rev cca aca cag aaa tta ttg taa agc qRT-PCR 21 
GAPDH_for tga acc acc aac tgc tta gc qRT-PCR 20 
GAPDH_rev tga acc acc aac tgc tta gc qRT-PCR 21 
 
For a complete list of the primers used for the detection of virulence genes, please see 
Johnson and Stell (2000) and for those used for determination of the phylogenetic group 
see Clermont et al. (2000).  
  
3.3. Plasmids  
 
All plasmids used during this study are listed below. 
 
Table 4. Plasmids used in this study. 
Plasmid Descr iption Reference  
pKD46 
 
repA101 (ts), araBp-gam-bet-exo (α red recombinase 
under the contol of araB promotor), ApR (bla) 
(Datsenko and Wanner, 2000) 
 
pKD3 
 
oriRγ, ApR, cat-gene flanked by FRT sites (Datsenko and Wanner, 2000) 
 
pKD4 
 
oriRγ, ApR, npt-gene flanked by FRT sites 
 
(Datsenko and Wanner, 2000) 
 
pCP20 Yeast Flp recombinase gene (FLP, aka exo) ts-rep, 
ApR, CmR 
(Datsenko and Wanner, 2000) 
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3.4. Chemicals and solutions  
Protein Work: 
4 x Protein Sample Buffer 
40 mM Tris/HCl, pH 8.0 
4 mM     EDTA 
8 %      SDS 
40 %     Glycerol 
0.004 %  Bromophenol blue 
   Aqua bidest 
 
10 % SDS solution 
100 g  SDS 
900 ml   H2O 
- pH adjusted to 7.2 and volume to 1 L by filling up with H2O  
- sterilized by autoclaving 
 
10 x Running Buffer (1 L) 
30 g   Tris 
188 g   Glycine 
10 g  SDS 
 
1M Tris (1 L) 
121.1 g  Tris base 
800 ml   H2O 
- pH adjusted to 7.4 and volume to 1 L by filling up with H2O  
 
Coomassie Brilliant Blue Stain 
25 %   Isopropanol 
10 %   Acetic acid 
0.04 %  Coomassie brilliant blue stain 
H2O 
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Destaining Solution 
5 %  Acetic acid 
7.5 %  Methanol 
H2O 
Semi-Dry Blot Buffer 
48 mM   Tris 
39 mM   Glycine 
0.0375% (w/v)SDS 
- dissolved in 800 ml H2O 
- filled with H2O up to 1 L mark 
- 20 % methanol added prior to use 
 
Block Buffer 
2 %   Milk powder in TBS or  
3 %   BSA in TBS 
 
Incubation Buffer 
0.2 %  Milk powder in TBS or 
0.3 %  BSA in TBS 
 
20 x TBS 
1 M   Tris/HCl, pH 7.5 
4 M  NaCl 
 
TBS-T 
1 x   TBS 
0.1 %  Tween-20 
 
TE Buffer 
10 mM  Tris/HCl, pH 8.0 
1 mM    EDTA 
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Membrane Staining Solution (Western Blot) 
50 ml  1x TBS 
3 ml  0.3 % 4-chloro-l-naphtol in methanol 
80 µl  H2O2  
 
LPS Silver Nitrate Staining 
2 x Fixation Solution 
250 ml   Isopropanol 
  70 ml   Acetic acid 
 
Periodate Solution 
0.87 g    Na-m-periodate (NaIO4) 
100 ml   1 x Fixation solution 
 
Silver Nitrate Solution 
1.4  ml    1 M NaOH 
   1  ml    NH3 (33%) 
70   ml    dH2O 
1.25 ml   20 % (w/v) AgNO3 
 
Developing Solution 
100 ml   2.5 % (w/v) Na2CO3 
27 µl      Formaldehyde 
 
DNA Work: 
6 x DNA Loading Buffer 
0.25 %   Bromophenol blue 
50 % (w/v)  Glycerol 
1 mM   EDTA 
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TAE buffer, 50 x 
242 g   Tris base 
57.1 ml  Glacial acetic acid 
22.6 g   EDTA 
- H2O added to a final volume of 1 L 
 
Ethidiumbromide stock solution 
10 mg/ml in TE (10 mM Tris/HCl, pH 7.5; 1 mM EDTA) 
 
DNA Polymerases: 
- Taq DNA Polymerase (Invitrogen, Qiagen) 
- GoTaq® DNA Polymerase (Promega) 
- Red Taq (Sigma)  
- DAP Goldstar Polymerase (Eurogentec) 
- Phusion Polymerase (Finnzymes) 
 
Biofilm Assay and Cell Culture: 
10 x PBS (1L) 
80 g  NaCl 
2 g  KCl 
14.4 g  Na2HPO4 
2.4 g  KH2PO4 
- dissolved in 800 ml H2O 
- pH set to 7.4  
- filled with H2O up to 1 L mark 
 
1 x PBS  
8 g  NaCl 
0.2 g   KCl 
1.44 g  Na2HPO4 
0.24 g  KH2PO4 
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800 ml  Distilled H2O 
- sterilized by autoclaving for 20 minutes 
 
Pulsed Field Gel Electrophoresis: 
NDE Buffer 
20 mm  Hepes 
50 mm  B-glycerophosphate 
15 mm  MgCl2 
20 mm  EGTA 
5 mm   NaF 
2 mm   DTT 
5 mm   Leupeptin 
5 mm   Pepstatin 
2 mg/ml   Aprotinin  
0.5 mm  Sodium orthovanadate 
10 mm  Ammonium molybdate 
10 mg/ml  Sodium 4-nitrophenylphosphate, 
- with PMSF added to 0.5 mm final concentration immediately before use, pH 7.4 
 
SE buffer         
10 mM  Tris-HCl, pH 7.5 
25 mM  EDTA, pH 7.5   
  
TE buffer 
75 mM  NaCl 
1 mM   EDTA, pH 7.5 
 
NDS buffer     
1 %               N-laurylsarcosine    
500 mM  EDTA, pH 9.5   
2 mg/ml  Proteinase K    
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LGT buffer 
10 mM             Tris-HCl, pH 7.5 
10 mM  MgCl2 
0.1 mM  EDTA, pH 7.5 
 
3.5. Media and antibiotics  
 
All media used were autoclaved for 20 min at 120 °C unless stated otherwise. Supplements 
for media and plates were sterile filtered through a 0.22-µm pore filter and added after 
cooling down the media to <50 °C.  
 
Liquid Media 
Lysogeny Broth (LB) 
10 g      Casein hydrolysate 
5 g        Bacto-yeast extract 
5 g        NaCl 
- H2Obidest  added to a final volume of 1 L 
- autoclaved and stored at 4 ºC until use 
 
Pooled Human Urine 
Human urine was collected from an equal number of healthy male and female volunteers, 
pooled and sterilized by filtration. Sterile urine was stored at 4 °C not longer than one 
week until use.  
 
Solid Media 
LB Agar (1L) 
5 g   Yeast 
10 g  Trypton 
5 g  NaCl 
15 g   Agar 
- H2Obidest  added to a final volume of 1 L 
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- autoclaved and cooled to 55 ºC 
- poured on plates and stored at 4 ºC until use 
 
Motility Agar Plates 
LB Plates (1 L) 
5 g   Yeast 
10 g  Trypton 
5 g  NaCl 
3 g  Agar 
- H2Obidest  added to a final volume of 1 L 
 
Urine Plates (1 L) 
3 g  Agar 
0.2 L  0.9 % NaCl 
0.8 L   Pooled human urine 
- agar and NaCl were first prepared and autoclaved before addition of pooled human 
urine 
 
Agar Plates for Phenotypic Assays 
Aerobactin and Colicin: 
Solution I. Tris Succinate Medium (1 L)  
5.8 g   NaCl 
3.7 g   KCl 
0.15 g   CaCl2 x 2 H2O 
0.1 g   MgCl2 x 6 H2O 
0.1 g   NH4Cl 
0.142 g  Na2SO4 
0.272 g  KH2PO4 
12.1 g    Tris (hydroxymethyl) aminomethane 
4.5 g      Succinic acid, pH 7.4 
- 20 min at 121 °C 
Materials 
 
-30- 
Solution II 
200 ml  Solution I 
2.4 g   Agar 
1 g   Casamino acids 
0.2 g   Peptone 
- 20 min at 121 °C 
- cooled to 50 °C and added the following components: 
 
Aerobactin Assay: 
2 ml   0.2 % Thiamine 
1200 µl  25 mm alpha-alpha-dipyridyl 
1 ml   OD600=0.6 E. coli strain LG1522 
 
Colicin Inhibition Assay: 
2 ml   0.2% Thiamine 
1 ml   OD600=0.6 E. coli strain DH5α 
 
Congo Red: No NaCl (800 ml) 
32 mg   Congo Red  
16 mg   Coomassie Red + Brilliant Blue (R250, Roth) 
8 g   Peptone 
4 g   Yeast Extract 
15 g   Agar 
 
Blood Agar: 
LB agar plate containing 5 % (v/v) Sheep Blood, Oxoid GmbH 
 
MacConkey Agar: 
BBLTM MacConkey Agar, Beckton Dickinson 
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Figure  3.  DNA and Protein Markers used in this study. A. GeneRuler™ 100 bp DNA Ladder B. 
GeneRuler™ 1 kb DNA Ladder C. Lambda Ladder PFG Marker D. PageRuler™ Plus Prestained Protein 
Ladder. 
 
Chromogenic Agar: 
Brilliance™ UTI Clarity™ Agar, Oxoid 
 
Calcofluor Plate: 
CFW fluorescent brightener (F-3543, Sigma) 
Antibiotics: 
When appropriate, media and plates were supplemented with the antibiotics listed below 
using the indicated concentrations. Stock solutions were sterile-filtered and stored at -20 
°C until use. 
 
Table 5. Antibiotics used in this study. 
Antibiotic Stock concentration Solvent Working concentration 
Chloramphenicol (Cm) 50 mg ml-1 EtOH 20 µg ml-1 
Ampicillin (Amp) 100 mg ml-1 dH2O 100 µg ml
-1 
Kanamycin (Kan) 50 mg ml-1 dH2O 50 µg ml
-1 
 
3.6. Electrophoresis markers 
 
To determine the size of DNA and protein fragments in agarose gels and membranes, the 
GeneRuler™ 100 bp DNA Ladder (MBI Fermentas) and GeneRuler™ 1 kb DNA Ladder 
(MBI Fermentas), Lambda Ladder PFG Marker (New England BioLabs) and 
PageRuler™ Plus Prestained Protein Ladder (MBI Fermentas) were used (Figure 3).  
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3.7. Kits and enzymes 
 
Enzymes used in this study were purchased from the following companies in Germany: 
New England Biolabs (Frankfurt am Main), Invitrogen (Karlsruhe), MBI Fermentas (St. 
Leon-Rot), Roche Diagnostics (Mannheim), Gibco BRL (Eggenstein), Merck 
(Darmstadt), Oxoid (Wesel), GE Healthcare/Amersham Biosciences (Freiburg), R & D 
Systems (Wiesbaden), Roth (Karlsruhe).  
 
The following commercial kits were used: 
- Plasmid Mini and Midi kit, QIAGEN (Hilden, Germany) 
- PCR purification kit, QIAGEN (Hilden, Germany) 
- Gel extraction kit, QIAGEN (Hilden, Germany) 
- RNeasy kit, QIAGEN (Hilden, Germany) 
- ABI Prism Big Dye Terminator Cycle Sequencing Ready Reaction kit, Applied 
Biosystems (Foster City, USA) 
- ECLTM Direct Acid Labeling and Detection System, and ECLTM advance system    
            GE Healthcare/Amersham Biosciences (Freiburg, Germany) 
- OpArray Hybridization Buffer Kit, Operon (Cologne, Germany) 
- Superscript III Reverse Transcriptase, Invitrogen ((Foster City, USA) 
- RevertAid TM First Strand cDNA Synthesis Kit, Fermentas (St. Leon-Rot,  
      Germany) 
- Human CXCL8/IL-8 Immunoassay, R & D Systems (Wiesbaden, Germany) 
- Quantikine HS Human IL-6 ELISA, R & D Systems (Wiesbaden, Germany) 
  
3.8. Antibodies 
 
The following antibodies were used for Western Blot, immunoblotting and agglutination: 
- rabbit polyclonal antibody against purified P-related P-fimbriae (Dr. Salam Kahn) 
- rabbit polyclonal antibody against purified S-fimbriae (Dr. Salam Kahn) 
- rabbit polyclonal antibody against flaA, flagellin sub-unit in Legionella 
pneumophila  
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- rabbit polyclonal antibody against poly-N-acetyl glucosamine (PIA)  
3.9. Technical equipment 
 
Autoclaves    Integra Bioscience, H+P Varioclav  
Balances     IL-180, Chyo Balance Corp 
     Kern 470 
 Ohaus Navigator 
Bioanalyzer     Agilent Technologies, 2100expert 
Centrifuges    Beckmann J2-HC® JA10 and JA20 rotors 
     Beckmann L-70 Ultracentrifuge 
     Heraeus Sepatech Megafuge1.OR 
     Heraeus Sepatech Biofuge 13R 
        Hettich Mikro20 
Clean bench    NUAIRE, Class II, type A/B3 
Documentation    BioRad GelDoc2000 + MultiAnalyst Software V1.1 
Electrophoresis systems  BioRad 
Electroporator    Gene Pulser, BioRad 
Hybridization oven    HybAid Mini 10 
Incubators    Memmert Tv40b (30 °C) 
     Heraeus B5050E (37 °C) 
Magnetic stirrer   Heidolf  MR3001K 
Microarray scanner    GenePix 4000B, Molecular Devices 
Microarray hybridization chamber Scienion 
Micropipettes    Eppendorf Research 0.5-10 µl, 2-20 µl  
     20-200 µl, 100-1000 µl 
Microwave AEG    Micromat 
Power supplies    BioRad Power Pac 300 
PCR Thermocycler    Biometra T3 
pH meter    WTW pH 525 
Photometer     Pharmacia Biotech Ultrospec 3000 
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     Thermo Scientific NanoDropTM 1000 
Phosphoimager   Amersham Biosciences, Typhoon 4600 
Real Time PCR Thermocycler Bio Rad, CFX96 
Scanner     HP ScanJet IIcx 
Shakers     Bühler TH30 SM-30 (37°C, 150 rpm) 
Innova 4300, New Brunswick Scientific (37°C, 220 
rpm) 
Innova 4230, New Brunswick Scientific (30°C, 220 
rpm) 
Speedvac     Savant SC110 
Thermoblocks     Liebisch 
Vaccum pump    Univac Uniequipe 
Videoprinter     Mitsubishi Hitachi, Cybertech Cb1 
Vortexer     Vortex-Genie 2TM Scientific Industries 
UV-Crosslinker     BioRad 
Waterbath     GFL 1083, Memmert 
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4. Methods 
 
The methods used in this study followed standard protocols described in the Molecular 
Cloning Manual (Sambrook et al., 1989) unless stated otherwise. Specific details of each 
method are found in Section 8.2, Appendices.  
 
4.1. Pheno- and genotypic characterization of ABU isolates and fecal 
isolates from healthy individuals  
 
74 E. coli ABU isolates and 39 fecal E. coli isolates from healthy individuals without any 
history of urinary tract infection from Sweden collected by C. Svanborg were sent from 
Lund, Sweden for characterization. The phylogenetic groups (E. coli group of reference 
strains, ECOR) of the isolates were typified (Clermont et al., 2000). In addition, multi-
locus sequence typing was performed to identify the sequence type of the isolates. The 
presence of various virulence-associated genes of extraintestinal pathogenic Escherichia 
coli was also determined through multiplex and single polymerase chain reactions 
(PCRs) (Johnson and Stell, 2000). Additionally, phenotypic expression of important 
virulence-associated traits (α-hemolysin, curli and cellulose, K5 capsule, aerobactin, 
colicin as well as type 1-, P- and S/F1C-fimbria) was compared between the ABU and 
fecal isolates.  
 
4.1.1. Phylogenetic Classification (E. coli group of reference strains, ECOR) 
 
A multiplex PCR (Taq DNA Polymerase, Invitrogen) which amplifies a combination of 
two genes (chuA and yjaA) and an anonymous DNA fragment (TspE4.C2) of E. coli was 
used for the determination of the phylogenetic group (A, B1, B2, and D) of the isolates 
(Figure 4) (Clermont et al., 2000). The PCR products were separated on a 1 % gel by 
electrophoresis.  
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Figure 4. Triplex PCR profiles specific for the four E. coli phylogenetic groups. Each 
combination of chuA and yjaA gene and DNA fragment TspE4.C2 amplification allowed 
the determination of the phylogenetic group of a given strain; B) Lanes 1 and 2, ECOR 
group A; lane 3, ECOR group B1; lanes 4 and 5, ECOR group D; lanes 6 and 7, group 
ECOR B2. Lane M, DNA size marker (Clermont, 2000). 
 
4.1.2. Multi-Locus Sequence Typing 
 
Multi-locus sequence typing (MLST) was done for the isolates studied using seven E. 
coli housekeeping genes that are evenly spread over the chromosome. The seven 
housekeeping genes included according to the Achtman MLST 
(http://www.shigatox.net/mlst)  were adk (adenylate kinase), fumC (fumarate hydratase), 
gyrB (DNA gyrase), icd (isocitrate/isopropylmalate dehydrogenase), mdh (malate 
dehydrogenase), purA (adenylosuccinate dehydrogenase) and recA  (ATP/GTP binding 
motif). Internal fragments of these house-keeping genes were amplified using PCR and 
concomitantly sequenced. The DNA sequences obtained were then used for allocation to 
different clonal groups. The MLST analysis was done in cooperation with the Institute for 
Hygiene, Westfälische Wilhelms-Universität Münster, Germany). 
 
4.1.3. Determination of Virulence-Associated Genes 
 
Multiplex and single PCRs (GoTaq® DNA Polymerase, Promega) were performed for the 
detection of extraintestinal pathogenic Escherichia coli-related virulence genes of the 
isolates. The multiplex PCR consists of 29 genes (Johnson and Stell, 2000) and the single 
chuA 
yjaA 
TspE4.C2 
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PCRs which were conducted for verification include genes encoding for siderophore 
aerobactin and hemolysin. 
 
4.1.4. Polymerase Chain Reaction 
 
Polymerase chain reaction is a method used to amplify a selected DNA fragment. It 
involves three steps. First of all, the template DNA is heat-denatured to separate its 
complementary strands. Then, primers anneal to the DNA on both sides of the sequence (5’ 
and 3’). Finally, DNA polymerase extends the primers and new copies of the fragment are 
generated, the amount depending on the number of cycles (Prescott, 2002).  
 
The following PCR mixes are used for PCR: 
 
4.1.4.1. Standard PCR 
 
Taq DNA Polymerase (Invitrogen, Qiagen) 
2 µl  10 x reaction buffer 
2 µl   20 mM dNTP mix 
0.6 µl   25 mM MgCl2 
1 µl   10 pM primer solution 1 
1 µl  10 pM primer solution 2 
1 µl   100 ng template DNA or bacterial cells 
0.05 µl  Taq DNA polymerase 
Add double distilled H2O for a total of 50 µl 
 
GoTaq® DNA Polymerase (Promega) 
1 µl   dNTPs 
0.25 µl  Taq polymerase 
2 µl   Primer mix 
4 µl   MgCl2   
1 µl   100 ng template DNA or bacterial cells 
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10 µl   PCR buffer 
Add double distilled H2O for a total of 50 µl 
 
Red Taq (Sigma)  
12.5 µl  Taq polymerase 
9.5 µl   Water 
2 µl   Primer mix 
1 µl   DNA template 
 
PCR reactions were carried out with the following conditions in a thermal cycler: 
 
Taq DNA Polymerase (Invitrogen, Qiagen) and Red Taq DNA Polymerase (Sigma)  
1. 94 °C   3 min 
2. 94 °C 30 sec 
3. 55-63 °C 30 sec 
4. 72 °C 1 min/kb* go back to step 2 and repeat 24 or 34 times 
5. 72 °C 10 min 
6. 16 °C ∞ 
 
GoTaq® DNA Polymerase (Promega) 
1. 95 °C 2 min 
2. 95 °C 30 sec 
3. 55-63 °C 30 sec 
4. 72 °C 1 min/kb* go back to step 2 and repeat 24 or 34 times 
5. 72 °C 5 min 
6. 16 °C ∞ 
4.1.4.2. PCR with proof-reading polymerases 
 
For cloning and sequencing, polymerases with 3’ → 5’ proof-reading activity was used in 
order to prevent misincorporations during extension. The composition of the PCR mixes 
is given below.  
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DAP Goldstar Polymerase (Eurogentec) 
5 µl  10 x Opti buffer 
5 µl   20 mM dNTP mix 
3.5 µl   50 mM MgCl2 
1 µl   10 pM primer solution 1 
1 µl  10 pM primer solution 2 
1 µl   100 ng µl-1 template DNA 
0.5 µl   DAP Goldstar polymerase 
Add double distilled H2O for a total of 50 µl 
  
 
Phusion Polymerase (Finnzymes) 
10 µl  5 x HF or GC buffer  
1 µl   20 mM dNTP mix 
1.5 µl   50 mM MgCl2 (optional) 
1 µl   10 pM primer solution 1 
1 µl  10 pM primer solution 2 
1 µl   100 ng µl-1 template DNA 
0.5 µl   Phusion polymerase  
Add double distilled H2O for a total of 50 µl 
 
PCR reactions were carried out with the following thermal cycling profiles: 
 
DAP Goldstar Polymerase (Eurogentec) 
1. 95 °C  2 min  
2. 95 °C  45 sec  
3. 54 – 60 °C 45 sec   
4. 72 °C  1 min /1kb * go back to step 2 and repeat 24 or 34 times 
5. 72 °C 10 min 
6. 16 °C ∞ 
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Phusion Polymerase (Finnzymes) 
1. 98 °C   30 sec  
2. 98 °C   10 sec 
3. 45 – 72 °C  30 sec   
4. 72 °C   30 sec /1kb * go back to step 2 and repeat 24 or 34 times 
5. 72 °C   10 min 
6. 16 °C  ∞ 
 
After running a PCR reaction, the PCR products were run on a 1 or 2 % agarose gel in an 
electrophoresis machine (Appendix 8.2.1). A list of the primers used can be found in 
Section 3.2, Materials.  
 
4.1.5. Phenotypic Analysis of Important Virulence-Associated Traits 
 
Bacterial samples used for the assays were prepared either by making a 50 µl saline 
bacterial suspension or an overnight culture. Each sample was spot-inoculated into the 
plate using a sterile pipette tip.  
 
Hemolysin Production Assay 
 
Upon preparation of the bacterial samples, they were spot inoculated on blood agar 
plates. Afterwards, they were incubated for 16 h at 37 °C. Hemolysin production was 
determined by the presence of a clear haemolytic halo around the spot. 
 
Aerobactin Production Assay 
 
Upon preparation of the bacterial samples, they were spot inoculated on the plates and 
incubated for 48 h at 37 °C.  Production of aerobactin was visualized by the presence of 
growth zones of indicator strain LG1522 around the colonies. 
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Colicin Inhibition Assay 
 
Upon preparation of the bacterial samples, they were spot inoculated on the plates. They 
were then incubated for 24 h at 37 °C. Assessment was done afterwards by the presence 
of clear zones of growths of inhibition of indicator strain DH5α around colonies of tested 
strains. 
 
Congo Red Staining Assay 
 
Upon preparation of the bacterial samples, they were spot inoculated on Congo Red 
plates. Incubation was done for 48 h at RT, 30 °C and 37 °C. Bacterial staining by the red 
dye was assessed. Red, dry and rough colonies indicate expression of curli and cellulose, 
white ones of cellulose and brown of curli. 
 
K5 Capsule Expression 
 
Bacterial samples were streaked out horizontally on LB agar plates. Next, a K5 phage 
lysate (108 PFUml-1) preparation was vertically streaked out into individual bacterial 
streaks made on the plates. Plates were incubated overnight at 37 °C. Lysis of bacterial 
cells grown on the plates indicated expression of K5 capsule.  
 
Fimbrial Expression 
 
Agglutination assays were done to determine expression of type 1, P- and S- fimbriae 
among the isolates. 
 
To determine the expression of type 1 fimbria, bacteria were statically grown overnight. 
The following day, 20 µl of overnight culture was pipetted onto a glass slide with 20 µl 
of 10 mg/ml yeast in sterile 0.9 % NaCl (with or without 2 % mannose). After thorough 
mixing, agglutination of yeast cells was observed. E. coli 536 was used as positive 
control while 83972 wt was used as negative control. 
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Next, for the detection of P-fimbrial expression, bacteria grown on LB agar plates were 
mixed with 30 µl α-Prf antibody on a glass slide. Agglutination was observed after 
mixing using E. coli 536 and J96 as positive controls and MG1655 as negative control. 
 
Finally, for the determination of S-fimbrial expression, bacteria grown on LB agar plates 
were mixed with 30 µl α-F1C antibody on a glass slide. Agglutination was observed after 
mixing using E coli 536 positive control and MG1655 as negative control. 
 
 4.2. Characterization of ABU re-isolates from symptomatic episodes  
 
Eight 83972 re-isolates taken from patients stably colonized with ABU 83972 wt at the 
Lund University Hospital, Lund, Sweden were analyzed. The said patients reported an 
episode of symptoms at the time of collection. Primarily, the phylogenetic groups (E. coli 
group of reference strains, ECOR) of the isolates were typified (Clermont et al., 2000). 
Then, the presence of various virulence-associated genes of uropathogenic E. coli was 
determined through multiplex and single polymerase chain reactions (PCRs) using 
primers previously used by Johnson and Stell (2000). In order to verify the presence of 
some genes, other primers were also used. On the other hand, phenotypic expression of 
the genes was verified through spot-inoculation of bacterial suspension or overnight 
culture of the samples in various agar plate preparations (i.e. blood agar for α-hemolysin, 
Congo red agar for curli and cellulose, agar with growth inhibiting strains for aerobactin 
and colicin) and agglutination tests using specific antibodies (i.e. for fimbrial expression). 
Moreover, the presence of the 1.2 kb cryptic plasmid and fimbrial gene deletion 
characteristic of E. coli 83972 were also determined using PCR. Finally, to analyze the 
genomic structure of the 83972 re-isolates, their genomic DNA was subjected to pulsed-
field gel electrophoresis (PFGE) after AvrII restriction. Further analysis of the re-isolates 
were done using motility assays, SDS-PAGE and Western Blot analysis, immuno dot 
blot, autoaggregation assay, biofilm assay, adhesion experiments, lipopolysaccharide 
(LPS) analysis, quantification of inflammatory markers secretion and expression, 
microarray experiments and qRT-PCR. 
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4.2.1. Genotypic and Phenotypic Analysis of the Re-isolates 
 
Determination of phylogenetic group, virulence-associated genes and phenotypic traits of 
the re-isolates was done in the same way as described for the ABU isolates and fecal 
isolates collected from healthy individuals. 
 
4.2.2. Verification of Re-isolates as 83972  
 
E. coli 83972 has two determining characteristics, the presence of the 1.2 kb cryptic 
plasmid and deletion within the type 1 fimbria gene cluster. For this reason, the re-
isolates were verified as 83972 by performing PCR amplifying these using primers 
pABU_for (5’-acatagatccctcatgcggtg -3’) and pABU_rev (5’-ctgcggtgttacagcgatgg-3’) 
and fim_for (5’-tctaatccgcatgctgagagc-3’) and fim_rev (5’-tgacctgtgcagtaccacgag-3’) for 
the cryptic plasmid and fimbrial gene deletion, respectively. In addition, the re-isolates 
were streaked out on Brilliance™ UTI Clarity™ agar (Oxoid) and MacConkey agar 
plates. Sequencing of the 16S rRNA was also done for verification in one re-isolate.  
 
4.2.3. Pulsed Field Gel Electrophoresis (PFGE) 
 
To determine the restriction pattern of the re-isolates, PFGE (Appendix 8.2.2) was 
performed. Bacterial samples were grown overnight in LB medium and mixed with 2 % 
low melting agarose gel. The gels were washed with TE buffer for 2 weeks until 
transparent. When ready, the gels were digested with AvrII (Finnzymes) for 1 h and and 
run on gel for 20 h.  
 
Digestion of agarose plugs containing DNA was done as follows: 
LGT agarose blocks containing the high molecular weight DNA were transferred into a 
new Eppendorf tube. Blocks were pre-incubated 1 h at 50 °C in 1 ml 1 × NEB buffer. 
Restriction was carried out for 3 h at 37 °C in a 150 µl overall reaction mixture 
containing 1 x restriction buffer and 30 U restriction enzyme. When recommended by 
manufacturer, BSA was added. 
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10 ×   NEB buffer 
  50 mM NaCl 
  10 mM Tris-HCl 
  10 mM MgCl 
  1   mM DTT 
 
4.2.4. Analysis of Motility and Flagellar Expression 
 
Motility Test 
 
Overnight cultures were stabbed into the middle of motility agar (0.3 %) plates through 
an inoculating needle. Plates were incubated for 16 h at 37 °C. Motility was then assessed 
by measuring the migration of the bacteria through the agar by zone of growth. Results 
are expressed (in mm) as the mean ± standard deviation of triplicate colonies from three 
independent experiments. 
 
Sodium dodecyl sulfate- Polyacrylamide gel electrophoresis (SDS-PAGE) and Western 
Blot 
 
Re-isolates that expressed motility on swarm agar plates (LB and urine) were further 
analyzed with regards to motility trait and flagellar expression.  First, bacterial cultures of 
the samples were prepared by growing overnight and standardized to OD600 = 0.1 the 
following day as starter culture. Bacteria were grown statically in pooled human urine in 
a 1:100 (bacterial inoculum: urine) ratio at 37 °C until they reached an OD600 = 0.3-0.4. 
The samples were centrifuged for 5 minutes at 4000 rpm and used for SDS-PAGE 
(Appendix 8.2.3). Following this, Western blot analyses (Appendix 8.2.4) of the samples 
were conducted using a polyclonal anti-serum raised against the flagellin of Legionella 
pneumophila. 
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4.2.5. Transcriptome analysis of the Re-isolates 
 
To analyze the role of increased motility and other traits of re-isolates BU04 63630, 
BU05 35364 and FIM 636 for the possible induction of host innate immune response, a 
transcriptome comparison upon in vitro growth of the re-isolates with that of the parent 
strain 83972 was conducted.  Expression profiling is a technique used to study the 
relative amounts of all transcripts at a given time of sample collection. This allows 
monitoring of the expression level of every single gene detectable by the array.  
 
Custom-tailored oligonucleotide glass microarrays (Operon Biotechnologies, Inc.) were 
used for expression profiling. A single Operon E. coli Custom 55156017 array contains 
10816 longmer oligonucleotide probes covering the complete genomes of six Escherichia 
coli strains (6 genomes and four plasmids). The number of open reading frames (ORFs) 
or genes represented is as follows: 4269 ORFs of non-pathogenic E. coli K-12 strain 
MG1655, 5306 ORFs of enterohemorrhagic E. coli O157:H7 strain EDL933, 5251 ORFs 
of enterohemorrhagic E. coli O157:H7 strain Sakai, 5366 ORFs of uropathogenic E. coli 
strain CFT073, 322 ORFs of uropathogenic E. coli strain 536, 448 ORFs of 
uropathogenic E. coli strain UTI89, 3 genes of EHEC plasmid OSAK1, 10 genes of 
EHEC plasmid pO157_Sakai, 97 genes of EHEC plasmid pO157_EDL933 and genes of 
UPEC plasmid pUTI89. In addition, the array also includes a number of positive and 
negative controls. Each probe contains an amino linker at the 5' end. Probes were spotted 
as single spots in 32 blocks (4 columns, 8 rows), each block with 18 columns x 19 rows.  
 
First, the samples were grown statically in pooled human urine at 37 °C until they reach 
mid-logarithmic phase. Samples were then treated with RNA Protect (Qiagen) followed 
by extraction of total RNA (Appendix 8.2.5). Next, traces of DNA were removed by 
RNAse-free DNAse treatment (Appendix 8.2.6). For probe synthesis, 10 µg of total RNA 
was reversed transcribed with direct incorporation of fluorescently-labelled nucleotides 
Cy3- and Cy-5-dCTP (Appendix 8.2.7). Following this, 160 pmol each of Cy3- and Cy5-
labelled probes were used for hybridization of oligonucleotide microarrays (Appendix 
8.2.8). The microarray hybridizations per strain pair were performed in triplicates.  
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Hybridized and washed slides were scanned using a GenePix Model 4000B Microarray 
Scanner (Axon Instruments Inc., USA) with a resolution of 5 µm pixel size. The 
excitation frequencies of the two lasers were 532 nm and 635 nm. The gain settings for 
the photomultiplier tubes were adjusted to use the entire dynamic range of the instrument 
and to get comparable fluorescence yields in both channels. Images of Cy3 and Cy5 
signals were recorded as 2 layer 16 bit TIFF files and analyzed using the GenePix Pro 6.0 
software. 
 
For each experiment, at least three independent hybridizations were performed, one with 
a dye switch. After removal of bad quality spots (if less than 70 % of foreground pixels 
were below background intensity plus 2 standard deviations in both channels or if the 
signal to noise ratio was below 3 in both channels or if the difference between ratio of 
medians and regression ratio exceeded 20 % in one of the channels) the remaining 
intensities were saved as gpr output data file. For statistical validation and further 
analysis the Acuity 4.0 (Molecular Devices, USA) software was used. For all data, the 
local background was subtracted from the intensity values of each spot on the array and 
normalized by both linear ratio-based methods and non-linear Lowess including print-tip 
groups. For statistical significance, one sample t-test was applied and the resulting data 
set was exported to Microsoft Excel. Hierarchical clustering of genes for visualization of 
expression patterns was performed with the CLUSTER software (Eisen et al., 1998). The 
output was displayed with the software TREEVIEW (Eisen et al., 1998). 
 
For data analysis, a cut-off value of 1.7 was used although the commonly used threshold 
value is two-fold (DeRisi et al., 1997; Wildsmith and Elcock, 2001). Several studies have 
shown that a lower cut-off ranging from 1.4 to 1.74 can be used reliably if the results are 
reproducible in more replicates (Perez-Amador et al., 2001).  
 
Microarray results were then confirmed by real-time PCR analysis with selected 
candidate genes. 
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4.2.6. Quantitative Real-Time PCR 
 
To evaluate expression of single genes, a quantitative Real-Time PCR (qRT-PCR) 
approach was used. This method employs polymerase chain reaction to amplify gene 
transcripts in presence of the SYBR Green I dye (BioRad). This fluorescent dye 
intercalates into double stranded DNA and emits signals collected by the optical camera 
within the MyiQ cycler (BioRad). The number of cycles needed to reach a certain 
fluorescent signal threshold (CT) was used to calculate transcript levels. Primers for 
selected genes were designed using the FastPCR software (Ruslan Kalendar, Institute for 
Biotechnology, University of Helsinki, Finland) with the following parameters: product 
length range from 190 to 300 nt and annealing temperature 57 - 59 °C. Before their use 
for expression profiling, the different primer pairs were checked for amplification 
efficiency with pooled cDNA from different experiments. Only primer pairs with 
amplification efficiency of at least 90 % were used.  For copy number estimation, cDNA 
samples derived from the reverse transcription reaction were 100-fold diluted in dH2O 
and the reaction mix was prepared (for one reaction) as follows: 
 
12.0 µl  cDNA 
12.5 µl  SYBR Green Mix, 2 × 
0.25 µl  Primer 1 (10 µmol) 
0.25 µl  Primer 2 (10 µmol) 
 
The following thermal cycling profile was used: 
 
95 °C  3 min   
95 °C  30 sec   
60 °C   30 sec  (40 cycles) 
72 °C  20 sec   
95 °C – 57 °C 30 sec  (melting curve) 
 
All PCR reactions were done in triplicates in three independent experiments. 
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4.2.7. Cell Adhesion Assay 
 
Cell adhesion assays were conducted to compare the re-isolates with their parent strain 
83972 with regards to their interaction with human bladder epithelial cell line T24. First, 
the eukaryotic cells were seeded in 24-well tissue culture plates (2.2 x 105 cells/well) and 
incubated overnight at 37 °C and 5 % CO2. Meanwhile, 107 bacteria of an overnight 
culture were co-cultivated with the eukaryotic cells for 3 h. Citrobacter freundii 3009 
was used as positive control. After 3 washing steps with PBS (pH 7.4), the T24 cells were  
lysed in 0.1 % TritonX-100 for 15 min. Appropriate dilutions of the inoculum and cell 
lysates were plated on LB agar and incubated overnight at 37 °C. Colony forming units 
were counted the following day. 
 
4.2.8. IL-8 and IL-6 Concentrations 
 
IL-8 and IL-6 concentrations were measured using the Quantikine® Kit (R & D 
Systems). The kit works in the same way as sandwich Enzyme-linked Immunosorbent 
Assay (ELISA). Human kidney cells A498 were seeded in 24-well tissue culture plates 
(2.2 x 105 cells/well) and incubated overnight at 37 °C and 5 % CO2. Next, 107 bacteria 
of an overnight culture were co-cultivated with the eukaryotic cells for 3h. Cell culture 
supernates were collected, particles removed by centrifugation and diluted according to 
manufacturer’s protocol. The assay followed immediately or cell culture supernates were 
stored in aliquots at -20 °C until use in the assay. Absorbance was read in a microplate 
reader at 450 nm with a wavelength correction set to 550 nm.   
 
4.2.9. Autoaggregation Assay 
 
Five milliliters of each sample was grown in Lysogeny Broth (LB) medium during the 
day for 6h at 37 °C with shaking. Following this, 100 µl of the culture was grown in 5 ml 
LB overnight under the same conditions. The next day, the optical density of the samples 
was adjusted to OD600= 3 in 3 ml LB. Cultures were left standing overnight at room 
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temperature. The following day, optical density was measured at 600 nm to quantitate 
aggregation of cells at the bottom of the tube. 
 
4.2.10. Biofilm Assay in Urine 
 
Bacteria were grown overnight in LB medium at 37 °C with shaking. The following day, 
filter-sterilized pooled human urine was inoculated (1:100) with the overnight bacterial 
culture. Next, 160 µl of the inoculum was pipetted into 96-well U-bottom flexible plates 
(BD Falcon), 8x per sample. Plates were incubated statically at 37 °C for 48 h. 
Afterwards, the medium was removed and plates were washed twice with 1 % PBS 
followed by drying at 65 °C for 10 min. The plates were then stained with 0.1 % crystal 
violet for another 10 min. Next, plates were washed twice with 1 % PBS and dried at 65 
°C for 10 min. Absorbed crystal violet was eluted using 180 µl acetone-ethanol (1:5), 
pooled and diluted 1:10. Finally, optical density was measured at 580 nm. 
 
4.2.11. Polysaccharide Intercellular Adhesin (PIA) Immuno Dot Blot 
 
Polysaccharide intercellular adhesin (PIA) is a biofilm exopolysaccharide made of N-
acetylglucosamine that is found in many bacterial biofilm-forming pathogens. In order to 
detect its expression among the re-isolates, an immuno dot blot assay was performed. 
Overnight cultures of bacteria were grown and blotted onto a nitrocellulose membrane. 
The membrane was washed and PIA was detected using antibody raised against PIA in 
Staphylococcus aureus (Appendix 8.2.9).   
 
4.2.12. Growth Curve Experiment 
 
Growth of the bacterial isolates was compared to 83972 wt by growing them in LB and 
pooled human urine overnight and inoculating a 30 ml fresh medium the following day 
with the overnight culture. Optical density was measured at 600 nm every hour for 8 h 
and overnight. Experiment was repeated three times using different batches of urine.  
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4.2.13. Analysis of Lipolysaccharide Phenotype 
 
Bacterial cells were first grown overnight on agar plates. Next, the cells were scraped off 
from the agar plates, transferred into Eppendorf tubes and weighed. The cells were 
resuspsended in distilled water to a final concentration of 1 mg cells/30 µl. This is then 
mixed with 10 µl 4 x SDS sample buffer and incubated at 100 °C for 10 minutes. Next, 
the samples were briefly cooled prior to addition of 20 µl proteinase K (100 µg in 1X 
SDS sample buffer). The samples were then incubated at 60 °C for an hour. 30 µl of this 
was run on denaturing SDS gel overnight at 8 mA. Afterwards, the gel was stained with 
silver nitrate for visualization of bands (Appendix 8.2.10). 
 
4.3. Reconstitution of a functional papGX gene from CFT073 into the 
83972 chromosome 
  
4.3.1. Complementation of papGX gene 
 
A papGX-83972 deletion mutant (83972∆papGX) was generated using lamda red 
homologous recombination technique (Datsenko and Wanner, 2000).  Briefly, the cat 
casette of pKD3 was amplified using primers ES3 and ES4 (Section 3.2, Materials), with 
overhangs homologous to the 5´and 3´regions of the 83972 papGX gene. Next, the PCR 
product was purified using QIAquick PCR Product Purification Kit (Qiagen™) 
(Appendix 8.2.11) and transformed into electrocompetent 83972 cells carrying the pKD4 
plasmid. Transformants were subsequently screened using PCR and Southern Blot 
analysis.  
 
Meanwhile, 74-mer primers pKD3_papG_for and pKD3_papX_rev (Section 3.2, 
Materials) containing 50 bp overhangs complementary to a region in the pKD3 upstream 
of the chloramphenicol cassette were used to amplify the papGX fragment from CFT073 
(Phusion Polymerase, New England Biolabs™). The resulting PCR product was purified 
using QIAquick PCR Product Purification Kit (Qiagen™). Following this, plasmid pKD3 
was linearized by restriction with BmgBI (New England Biolabs™) for 1.5 h, followed by 
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a 30 min dephosphorylation with Antartic phosphatase (New England Biolabs™) at 37 
°C. The plasmid was then gel purified and precipitated using ethanol. This was co-
transformed with the papGX fragment into E. coli SW102 λ pir electrocompetent cells by 
electroporation. Selection of transformants was done on LB agar plate supplemented with 
chloramphenicol (20 µg/ml) at 30 °C. Screening for the correct clone was made by PCR 
and verified by sequencing. 
 
Next, primers F13 and F14b (Section 3.2, Materials) were used for the amplification of 
the papGX-cat construct in the pKD3 plasmid with homologous overhangs to the tnpA 
and papF regions of the 83972 chromosome (Phusion Polymerase, New England 
Biolabs™). The PCR fragment was gel-purified (Gel Extraction Kit, Qiagen™) 
(Appendix 8.2.11) and used for transformation into 83972∆papGX electrocompetent cells 
carrying the pKD46 plasmid via homologous recombination (Datsenko and Wanner, 
2000). 
 
Clones were screened using PCR and verified by sequencing. To test for fitness of the 
mutant strain, growth curve experiments (see 4.2.12) were performed. In addition, 
phenotypic assay for the presence of P-fimbriae (see 4.1.5) was also carried out.  
 
4.3.2. Mutant Curing from Antibiotic Resistance Cassette 
 
Electro-competent cells of the mutant strain were transformed with plasmid pCP20 
(Amp/Cm) and allowed to recover for 2 h by shaking. They were then plated on agar 
supplemented with antibiotics. Plates were incubated at 30 °C overnight. Four to eight 
colonies were picked from each plate and individually re-plated on Amp-agar followed 
by overnight incubation at 30 °C. This was repeated three consecutive times. Next, single 
colonies were plated on LB-agar and incubated overnight at 42 °C. Single colonies were 
picked from the 42 °C culture and plated on LB-agar followed by overnight incubation at 
37 °C. Finally, single colonies were plated on Amp, Cm, Kan and LB-agar and incubated 
overnight at 37 °C.  
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4.3.3. Southern Blot Analysis 
 
For verification of the mutants, Southern Blot hybridization and analysis was performed. 
First, chromosomal DNA was isolated. Following this, the DNA was hybridized to a 
membrane, probed with a specific PCR product and detected by chemiluminescence on 
an X-ray film (Appendix 8.2.12).   
 
4.3.4. Plasmid and Chromosomal DNA Isolation  
 
Bacterial samples were grown overnight. Following this, plasmid was isolated using the 
QIAGEN Plasmid Midi Kit (Qiagen™) (Appendix 8.2.13). On the other hand, 
chromosomal DNA was isolated by using phenol with prior treatment with lysozyme and 
proteinase K (Appendix 8.2.14).  
 
4.3.5. DNA Sequencing 
 
Verification of transformants on plates following electroporation was carried out by DNA 
sequencing. The following components and program are used for the sequencing 
reaction: 
Sequencing Reaction Mix 
0.5 µl  DNA 
2 µl     5 x Buffer 
2 µl     Premix 
1 µl     Primer 
4.5 µl  dH2O 
 
Sequencing PCR Program 
94 °C  3 min 
94 °C  30 sec 
58 °C  15 sec          
60 °C   4 min * go back to step 2 and repeat 34 times 
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The following components were mixed in a 1.5 ml Eppendorf tube following sequencing 
reaction: 
10 µl   Sequencing reaction 
80 µl   ROTIPURAN®  Low organic  water (Roth ™) 
10 µl  3 M Sodium acetate, pH 4.8 
250 µl 100% ethanol (Roth ™) 
 
The mixture is then centrifuged for 15 min at 13000 rpm, room temperature (RT). The 
supernatant was removed and the pellet was dried. This was followed by washing with 70 
% ethanol then vortexing. Next, it was centrifuged for 5 min at 13000 rpm, RT. Again, 
the supernatant was removed and the pellet was dried. Afterwards, this was centrifuged 
for 5 min at 13000 rpm, RT to dry completely. Finally, 25 µl HiDi Formamide was 
added. This was then loaded into the sequencing machine. Data were analyzed using the 
Vector NTI® software (Invitrogen). 
4.3.6. Preparation of Electro-competent Cells 
 
For recombination experiments, electro-competent cells were prepared by inoculating 50 
ml of LB medium with 500 µl fresh overnight culture of bacteria. The cells were grown 
(and induced with arabinose when necessary) with vigorous shaking at the appropriate 
temperature until they reach an optical density (OD600) = 0.7. Next, the cells were 
harvested by centrifugation in a cold rotor at 4000 x gmax for 15 min after chilling on ice 
for 15 min. The cells were washed three times with ice cold water after which they were 
resuspended in 1 ml cold 10 % glycerol. Finally after centrifugation, the cells were 
resuspended in 150 µl cold 10 % glycerol and aliquots of 40 µl were pipetted into 1.5 ml 
Eppendorf tubes. 
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4.3.7. Preparation of Glycerol Stocks of Bacterial Strains 
 
To make conserve stocks of bacterial strains, overnight cultures of the bacteria were 
grown. Then, to 1 ml of the culture, 300 µl of 87% glycerol was added and mixed. 
Finally, the stocks were stored at -20°C until use. 
 
4.3.8. Digestion of DNA with Restriction Endonucleases 
 
 
DNA was dissolved in dH2O and mixed with 0.2 vol 10 x reaction buffer and 1 U of 
restriction enzyme per 1 µg of DNA. The final volume of the sample was 15 µl for 
plasmid DNA and 50 µl for genomic DNA. The reaction mixture was incubated at 37 °C 
depending of the specific requirements of the enzyme (stated by supplier).  Plasmid DNA 
was digested for one to two hours and genomic DNA at least for three hours, or 
eventually overnight. When appropriate, the reaction mix was stopped by heat 
inactivation (20 min at 65 °C). 
 
4.4. In silico analysis 
 
For standard sequence comparison and similarity searches, the Basic Local Alignment 
Search Tool (BLAST) at the National Center for Biotechnology Information (NCBI) 
homepage was used. For alignments of nucleotide and amino acid sequences, the BioEdit 
sequence alignment editor V7.0.1 and Vector NTI V7.0 were used. Genome comparison 
was performed using the Artemis Comparison Tool (ACT) Release 4 of the Sanger 
Institute. 
4.5. Statistical analysis 
 
Comparisons of χ2 P value between the ABU and fecal group of isolates were done using 
SPSS statistical software. Differences in IL-6 and IL-8 secretions among the re-isolates 
were compared using ANOVA.  
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Figure 5. ECOR Grouping of the various isolates.                            
FN- fecal isolates. 
5. Results 
 
5.1. Pheno- and genotypic characterization of ABU isolates and fecal 
isolates from healthy individuals  
 
In characterizing various isolates, it is important to have a look at virulence factors since 
they play a major role in the induction of host response. Thus, the presence of various 
virulence genes and their phenotypic expression were tested among 74 ABU and 39 fecal 
isolates in a strain collection from Lund, Sweden. Although this study deals more on 
ABU isolates, fecal isolates were included to ascertain the relatedness of ABU to 
commensal isolates due to the former’s commensal-like behavior.    
 
5.1.1. Phylogenetic Classification  
 
To find out whether ABU isolates are more related to pathogenic or commensal isolates, 
a triplex PCR was performed. E. coli strains fall into four main phylogenetic groups (A, 
B1, B2, and D) (Clermont et al., 2000). Results show that among the 74 ABU isolates 
studied, 51 % and 5 % belong to Groups B2 and D which are groups that typically 
include virulent extra-intestinal strains, respectively, whereas 38 % and 5 % belong to 
typical commensal ECOR Groups A and B1, respectively (Figure 5). This shows that 
more than half of all the ABU isolates included in the study are related to a typical 
pathogenic group. 
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In addition to ECOR phylogenetic classification, multi-locus sequence typing (MLST) 
was also carried out in collaboration with the Institute for Hygiene (University of 
Münster) according to the MLST system established by Mark Achtman using seven 
housekeeping genes namely adk (adenylate kinase), fumC (fumarate hydratase), gyrB 
(DNA gyrase), icd (isocitrate/isopropylmalate dehydrogenase), mdh (malate 
dehydrogenase), purA (adenylosuccinate dehydrogenase) and recA  (ATP/GTP binding 
motif). 
Results show that ABU isolates belong to multiple clonal groups. With a few exceptions, 
ABU and fecal isolates belong to different clonal lineages.  ABU isolates are frequently 
clustered within clonal complex (CC)73 and CC10. Some others belonged to CC14 and 
sequence type (ST)53. ABU isolates were also found to share the same cluster as the 
fecal isolates in ST59 and ST95 (Figure 6).   
 
A study by Wirth et al. (2006) showed that UTI strains as well as those with 
O25:H1/O6:H1 serotype clustered in CC73. On the other hand, those which mostly 
belong to phylogenetic group A as well as a few entoinvasive/entoaggregative E. coli 
(ETEC/EAEC) pathogens were grouped under CC10. Meanwhile, CC14 was majorly 
comprised of UPEC and UTI  strains whereas CC95 was found to be composed of a 
combination of APEC, sepsis/UTI/neonatal bacterial meningitis (NBM), O1/O2/O18:K1 
and OMP 6/9 strains. 
 
As shown in Figure 6, no strict separation in clustering within clonal complexes can be 
observed between ABU and fecal isolates as they were both sometimes found within the 
same complex.  
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Figure 6. Minimum spanning tree (SeqSphere) based on MLST analysis (Achtman). 
Major sequence types and clonal complexes are indicated by boxes. 
 
ABU 
Fecal 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.1.2. Distribution of Virulence Factors 
 
A series of multiplex and single PCRs were perfomed using primers previously used by 
Johnson and Stell (2000). The prevalence of 30 defined virulence genes commonly 
associated with extra-intestinal pathogenic E. coli (ExPEC) was determined (Table 5). In 
addition, phenotypic assays that correspond to the expression of these genes were also 
conducted (Table 6). 
 
5.1.2.1. Genotypic Traits  
 
Toxin Genes 
 
Of the three exported virulence factors studied, namely hlyA (α-hemolysin), cnf1 
(cytotoxic necrotizing factor) and cdtB (cytolethal distending toxin), ABU isolates 
harbored only hlyA and cnf1. The toxin encoded by the cnf1 gene interferes with 
polymorphonuclear phagocytosis and evokes apoptotic death of bladder epithelial cells 
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α-Hemolysin    hlyA     cnf1      cdtB Colicins 
A 
  Aerobactin   iutA  fyuA   iroN 
B 
* * 
Figure 7. (A) Toxin genes (B) Genes involved in iron-uptake. FN- fecal isolates. Significant difference 
between ABU and FN is indicated by an asterisk (p <0.05). 
 
(Fiorentini et al., 1997). Fecal isolates, in comparison, were found to have only the hlyA 
gene. None of the isolates, however, were found to have the cdt gene which encodes for a 
toxin that causes apoptosis of host cells (Emődy et al., 2003) (Figure 7A). The hlyA gene, 
encoding a pore-forming toxin (Emődy et al., 2003), was more prevalent among ABU 
than fecal isolates with 20.27 % of them harboring the gene versus 2.56 % among fecal 
isolates.  
 
 
 
 
 
 
 
 
 
 
Siderophore Systems 
 
During growth under iron-limiting conditions, bacterial mechanisms are required to 
compete successfully for iron in the host. Low molecular weight siderophores like 
aerobactin, enterobactin and yersiniabactin are involved in this process (Guerinot, 1994; 
Braun et al., 1998; Schubert et al., 2002). Siderophores are responsible for iron uptake 
and transport. Free iron is very limited in the human urinary tract. Due to this, there is a 
tight competition between the host and infectious bacteria for this essential element. 
 
The presence of three siderophore genes namely fyuA (yersiniabactin), iutA (aerobactin 
receptor; inorganic iron transport and metabolism) and iroN (salmochelin receptor and 
adhesin) was tested for all the isolates. Results showed that the yersiniabactin gene 
cluster was more prevalent in ABU isolates (44.6 %) compared to their fecal counterparts 
(p = 0.002). The fyuA gene, encoding the yersiniabactin receptor, is one of the most 
upregulated genes in biofilm. It is highly important for biofilm formation in iron-poor 
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Figure 8. K capsule genes present among the isolates. FN- fecal isolates. 
Significant difference between ABU and FN is indicated by an asterisk (p <0.05). 
 
kpsMT K1   kpsMT K5 K5 capsule kpsMT II kpsMT III 
environments such as human urine (Hancock et al., 2008). Only 23 % of the ABU 
isolates, however, had the iroN gene compared to 43.6 % of the fecal isolates (p = 0.024) 
(Figure 7B).  
 
Capsules 
 
Polysaccharide capsules make up the outermost layer of the cell. Hence, it may mediate 
direct interactions between the bacterium and its immediate environment and has been 
implicated as an important factor in the virulence of many animal and plant pathogens. 
They are known to function in prevention of cell desiccation, adherence and resistance to 
both specific and non-specific host immunity (Roberts, 1996). There are several groups 
of K capsules. In this study, the presence of two K capsule groups, group II and group III,   
was determined through the presence of the kpsMT genes which make up the third of the 
three regions of the K capsule determinants. K1 and K5 are capsular types under group II.  
 
In the investigation of the presence of capsules, it has been found that 47.30 % of the 
ABU isolates and 30.77 % of the fecal isolates have group II capsules. 35.14 % of the 
ABU isolates harbored the gene for K5 capsule which is frequently associated with 
symptomatic UTI (Herias et al., 1997).  
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Type 1 fim  fimH      S fim  sfa/focDE  sfaS focG 
* 
* 
* 
A 
P fim papAH papEF papC 
B 
Figure 9. Fimbrial genes present in the various isolates. (A) Fimbrial genes (B) P-fimbrial genes. 
FN- fecal isolates. Significant difference between ABU and FN is indicated by an asterisk (p <0.05). 
Fimbriae 
 
Fimbriae, located at the surface of the cell, are very important inducers of host response. 
Presence of the fimH gene which encodes the mannose-specific adhesion sub-unit of type 
1 fimbria, the adhesin genes focG/sfaS of the sfa/foc operon encoding for F1C/S fimbria 
and genes encoding for some regions of the pap operon encoding for P fimbria in the 
various isolates had been determined. Data show that most of the isolates harbored the 
fimH gene (87.84 % ABU and 92.31 % fecal) and was thus the most prevalent virulence 
gene in both groups. Meanwhile, more ABU isolates had the sfaS gene (13.52 % versus 
2.56 % for fecal isolates). In addition, only 2.56 % of the fecal isolates harbored the 
sfa/focDE and focG genes. With regards to P-fimbria, 28.38 %, 29.73 % and 28.38 % of 
the ABU isolates harbored the papAH, papEF and papC genes versus 15.38 %, 15.38 % 
and 12.82 % in the fecal isolates, respectively.  
 
 
 
 
 
 
 
 
 
* 
* * * 
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Miscellaneous Virulence Genes 
 
Other genes included in the multiplex PCR reaction included a pathogenicity island (PAI) 
marker malX, cvaC (colicin V), ibeA (brain microvascular endothelial cell invasion), 
bmaE (M-agglutinin), rfc (participates in O4 LPS biosynthesis), traT (contributes to 
serum survival), gafD (N-acetyl-D-glucosamine-specific fimbrial lectin) and afa/draBC 
(afimbrial adhesin). Most of them were more prevalent among ABU isolates except 
bmaE and rfc, which were both more prevalent in fecal isolates (p = 0.001).  
  
 
 
 
 
 
 
 
 
 
 
All genes included in the PCR were found among the ABU isolates whereas cnf1 
(cytotoxic necrotizing factor), papG alleleI, papG alleleIII, papGI (papG fimbrial 
adhesin), sfa/focDE, focG, gafD and afa/draBC were not found among the fecal isolates.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Miscellaneous virulence genes. FN- fecal isolates. Significant 
difference between ABU and FN is indicated by an asterisk (p <0.05). 
  
  * 
* 
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Table 6. Distribution of Virulence Genes among ABU and Fecal Isolates 
Gene                ABU (n = 74)             Fecal (n = 39)              p-value* 
       n (%)                    n (%)    
 
hlyA     15 (20.27)  1 (2.564)  0.324 
 
cnf1    3 (4.05)   0 (0)   0.080 
 
cdtB    5 (6.8)   1 (2.56)   0.345 
 
iutA    14 (18.92)  6 (15.38)  0.054 
 
fyuA    33 (44.6)  6 (15.4)   0.002 
 
fimH    65 (87.84)  36 (92.31)  0.0 
 
papAH    21 (28.38)  6 (15.38)  0.001 
 
papEF    22 (29.73)  6 (15.38)  0.001  
 
papC     21 (28.38)  5 (12.82)  0.001 
 
papG allele I   2 (2.70)   0 (0)   0.300 
 
papG allele II   15 (20.27)  4 (10.26)  0.007 
 
papG allele III   5 (6.8)   0 (0)   0.023 
 
papG I    5 (6.8)   0 (0)   0.097 
 
papG II,III   10 (13.51)  1 (2.56)   0.005 
 
sfa/focDE   12 (16.22)  1 (2.56)   0.001 
 
sfaS    10 (13.52)  1 (2.56)   0.435 
 
focG    6 (8.11)   0 (0)   0.047 
 
kpsMT K1   8 (10.81)  3 (7.69)   0.463 
 
kpsMT K5   26 (35.14)  9 (23.08)  0.081 
 
kpsMT II   35 (47.30)  12 (30.77)  0.192 
 
kpsMT III   2 (2.703)  1 (2.56)   0.965 
 
malX    19 (25.68)  8 (20.51)  0.541 
 
cvaC    5 (6.76)   1 (2.56)   0.345 
 
ibeA    7 (9.46)   3 (7.69)   0.190 
 
bmaE    4 (5.41)   11 (28.2)  0.001 
 
rfc    2 (2.703)  9 (23.08)  0.001 
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Table 6. - Continued 
Gene               ABU (n = 74)          Fecal (n = 39)              p-value* 
        n (%)                 n (%)    
 
traT    11 (14.9)  2 (5.13)   0.123 
 
gafD    2 (2.703)  0 (0)   0.302 
 
afa/draBC   4 (5.41)   0 (0)   0.141 
 
iroN    17 (23)   17 (43.6)  0.024 
 
*Pearson’s Uncorrected Chi-Square Test 
 
 
5.1.2.2. Phenotypic Traits 
 
To complement investigation of virulence genes present among the isolates, phenotypic 
tests were also conducted. Among these were tests for hemolysis, aerobactin and colicin 
production, K5 phage lysis, ability to bind Congo red dye, and agglutination tests.  
 
Hemolytic Activity 
 
To check the ability of the isolates to express α-hemolysin, they were plated on sheep 
agar plates. Growth on the plates indicated that not all isolates that harbored the hlyA 
gene were able to lyse erythrocytes. 66.67 % of the ABU isolates that harbored the hlyA 
gene and 100% of the fecal isolates express α-hemolysin (Figure 7A; Table 7). 
 
Iron Uptake 
 
The isolates were grown on plates containing bacterial strain LG1522 to look at their 
ability to produce aerobactin. The presence of growth zones of LG1522 around the 
colonies indicated a positive result. In the same way that not all those that harbored the 
gene for α-hemolysin expressed it, not all the isolates that harbored the iutA gene, both 
for ABU and fecal groups, were shown to produce aerobactin, i.e. only 64.29 % and 
83.33 % of them, respectively (Figure 7B; Table 7). 
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Colicin Production 
 
Colicins are bacterial toxins that kill E. coli and related cells (Gökçe and Lakey, 2003). 
To look at colicin production among the isolates, they were grown on plates containing 
indicator strain DH5α. The presence of zones of inhibition around colonies of tested 
strains indicated colicin production. Results show that 40.5 % of ABU isolates were able 
to produce colicins that kill indicator strain DH5α whereas 33.3 % of fecal isolates did.  
 
K5 lysis  
 
An assay whereby a K5 bacteriophage lysate (kindly provided by Ian Roberts, University 
of Manchester) could be used to lyse bacterial cells to show expression of K5 capsule 
was conducted. If the cells were lysed, it meant that the bacteria contained binding sites 
recognized by the K5 bacteriophage and were thus positive for K5 capsule to which the 
K5-specific bacteriophages bound. Of the 26 (35.14 %) ABU isolates that harbored the 
kpsMTK5 gene, only 6 (8.10 %) were able to express K5 capsule as shown by the lysis 
assay (Figure 8; Table 7).  
 
Fimbrial and Cellulose Expression  
 
Fimbriae facilitate the colonization of the urinary tract and promote E. coli colonization 
and persistence in the colon or vagina which acts as reservoir for ascending infection in 
the urinary tract. Of all the three major types of fimbriae (type 1, S- and P-fimbria), type 
1 fimbria was the most common in pathogenic and even less virulent strains. It enhances 
bacterial survival, stimulates mucosal inflammation and promotes bacterial invasion. P 
fimbria, on the other hand, is recognized as a key determinant in promoting the virulence 
of E. coli in UTI.  
 
In this study, results showed that 69.23 % of ABU isolates expressed type 1 fimbria, 
making it one of the most highly expressed virulence traits. This is in affirmation to PCR 
results showing that fimH, encoding for this fimbria, was the most common of all the 
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virulence genes tested in ABU. S-fimbriae were also commonly expressed among ABU 
as well as the the fecal isolates that harbored any of the genes encoding for S-fimbriae 
(55.56% and 100%, respectively). Finally, only 14.29 % of the ABU isolates and 66.67 % 
of the fecal isolates that harbored any of the genes encoding for P-fimbriae functionally 
expressed P-fimbria as shown by agglutination tests using yeast cells and antibodies 
raised against the fimbriae (Figure 9; Table 7).  
 
Meanwhile, the bacterial isolates were also grown on Congo red agar to determine curli 
fimbriae and cellulose production. The assays revealed that 62.16 % of ABU produced 
curli and 43.24 % expressed cellulose while 71.79 % of the fecal isolates produced curli 
and 56.41 % manifested cellulose production at room temperature. On the other hand, 
35.13 % of ABU produced curli and 75.67 % expressed cellulose while 35.89 % and 
53.84 % fecal isolates produced curli and cellulose respectively at 30 °C. Finally, 95.94 
% of ABU expressed curli at 37 °C as compared to 30.77 % among the fecal isolates and 
71.79 % of ABU and 12.16% fecal isolates manifested cellulose production (Figure 11; 
Table 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Curli fimbriae and cellulose expression detected by growth on Congo red 
agar at room temperature (RT), 30 °C and 37 °C. FN- fecal isolates. Significant difference 
between ABU and FN is indicated by an asterisk (p <0.05). 
RT 30°C 37°C 
  * 
* 
* 
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Table 7. Phenotypic Characteristics of ABU and Fecal Isolates 
 
Phenotype                  ABU                                Fecal                             p-value* 
       n**      n (%)  n**          n (%)    
 
α-Hemolysin     15  10 (66.67) 1 1 (100)   0.486 
  
Aerobactin     14  9 (64.29) 6 5 (83.33)  0.394 
 
Colicins     30 (40.5)  13 (33.3)  0.453 
  
Type 1 fimbria     65  45 (69.23) 36 31 (86.11)  0.060 
 
P- fimbria     21***  3 (14.29) 6*** 4 (66.67)  0.010 
 
S-fimbria       9***  5 (55.56) 1*** 1 (100)   0.389 
 
K5 Capsule     26  6 (8.108) 9 3 (7.692)  0.544 
 
Curli Fimbriae RT   46 (62.16)  28 (71.79)  0.306 
 
30°C   26 (35.13)  14 (35.89)  0.936 
 
37°C   53 (95.94)  12 (30.77)  0.000 
 
Cellulose RT   32 (43.24)  22 (56.41)  0.183 
  
30°C   56 (75.67)  21 (53.84)  0.018 
 
37°C   71 (71.79)  5 (12.16)  0.000 
 
 
 
 
 
 
5.2. Characterization of ABU re-isolates from symptomatic episodes  
 
In addition to the ABU isolates sampled from healthy individuals, eight other ABU 
isolates taken from patients stably colonized with E. coli 83972 as prophylactic treatment 
for recurring urinary tract infection were also characterized. Glycerol stocks of these 
eight re-isolates namely BU05 17629, BU05 42290, BU04 50907, BU04 41631, BU04 
63630, BU04 68088, BU05 35364 and FIM 636 were sent from the Lund University 
*Pearson’s Uncorrected Chi-Square Test 
** n = the number of isolates that harbor the gene for the phenotype. When not indicated, computation of 
percentage was based on the total number of isolates (i.e. ABU, n=74; FN, n=39). 
*** n = the mean number of the genes harbored by the isolates that correspond to the phenotype when 
there is more than one gene tested for the phenotype (e.g. for S fimbria -  sfaS/focDE, sfaS and focG). 
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Hospital, University of Lund, Sweden to the Institute for Molecular Infection Biology, 
University of Würzburg, Germany, as materials for characterization. These isolates were 
re-isolated from asymptomatically colonized patients that reported very rare cases of 
symptoms while undergoing prophylactic treatment.  
5.2.1. Phylogenetic Classification  
 
The eight re-isolates were primarily phylogenetically classified. According to results, 25 
% of the re-isolates namely BU05 17629 and BU05 42290 belonged to group A while the 
remaining 75 % belonged to group B2, the same group to which parent strain E. coli 
83972 belongs. 
5.2.2. Verification of Re-isolates as E. coli 83972 
 
To verify whether the eight re-isolates were ABU isolate 83972 or not, 20 colonies were 
randomly picked from overnight-grown samples on agar plate at 37 °C. Following this, 
all 20 colonies from each re-isolate were subjected to PCR to detect the presence of the 
cryptic plasmid and the internal deletion of the type 1 fimbrial gene cluster characteristic 
of the parent strain. Results showed that 75 % of them were positive for the PCR while 
25 %, namely BU05 17629 and BU05 42290, were not.  
In addition to PCR, the re-isolates were grown in chromogenic agar (Brilliance™ UTI 
Clarity™ agar (Oxoid)). Brilliance UTI Clarity Agar is a non-selective, differential agar 
which provides presumptive identification of the main pathogens which cause infection 
of the urinary tract. This medium contains two chromogenic substrates which are cleaved 
by enzymes produced by E. coli, Enterococcus spp. and coliforms. Of the two 
chromogens included in the medium, one is metabolized by β-galactosidase, an enzyme 
produced by E. coli, which yields pink colonies. The other is cleaved by β-glucosidase 
enzyme activity, allowing the specific detection of enterococci which form blue or 
turquoise colonies (http://www.oxoid.com/UK). 
All re-isolates produced a pink color on plate except BU05 17629 which grew as green 
colonies. This implied that BU05 17629 was a pseudomonad. On the other hand, BU05 
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Figure 12. Five BU04 50907 colonies 
growing almost transluscent and 
with morphology similar to small 
colony variants in chromogenic 
agar. 
A B 
Figure 13. Confirmation of the re-isolates as ABU isolate 83972. (A) 20 colonies of each re-isolate 
grown on MacConkey agar at 37 °C. (B) 20 colonies of each re-isolate grown on chromogenic agar at 
37 °C. (1) BU04 41631 and AS; (2) BU05 42290 and BU05 35364; (3) BU04 50907, BU04 63630 
and FIM 636; (4) BU04 68088. 
42290 even though not ABU isolate 83972, was E. coli. Moreover, interestingly, five of 
the 20 colonies of BU04 50907 grew as very small, transparent colonies in chromogenic 
agar (Figure 12) wherein E. coli should grow as pink colonies. In addition, they grew as 
very small colonies in sheep blood agar. To verify that they were E. coli, sequencing of 
the 16S rRNA region was done. The sequencing data obtained verified that these isolates 
were indeed E. coli.  
 
 
 
The re-isolates were also grown on MacConkey agar. MacConkey is known as an 
"indicator medium". It distinguishes the Gram-negative bacteria that can ferment the 
sugar lactose (Lac+) from those that cannot (Lac-). Lactose is utilized by the Lac+ ones 
producing acid which results in the appearance of red/pink colonies. On the other hand, 
Lac- ones cannot utilize lactose and this leads to the formation of white/colorless 
colonies. Except for BU05 17629, all re-isolates grew pink on MacConkey agar (Figure 
13). 
All those re-isolates confirmed to be E. coli 83972 were further investigated. 
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5.2.3. Morphology of the Re-isolates 
 
Growth of the re-isolates on different agar media showed that all of them, except BU04 
50907 and BU04 68088, exhibited homogeneous colony morphology with regards to size 
and appearance. The two aforementioned re-isolates exhibited heterogeneous colony 
morphology on agar plates. BU04 50907 grew relatively small, resembling small colony 
variants (SCV) or normal, resembling ABU isolate 83972 wt. BU04 68088, on the other 
hand, grew as small colonies, the size of which was bigger than BU04 50907 resembling 
SCV, or normal like ABU isolate 83972 wt. 
 
5.2.4. Genotypic and Phenotypic Analysis of the Re-isolates 
 
The re-isolates were characterized using standard genotypic and phenotypic assays. With 
the exception of aerobactin and colicin phenotypic assays, similar tests were performed 
for all re-isolates as done to those that belong to the isolates collection taken from healthy 
individuals. In addition, motility test was also conducted by observing swarming on soft 
agar. A summary of the various phenotypic and genotypic characteristics of the re-
isolates can be found in Tables 8 and 9. 
 
5.2.5. Virulence Genes 
 
E. coli 83972 harbors virulence genes characteristic of uropathogenic Escherichia coli 
(UPEC). However, it does not express most of these genes. PCR results showed that all 
re-isolates were similar to isolate 83972 wt in harboring the various virulence genes 
included in the PCR with the exception of BU05 17629 which did not harbor the fimH or 
any of the pap genes and was not at all E. coli. 
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Figure 14. Cellulose 
and curli fimbriae 
expression among the 
re-isolates. White 
background- Congo Red; 
Blue background- 
Calcofluor. 
5.2.6. Phenotypic Traits 
 
Curli Fimbria and Cellulose 
 
Based on the assay conducted, re-isolates BU04 63630, BU04 41631 and BU05 35364 
produced cellulose at 37 °C while BU04 68088 and BU04 50907 expressed both curli 
and cellulose. On the other hand, BU04 63630, BU04 68088 and FIM 636 manifested 
cellulose production at 30 °C. To verify the results of the Congo red assay, the re-isolates 
were also grown on calcofluor (fluorescent brightener 28) plates. FIM 636 was positive 
for cellulose production at 30 °C (Table 9; Figure 14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Autoaggregation Assay 
 
Autoaggregation is the cell-cell interaction of bacteria belonging to the same strain 
(Khemaleelakul et al., 2006). The ability of bacterial cells to autoaggregate is important 
in establishing biofilms and is thus a known virulence trait. To find out whether the re-
Results 
 
-71- 
Figure 15. Autoaggregation of re-isolates in LB medium. BU05 13813 is an asymptomatic re-isolate 
used for control. 
Figure 16. Biofilm formation among the different re-isolates in pooled human urine at 37 °C.                     
(A). Biofilm formation of the tested isolates standardized to that of ABU isolate 83972 wt. (B) Biofilm 
formation in pooled human urine. Results significantly different from ABU isolate 83972 wt are indicated by 
an asterisk. (p <0.05). Error bars shown are standard deviations of three independent experiments. AS is an 
asymptomatic re-isolate. 
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isolates have the ability to autoaggregate, they were grown on LB medium and left 
overnight at room temperature. The following day, the appearance of the cells as a result 
of clumping together was observed. The assay conducted showed that there was no 
difference among the re-isolates and ABU isolate 83972 wt with regards to their ability to 
autoaggregate in LB medium (Figure 15). 
 
 
 
 
 
 
 
 
Biofilm Assay in Urine 
 
Based on the assays conducted BU04 41631, BU04 63630 (clones 1 and 14) and FIM 636 
(clones 8 and 9) could form biofilm equal to ABU isolate 83972 wt. On the other hand, 
all the other re-isolates could form less biofilm (Figure 16). 
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Figure 17. Detection of the poly-GlcNAc extracellular polysaccharide by 
immuno-blot of the different re-isolates using antiserum against PIA in 
Staphylococcus aureus raised in rabbit. Staphylococcus strains RP62A and TM 
300 were used as positive and negative controls, respectively. 
Polysaccharide Intercellular Adhesin (PIA) Immuno Dot Blot 
 
The polysaccharide intercellular adhesin (PIA) is a biofilm-related exopolysaccharide 
made of N-acetylglucosamine that is found in staphylococci and many other bacterial 
biofilm-forming pathogens (Vuong and Otto, 2008). In E. coli, this β-1,6-GlcNAc 
polysaccharide promotes surface binding, intercellular adhesion, and biofilm formation 
(Wang et al., 2004). For quantification of PIA among the eight re-isolates immuno dot 
blot assay was conducted. Results show that only the motile re-isolate BU05 35364 
produced more PIA than ABU isolate 83972 wt (Figure 17).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lipopolysaccharide (LPS) 
 
Isolation of lipopolysaccharide (LPS) from cells grown on agar plates revealed that all re-
isolates exhibited a rough LPS phenotype similar to ABU isolate 83972 wt. The intensity 
of the bands produced by the re-isolates was also similar to the parent isolate. Rough LPS 
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Figure 18. Phenotypic analysis 
of lipopolysaccharide among the 
various re-isolates using silver 
nitrate staining. 
 
has shorter or no O-side chain. On the other hand, smooth LPS has full-length O-side 
chains, such as in case of UPEC strain 536. In this study, all re-isolates expressed no 
longer O-side chain and thus exhibited a similar LPS phenotype as isolate 83972 wt 
(Figure 18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
K5 Phage Lysis 
 
Capsules inhibit the opsonizing activities of complement, decreasing the elimination by 
phagocytes, or escape the immune response by mimicking host molecules thereby 
increasing bacterial virulence (Bayer and Bayer, 1994; Boulnois and Roberts, 1990; 
Cross et al., 1990). The E. coli K1 and K5 capsules are frequently found among isolates 
causing extraintestinal infections. K1 is more commonly associated with neonatal 
septicemia and K5 with sepsis and urinary tract infection (Cross et al., 1990). ABU 
isolate 83972 wt and all the re-isolates except BU04 63630 and BU05 35364 were found 
to express K5 capsule by lysing of cells with a K5 bacteriophage lysate (Figure 19). 
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Figure 19. K5 lysis assay using K5 bacteriophage lysate.               
E. coli Nissle (EcN) 1917 was used as positive control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of Motility and Flagella Expression 
 
Expression of flagella is one of the virulence traits of UPEC. Therefore, to analyze 
whether or not this UPEC trait is expressed in the 83972 re-isolates, motility tests on soft 
LB or urine agar followed by confirmation by SDS-PAGE and Western Blot analysis 
were done.  
 
Motility Test 
 
Among the six re-isolates tested on soft agar, three re-isolates stood out with regards to 
motility expression. Marked motility was observed in BU04 63630, BU05 35364 and 
FIM 636. Eighteen out of 20 colonies of BU04 63630 were found to be more or as 
equally motile than/as that of E. coli 83972 wt. On the other hand, all 20 colonies of 
BU05 35364 were found to be either equally or more motile as/than ABU isolate 83972 
wt. Finally, FIM 636 displayed a mixture of less, equally and more motile colonies 
compared to the parent strain (Figure 20 and Tables 7A-C). An average of 32 % of the 
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Figure 20. Motility on urine plates. The swarming ability of the re-isolates varied from 
being non-motile, less motile, equally motile and more motile compared to ABU isolate 
83972 wt. 
colonies tested for FIM 636 were found to be more motile in urine and LB agar compared 
to ABU isolate 83972 wt.  
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Table 8. Average Swarming Diameter of Motile Re-isolate BU04 63630 
 
Clone Motility (mm)       Comparison with      Motility (mm)                  Comparison with 
                 Urine agar  ABU isolate 83972 wt*          LB agar              ABU isolate 83972 wt* 
 
1       34   ↑   18   ↓ 
 
2       10   ↓   5   ↓ 
 
3       43   ↑   23   ↓ 
 
4       16   =   28   ↑ 
 
5       43   ↑   48   ↑  
 
6       25   ↑   15   ↓ 
 
7       43   ↑   45   ↑  
        
8       44   ↑   48   ↑ 
 
9       56   ↑   38   ↑ 
 
10       26   ↑   30   ↑ 
 
11       37   ↑   25   = 
 
12       39   ↑   25   = 
 
13       55   ↑   48   ↑ 
 
14         4   ↓   10   ↓ 
 
15       46   ↑   43   ↑  
  
16       35   ↑   45   ↑ 
 
17       58   ↑   38   ↑ 
 
18       39   ↑   43   ↑ 
 
19       58   ↑   35   ↑ 
 
20       31   ↑   28   ↑ 
 
 
*Values for ABU isolate 83972: Urine = 16 mm; LB= 25 mm. ↑ refers to an increased motility, ↓ refers to 
a decreased motility, = refers to equal motility with respect to ABU isolate 83972 wt. 
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Table 9. Average Swarming Diameter of Motile Re-isolate BU05 35364 
 
Clone Motility (mm)       Comparison with      Motility (mm)                  Comparison with 
                 Urine agar  ABU isolate 83972 wt*          LB agar              ABU isolate 83972 wt* 
 
1       37   ↑   55   ↑ 
 
2       57   ↑   65   ↑ 
 
3       49   ↑   40   ↑ 
 
4       53   ↑   60   ↑ 
 
5       48   ↑   65   ↑  
 
6       54   ↑   68   ↑ 
 
7       50   ↑   65   ↑  
        
8       52   ↑   58   ↑ 
 
9       41   ↑   65   ↑ 
 
10       42   ↑   53   ↑ 
 
11       24   ↑   65   ↑ 
 
12       39   ↑   65   ↑ 
 
13       45   ↑   63   ↑ 
 
14       41   ↑   42   ↑ 
 
15       35   ↑   50   ↑  
  
16       49   ↑   49   ↑ 
 
17       33   ↑   47   ↑ 
 
18       35   ↑   60   ↑ 
 
19       43   ↑   48   ↑ 
 
20       16   =   48   ↑  
         
 
*Values for ABU isolate 83972: Urine = 16 mm; LB= 25 mm. ↑ refers to an increased motility, ↓ refers to 
a decreased motility, = refers to equal motility with respect to ABU isolate 83972 wt. 
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Table 10. Average Swarming Diameter of Motile Re-isolate FIM 636 
 
Clone Motility (mm)       Comparison with      Motility (mm)                  Comparison with 
                 Urine agar  ABU isolate 83972 wt*          LB agar              ABU isolate 83972 wt* 
 
1        4   ↓   31   ↑ 
 
2        4   ↓     0   ↓ 
 
3       17   ↑     0   ↓ 
 
4        6   ↓   44   ↑ 
 
5       15   ↓   29   ↑  
 
6       12   ↓   21   ↓ 
 
7       10   ↓   26   ↑  
        
8       23   ↑   41   ↑ 
 
9         7   ↓     0   ↓ 
 
10       26   ↑     0   ↓ 
 
11        5   ↓   18   ↓ 
 
12       11   ↓   15   ↓ 
 
13       11   ↓   28   ↑ 
 
14         9   ↓   18   ↓ 
 
15       12   ↓   30   ↑  
  
16         7   ↓   21   ↓ 
 
17       17   ↑   20   ↓ 
 
18         9   ↓   33   ↑ 
 
19       16   =     0   ↓ 
 
20       19   ↑   18   ↓  
 
 
*Values for ABU isolate 83972: Urine = 16 mm; LB= 25 mm. ↑ refers to an increased motility, ↓ refers to 
a decreased motility, = refers to equal motility with respect to ABU isolate 83972 wt. 
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Figure 21. Detection of flagellin in the 
motile re-isolates through Western Blot. 
Flagellin expressed in the different 83972 re-
isolates were detected using a polyclonal anti-
flaA serum raised in rabbits against the  
Legionella flagellin FlaA.  
 
SDS-PAGE and Western Blot 
 
Western Blot results showed that there was an increased amount of flagellin detectable in 
the more motile re-isolates (i.e. BU05 35364 and BU04 63630) compared to FIM 636 
which contained a mixture of colonies that are non-motile or only as equally motile as 
ABU isolate 83972 wt. As control, a fliC deletion mutant was constructed from ABU 
isolate 83972 wt using the lamda red homologous recombination technique (Datsenko 
and Wanner, 2000). The fliC gene encodes the flagellin protein which is the major 
component of the flagella. The deletion mutant generated a very faint band in the 
Western Blot assay (Figure 21). 
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Figure 22. Adhesion of re-isolates to T24 bladder cells. Standard (100%) was set for 
positive control Citrobacter freundii 3009. The Citrobacter strain possesses a high 
internalization capacity. In contrast, E. coli HB 101 is internalized only with a low number 
of bacterial cells and was used as negative control strain. The papGX mutant is E. coli 
83972 complemented with a functional papG gene from E. coli CFT073. Adhesion levels 
of the re-isolates were not significantly different from ABU isolate 83972 wt. Error bars 
shown are standard deviations of three independent experiments.  
 
Adhesion Assay 
 
Results of the adhesion assays showed that none of the re-isolates had the ability to 
adhere more to T24 bladder cells compared to ABU isolate 83972 wt (Figure 22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2.7. Restriction Pattern Analysis 
 
The genome structure of the re-isolates was further characterized through pulsed field gel 
electrophoresis (PFGE). The genomic AvrII restriction fragment pattern of all six re-
isolates proven by other tests to be ABU isolate 83972 were identical to that of ABU 
isolate 83972 wt (Figure 23). On the other hand, those that had been confirmed to be not 
E. coli 83972 show completely different genomic restriction profiles (Figure 24). 
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Figure 23. Comparison of the genomic fingerprints of the 
various re-isolates confirmed as ABU isolate 83972 using 
PFGE following digestion with AvrII. 
Figure 24. Genomic fingerprints of re-isolates confirmed not to 
be E. coli 83972 by PFGE following digestion with AvrII. BU05 
42290 was found to be E. coli but not ABU isolate 83972 and 
BU05 17629 was found to be Pseudomonas spp.. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2.8. Growth characteristics 
 
Analysis of growth in different media showed that all the re-isolates had relatively similar 
growth rates in urine as well as in LB compared to ABU isolate 83972 wt. Exceptions 
were BU04 50907-1 and BU04 50907-11 resembling small colony variants and BU04 
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Figure 25. Growth curve of the different re-isolates in urine at 37 °C. Different 
numbers following strain designations pertain to different colonies of the same re-
isolate (i.e. BU04 50907-1 is a normal-sized colony while BU04 50907-11 
resembles SCV. BU04 63630-1 is a motile colony while BU04 63630-14 is non-
motile. FIM 636-8 is more motile than E. coli 83972 wt while FIM 636-9 is non-
motile. FIM 636-4 is non-motile in urine agar but motile in LB agar). Data shown 
are average results of three independent experiments. 
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68088, a mixture of small and big colonies, which grew relatively slow (Figure 25). It is 
also interesting to note that re-isolate BU04 68088 did not grow at all in M63 medium. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           
 
R
es
ul
ts
 
 
-8
3-
 
   
   
   
 T
ab
le
 1
1.
 P
ri
m
ar
y 
ch
ar
ac
te
ri
st
ic
s 
of
 re
-i
so
la
te
s 
fr
om
 s
ym
pt
om
at
ic
 e
pi
so
de
s 
co
m
pa
re
d 
to
 p
ar
en
t s
tr
ai
n 
 S
am
pl
e 
ID
 
P
at
ie
nt
 
ID
 
C
hr
om
 A
ga
r 
pA
B
U
 
fi
m
 d
el
 
IL
-6
 
(p
g/
m
l)
 
IL
-8
 
(p
g/
m
l)
 
P
M
N
 
(x
10
4 )
 
R
em
ar
ks
 
A
B
U
 is
ol
at
e 
83
97
2 
w
t 
  
E
. c
ol
i 
+ 
+ 
- 
- 
- 
83
97
2 
B
U
05
 1
76
29
 
H
K
1 
P
se
ud
om
on
as
 
- 
- 
3 
37
8 
28
 
su
pe
ri
nf
ec
tio
n,
 
P
se
ud
om
on
as
 
B
U
05
 4
22
90
 
SN
1 
E
. c
ol
i 
- 
- 
36
 
27
81
 
69
 
E
. c
ol
i b
ut
 n
ot
 
83
97
2 
B
U
04
 5
09
07
 (C
lo
ne
 1
) 
B
JK
2 
E
. c
ol
i 
+ 
+ 
66
 
32
68
 
96
0 
83
97
2 
B
U
04
 5
09
07
 (C
lo
ne
 1
1)
 
B
JK
2 
E
. c
ol
i 
+ 
+ 
66
 
32
68
 
96
0 
83
97
2 
B
U
04
 4
16
31
 
IJ
2 
E
. c
ol
i  
+ 
+ 
18
 
47
06
 
24
0 
83
97
2 
B
U
04
 6
36
30
 (C
lo
ne
 1
) 
B
JK
3 
E
. c
ol
i 
+ 
+ 
10
7 
55
1 
80
0 
83
97
2 
B
U
04
 6
36
30
 (C
lo
ne
 1
4)
 
B
JK
3 
E
. c
ol
i 
+ 
+ 
10
7 
55
1 
80
0 
83
97
2 
B
U
04
 6
80
88
 
R
N
2 
E
. c
ol
i 
+ 
+ 
8 
43
1 
- 
83
97
2 
B
U
05
 3
53
64
 
B
O
2 
E
. c
ol
i 
+ 
+ 
30
0 
75
00
 
20
00
0 
83
97
2 
FI
M
 6
36
 (C
lo
ne
 4
) 
K
A
 
E
. c
ol
i 
+ 
+ 
41
 
98
2 
1.
39
E
+0
6 
 
83
97
2 
FI
M
 6
36
 (C
lo
ne
 8
) 
K
A
 
E
. c
ol
i 
+ 
+ 
41
 
98
2 
1.
39
E
+0
6 
 
83
97
2 
FI
M
 6
36
 (C
lo
ne
 9
) 
K
A
 
E
. c
ol
i 
+ 
+ 
41
 
98
2 
1.
39
E
+0
6 
 
83
97
2 
 *
D
at
a 
fo
r 
IL
-6
, I
L-
8 
an
d 
P
M
N
 le
ve
ls
 w
er
e 
pr
ov
id
ed
 b
y 
B
. W
ul
lt 
fr
om
 L
un
d,
 S
w
ed
en
. L
ev
el
s 
w
er
e 
de
te
ct
ed
 u
si
ng
 r
ou
tin
e 
E
LI
SA
 te
st
 o
n 
ur
in
e 
sa
m
pl
es
 
  f
ro
m
 p
at
ie
nt
s.
 D
iff
er
en
t n
um
be
rs
 fo
llo
w
in
g 
st
ra
in
 d
es
ig
na
tio
ns
 p
er
ta
in
 to
 d
iff
er
en
t c
ol
on
ie
s 
of
 th
e 
sa
m
e 
re
-i
so
la
te
. P
le
as
e 
se
e 
F
ig
ur
e 
25
. 
R
es
ul
ts
 
 
-8
4-
 
   
   
   
T
ab
le
12
. S
um
m
ar
y 
of
 g
en
ot
yp
ic
 a
nd
 p
he
no
ty
pi
c 
ch
ar
ac
te
ri
st
ic
s 
of
 th
e 
re
-i
so
la
te
s 
Sa
m
pl
e 
ID
 
E
xP
E
C
 
P
C
R
 
A
ut
oa
gg
re
ga
ti
on
 
M
ot
ili
ty
* 
B
io
fi
lm
* 
K
5 
ca
ps
ul
e 
P
IA
 
C
el
lu
lo
se
 
C
ur
li 
A
B
U
 is
ol
at
e 
83
97
2 
w
t 
+ 
+ 
+ 
+ 
+ 
- 
30
°C
 
30
°C
 
B
U
05
 1
76
29
 
n/
a 
n/
a 
n/
a 
n/
a 
n/
a 
n/
a 
n/
a 
n/
a 
B
U
05
 4
22
90
 
n/
a 
n/
a 
n/
a 
n/
a 
n/
a 
n/
a 
n/
a 
n/
a 
B
U
04
 5
09
07
 (C
lo
ne
 1
) 
+ 
+ 
- 
- 
+ 
- 
37
°C
 
37
°C
  
B
U
04
 5
09
07
 (C
lo
ne
 1
1)
 
+ 
+ 
- 
- 
+ 
- 
37
°C
 
37
°C
  
B
U
04
 4
16
31
 
+ 
+ 
- 
< 
+ 
- 
- 
- 
B
U
04
 6
36
30
 (C
lo
ne
 1
) 
+ 
+ 
> 
> 
- 
- 
30
°,
 3
7°
C
 
- 
B
U
04
 6
36
30
 (C
lo
ne
 1
4)
 
+ 
+ 
- 
> 
- 
- 
30
°,
 3
7°
C
 
- 
B
U
04
 6
80
88
 
+ 
+ 
- 
- 
+ 
- 
30
°,
 3
7°
C
 
37
°C
 
B
U
05
 3
53
64
 
+ 
+ 
> 
- 
- 
+ 
- 
- 
FI
M
 6
36
 (C
lo
ne
 4
) 
+ 
+ 
- 
- 
+ 
- 
30
°C
 
- 
FI
M
 6
36
 (C
lo
ne
 8
) 
+ 
+ 
> 
> 
+ 
- 
30
°C
 
- 
FI
M
 6
36
 (C
lo
ne
 9
) 
+ 
+ 
- 
= 
+ 
- 
30
°C
 
- 
 *
R
e-
is
ol
at
es
 d
at
a 
re
la
tiv
e 
to
 A
B
U
 is
ol
at
e 
83
97
2 
(e
qu
al
, m
or
e 
or
 le
ss
 c
om
pa
re
d 
to
 A
B
U
 is
ol
at
e 
83
97
2 
w
t;
 n
/a
- n
o 
fu
rt
he
r 
te
st
s 
w
er
e 
co
nd
uc
te
d)
.  
 D
iff
er
en
t n
um
be
rs
 fo
llo
w
in
g 
st
ra
in
 d
es
ig
na
tio
ns
 p
er
ta
in
 to
 d
iff
er
en
t c
ol
on
ie
s 
of
 th
e 
sa
m
e 
re
-i
so
la
te
. P
le
as
e 
se
e 
F
ig
ur
e 
25
. 
  
Results 
 
-85- 
Figure 26. Distribution of the deregulated genes among the motile re-isolates into functional groups.                
(A). Upregulated genes. (B). Downregulated genes.  
A B 
5.2.9. Transcriptome analysis of the Motile Re-isolates 
 
The various phenotypic analyses revealed differences in expression of virulence traits 
among the different re-isolates. In order to evaluate the changes among selected re-
isolates in the transcriptional level, microarray experiments were performed. 
Transcriptome analysis was conducted for the three motile re-isolates namely BU04 
63630, BU05 35364 and FIM 636. Results showed that deregulation of genes was unique 
for each of the re-isolates since not a lot of genes were commonly de-regulated in all 
three or any two of them. A total of 220 genes were de-regulated in the three re-isolates. 
Of these, 193 were upregulated and 27 were downregulated (Figures 27 and 28). 
 
Most genes that were upregulated in BU04 63630 encode for phages and cell structures. 
On the other hand, most of the upregulated genes in BU05 35364 are involved in 
transport processes. Finally, for FIM 636, most of the upregulated genes function for cell 
processes which include adaptation and protection. Meanwhile, most of the 
downregulated genes in all three re-isolates are involved in cellular processes (Figure 26). 
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5.2.9.1. Deregulated Genes among the Re-isolates 
 
Motility/Chemotaxis 
 
Flagella enhance the fitness of UPEC throughout the urinary tract. They are thought to 
contribute to UPEC virulence during urinary tract infection since they play putative roles 
in adherence, ascension, biofilm formation and dispersal (Wright et al., 2005). ABU 
isolate 83972 does not swarm when grown on soft LB/urine-agar. However, three of the 
re-isolates showed marked motility compared to parent strain ABU isolate 83972 and 
these were included in the transcriptome analysis. 
 
The microarray data revealed that BU05 35364 which was 100 % motile (i.e. 20/20 
colonies grown in soft agar exhibited swarming) had significantly upregulated genes 
involved in flagellar assembly and biosynthesis (flgA and flgDEFG, flhA and fliA, fliG 
and fliO). In comparison, BU04 63630 which was 90 % motile (i.e. 18/20 colonies grown 
in soft agar exhibited swarming) had only the flagellar motor protein motA upregulated. 
Meanwhile, the mixed motile and non-motile FIM 636 was shown to have the fumarate 
reductase involved in anaerobic respiration and flagellar motility upregulated.  
 
Resistance/Adaptation 
 
Changes in the environment call for adaptation which could bring about stress in an 
organism. The microarray data showed that there were several genes involved in 
resistance to various conditions and coping up mechanisms which had been upregulated 
among the re-isolates.  
 
For instance, in FIM 636, genes involved in formic acid metabolism (frmRAB), formate 
dehydrogenase (fdnGHI) and nitrate reductase (narHIJ, which forms a respiratory chain 
with formate dehydrogenase, and napAGBC) as well as those involved in reduction of 
nitrite to ammonia (nirBDC) and those that act as scavengers of toxic by-products of 
nitrogen metabolism (hcp/hcr) were significantly upregulated.  
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Meanwhile, BU04 63630 have genes involved in acid resistance (gadA and gadB, hdeAB, 
cadB, slp), RNA polymerase sigma factor (rpoA, rpoE and rpoS), osmotic stress (osmB) 
and SOS response to DNA damage (recA and recN, lexA, yebG, psb1, sulA, dinB and 
dinI, ruvB, umuD, and rus) upregulated. 
 
In BU05 35364, on the other hand, few genes were upregulated such as those involved in 
heat shock (groEL and groES). The gene degP involved in survival at high temperature 
was upregulated in all three re-isolates.  
 
Adhesins 
 
ABU isolate 83972 harbors a non-functional pap gene cluster encoding P fimbriae, and a 
truncated fim gene cluster encoding type 1 fimbriae (Klemm et al., 2005). 
 
According to the microarray data, FIM 636 was shown to have several upregulated 
adhesin genes such as papACDEFHK (P fimbria), focA and focC, and sfaB and sfaD 
(F1C).  The P-fimbrial genes papAF was also upregulated in BU05 35364 while only 
papA was upregulated in BU04 63630.  
 
Polysaccharides 
 
The cell walls of gram-negative bacteria are made up of polysaccharides specifically 
lipopolysaccharide (LPS). LPS makes up the major part of the outer leaflet of the outer 
membrane of E. coli. Its two main components are the lipid A core that imparts most of 
the biological effects of the LPS and the O-antigen which is important in the colonization 
of the host and resistance to complement-mediated killing as well as cationic 
antimicrobial peptides which are key elements of the innate immune system. (Ullrich, 
2009). Meanwhile, mucoid (slimy) strains contain a polysaccharide capsule that 
surrounds the whole cell, which may have a role in virulence. The capsular 
polysaccharides and LPS represent the first line of defense against complement and 
bacteriophages (Varki et al., 2009).  
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Several LPS genes such as rfaGPIJY, waaV and waaW were found to be significantly 
upregulated in BU05 35364. In addition, N-acetyl glucosamine-related genes such as 
glmUS and lpxAB were also upregulated in this re-isolate.  
 
Toxins 
 
Bacterial toxins are a major group of virulence factors. Two types of toxins exist, the first 
being the endotoxin lipid A. The second type, called exotoxins are those secreted by the 
cell.  
 
Based on the microarray results, toxin genes which were upregulated were cnf1 
(cytotoxic necrotizing factor) in BU05 35364 and BU04 63630 as well as colicin-related 
genes cvpA and cirA in BU05 35364, and ECP_0113 in all three re-isolates.  
 
Iron   
 
BU05 35364 was shown to have iron-uptake related genes which were upregulated such 
as the genes involved in heme utilization (chuATUWXY) and those involved in the 
enterochelin biosynthetic pathway (entCA).  
 
Other Genes 
 
Other genes which were upregulated in any one or two or all of the three isolates were 
those involved in transport and secretion, amino acid biosynthesis, several enzymes, 
ribosomal proteins, phage related proteins and a number of hypothetical proteins. 
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5.2.9.2. Changes in gene expression in individual re-isolates 
 
Alterations in the transcriptome of re-isolate BU04 63630 relative to ABU isolate 
83972 wt 
 
Most of the genes with known functions which were highly upregulated in re-isolate 
BU04 63630 are involved in SOS response to DNA damage. The recA gene, which is a 
part of the SOS regulon induced by inhibition of DNA replication as a result of DNA 
damage, was the most upregulated gene in re-isolate BU04 63630 (Appendix Table 11). 
Interestingly, another gene in the SOS regulon, recN, which is responsible for 
recombinatorial repair, was also upregulated. In addition to these two, other genes 
involved in SOS response such as lexA, ruvB, dinI, dinB, sulA, yebG and umuD were also 
upregulated. Other genes which were upregulated in BU04 63630 are those involved in 
acid resistance and the remaining ones either have unknown functions or are phage-
related. 
In contrast, a group of significantly downregulated genes found in re-isolate BU04 63630 
code for phospho-transferase transport systems (PTS) (Appendix Table 18). The 
phosphotransferase systems or PTS are distinct transport systems used by bacteria to take 
up numerous carbohydrates and convert them into their respective phosphoesters during 
transport where the source of energy is from phosphoenolpyruvate (Deutscher et al., 
2006). PTS transports many sugars into bacteria, including glucose, mannose, fructose 
and cellobiose. It is also involved in metabolic and transcriptional regulation (Saier, 
2001).  
Alterations in the transcriptome of re-isolate BU05 35364 relative to ABU isolate 
83972 wt 
 
BU05 35364, the re-isolate which was found to be 100 % motile in soft agar swarming 
assay, was shown to have a group of genes involved in flagellar expression and 
biosynthesis significantly upregulated (Appendix Table  12). In addition, it was also 
found to have other groups of significantly upregulated genes which include those that 
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are involved in LPS synthesis, N-acetyl glucosamine biosynthesis, heme utilization, 
colicin production, enterochelin biosynthetic pathway, maltose transport and amino acid 
biosynthesis. There were, however, not so many significantly downregulated genes in this 
re-isolate which could be grouped together except those involved in galactose ABC 
transporter (mglAB) and formate-dependent nitrite reductase (nrfABC) (Appendix Table  
19).   
 
Alterations in the transcriptome of re-isolate FIM 636 relative to ABU isolate 83972 wt 
 
The most highly upregulated genes in re-isolate FIM 636 were those that make up the 
entire formic acid metabolism (frmRAB) gene cluster (Appendix Table 13). The frmA 
gene encodes for a glutathione-dependent alcohol dehydrogenase which, together with 
frmB, is involved in the metabolism of endogenously formed formaldehyde as well as 
detoxification of exogenous formaldehyde (Gutheil et al., 1997). Interestingly, this 
alcohol dehydrogenase is also involved in protection against nitrosative stress (Liu et al., 
2001). Other upregulated genes in re-isolate FIM 636 include those involved in formate 
dehydrogenase, nitrate reductase, fumarate reductase, P- and F-fimbriae, PTS (mannose) 
and amino acid biosynthesis. On the contrary, only one gene, a predicted hydrolase was 
shown to be downregulated in FIM 636 (Appendix Table 20).  
 
5.2.9.3. Common changes in gene expression among the re-isolates 
 
Common alterations in the transcriptome of both re-isolate BU04 63630 and BU05 
35364 relative to ABU isolate 83972 wt 
 
Only two genes having similar function, i.e. encoding for 50S ribosomal protein were 
upregulated for both BU04 63630 and BU05 35364 (Appendix Table 14). The other 
commonly upregulated genes have unrelated functions. 
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Figure 27. Hierarchical cluster analysis of all de-regulated genes in the motile re-
isolates BU05 35364, BU04 63630 and FIM 636 relative to their parent strain ABU 
isolate 83972 wt. The strains were grown in vitro at 37 °C in pooled human urine. Each bar 
represents one gene and its expression level corresponds to the color bar on the bottom left 
hand side. Numbers from 1 to 5 indicate five sub-clusters of commonly regulated genes in 
one re-isolate. The datasets for each strain are mean values of the expression ratio from at 
least three independent microarray experiments. Genes without statistically significant 
changes in their expression pattern (p>0.05) are shown in black. 
flagellar assembly and biosynthesis, 
LPS, N-acetyl glucosamine, heme, 
amino acid biosyntehsis  
acid resistance, stress response, SOS 
response, phage-related proteins, 
hypothetical proteins 
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dehydrogenase, phage-related proteins 
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Common alterations in the transcriptome of both re-isolate BU04 63630 and FIM 636 
relative to ABU isolate 83972 wt 
 
The microarray expression data showed several genes to be upregulated in both BU04 
63630 and FIM 636. Two of these genes are involved in biofilm formation (Appendix 
Table  15). Noteworthy, however, is that in the biofilm assay, none of the re-isolates were 
observed to form significantly stronger biofilm compared to ABU isolate 83972 wt. 
Other genes upregulated in both re-isolates are those that play a role in glucarate 
transport, as well as 30S and 50S ribosomal protein synthesis.  
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Figure 28. Venn Diagram of De-regulated Genes. (A). Upregulated. (B). Downregulated. 
A B 
Common alterations in the transcriptome of all three re-isolates relative to ABU isolate 
83972 wt 
 
Most of the genes that were commonly upregulated in all three re-isolates have no known 
function. Only the P-fimbrial gene papA was shown to be significantly upregulated in all 
three re-isolates.   
 
 
 
 
 
 
 
5.2.10. Verification of microarray results by quantitative RT-PCR 
 
 
To validate the data generated from the microarray experiments, quantitative real time 
PCR was performed. Six genes (fliA, chuA, rfaG, frmA, narI and papA) shown to be 
upregulated in any one of the re-isolates were randomly selected and used. Meanwhile, 
the rrnB gene encoding for 16S rRNA was used as positive control. 
 
Based on the results gathered, the only gene with a remarkable increase in expression 
level was fliA, which yielded a 160-fold higher expression in BU05 35364 compared to 
ABU isolate 83972. In addition, chuA and rfaG also showed significantly higher 
expression levels (6- and 5-fold, respectively) for re-isolate BU05 35364. As for the other 
genes included in the experiments, frmA and narI showed a 4- and 6-fold increase in 
expression levels for re-isolate BU04 63630, respectively. It can be noted that frmA was 
significantly upregulated in FIM 636 in the microarray experiments but this was not 
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Figure 29. Real Time-PCR-based quantification of transcript levels of selected genes in ABU 
re-isolates. Relative expression of genes in the re-isolates was normalized to that of parent strain 
ABU isolate 83972. All experiments were performed in triplicate. Gene expression was 
standardized using the rrnB gene as positive control.  
0
50
100
150
200
250
83
97
2
F
IM
 6
36
B
U
04
 6
36
30
B
U
05
 3
53
64
83
97
2
F
IM
 6
36
B
U
04
 6
36
30
B
U
05
 3
53
64
83
97
2
F
IM
 6
36
B
U
04
 6
36
30
B
U
05
 3
53
64
83
97
2
F
IM
 6
36
B
U
04
 6
36
30
B
U
05
 3
53
64
83
97
2
F
IM
 6
36
B
U
04
 6
36
30
B
U
05
 3
53
64
83
97
2
F
IM
 6
36
B
U
04
 6
36
30
B
U
05
 3
53
64
chuA fliA frmA narI papA rfaG
Virulence Genes
N
o
rm
al
iz
ed
 F
o
ld
 E
xp
re
ss
io
n
confirmed in quantitative RT-PCR. Meanwhile, papA was upregulated in both BU05 
35364 and FIM 636 (28- and 9-fold respectively) (Figure 29). 
 
Although the increase in expression levels of the genes tested were not very high, in 
general, the trend of upregulation of gene expression as determined by microarray results 
could be confirmed by quantitative RT-PCR. 
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5.2.11. Induction of Inflammatory Markers by the Motile Re-isolates 
 
Levels of IL-6 and IL-8 concentration as well as PMN influx in the bladder were 
routinely checked at every urine sampling time point to monitor patients enrolled in the 
colonization study. Patients that reported cases of symptoms showed considerable 
increase in the concentration of inflammatory markers at the specific time point where 
episodes of symptoms occurred as compared to time points when they reported no 
symptoms. Data show that there is a rising trend of inflammatory markers among the re-
isolates from the beginning of inoculation to the time point wherein the patients reported 
to have experienced symptoms. In re-isolate FIM 636, however, there has been an 
increase in the inflammatory markers 40 days post inoculation which went down again 
and went up once more 192 days post inoculation (Appendix Figure 47). It was only after 
192 days, however, that the patient reported having symptoms like fever of 38 °C and 
pain in the "lower region" of the urinary tract.  
 
During the sampling point where the patients each reported symptoms, the motile re-
isolate BU05 35364 induced very high levels of IL-6 and IL-8 compared to the other re-
isolates. FIM 636, on the other hand, had a very high influx of PMN into the bladder. 
(Figure 30). 
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Figure 30. Host response parameters in urine samples collected from patients 
during episode of symptoms. A.) IL-6 concentration B.) IL-8 concentration C.) PMN 
influx into the bladder. Data kindly provided by Dr. B. Wullt, Lund, Sweden.  
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Figure 31. Levels of secreted (A) IL-6 and (B) IL-8 from A498 kidney cell supernatant after 3h          
co-incubation with re-isolates. The very motile E. coli Nissle strain (super swimmer) was used as 
positive control. SN25 is a motile E. coli 83972 re-isolate from a non-symptomatic episode used in 
another study. Error bars shown are standard deviations of five independent experiments. 
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Meanwhile, to determine if there is a link between the marked motility of the re-isolates 
and the occurrence of symptoms, levels of secreted IL-6 and IL-8 in supernatant of A498 
kidney cells co-incubated with the motile re-isolates for 3h were determined by ELISA. 
A498 kidney cells secrete Toll-like receptor (TLR) 5 which recognizes flagellin, the 
major protein sub-unit of the flagellum.  
 
Results of the assays showed that there was no considerable difference in the ability of 
the motile re-isolates to induce host response (i.e. IL-6 and IL-8) compared to ABU 
isolate 83972 wt. Moreover, compared to the positive control E. coli Nissle 1917 super 
swimmer (i.e. a hyperflagellated strain), the re-isolates did not show significantly high 
secretion levels of both IL-6 and IL-8 (Figure 31). In addition, the IL-6 and IL-8 
secretion levels generated from the flagellin (fliC) deletion mutant of ABU isolate 83972 
did not at all vary from the wild type. 
 
 
 
 
In addition to checking the secreted IL-6 and IL-8 levels in cell culture supernatants after 
co-incubation with the motile re-isolates to see if flagella play a role in induction of 
immune host response, the transcriptional expression of these inflammatory markers was 
also checked. qRT-PCR was performed for lysates of A498 cells co-incubated with the 
motile re-isolate BU05 35364 at 0, 1 and 3h incubation periods. Results show that 
expression of IL-6 and IL-8 was not significantly increased in re-isolate BU05 35364.  
Increased expression levels, however, was observed with increased incubation time 
(Figure 32). 
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The experiment was performed three times under the same conditions. However, the 
results generated from the three independent experiments were variable and cannot be 
reproduced.  
 
 
 
 
 
 
 
 
 
5.3. Reconstitution of a functional papG gene into the E. coli 83972 
chromosome 
 
P fimbriae are known to improve the establishment of bacteriuria and activate the innate 
immune response in animal models as well as the human urinary tract (Bergsten et al., 
2004; Wullt et al., 2003, 2002, 2001). At the tips of the fimbriae is the PapG adhesin, 
which recognizes the α-D-galactopyranosyl-(1-4)-β-D-galactopyranoside receptor epitope 
in the globoseries of glycolipids thus mediating binding (Bock et al., 1985; Leffler and  
Svanborg-Edén, 1980; Lund et al., 1987). E. coli 83972 contains pap gene sequences 
(Hull et al., 1999) but has never been shown to express P fimbriae. However, Klemm et 
al. (2006) observed under transmission electron microscopy that the majority produced 
fimbriae but did not hemagglutinate human red blood cells (RBCs). In addition, the pap 
gene cluster in E. coli 83972 was attenuated by the acquisition of multiple point 
mutations, and as a consequence, the PapG adhesin was inactivated (Zdziarski et al., 
2008). Thus, ABU isolate 83972 is shown to produce P fimbriae but these are unable to 
bind to the receptor.   
 
An ABU isolate 83972 mutant complemented with the papGX gene from the UPEC 
strain CFT073 was constructed. The papGX gene of the wild type was first deleted and 
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Figure 32. Transcriptional expression of (A) IL-6 and (B) IL-8 in A498 cells after 0, 1, and 3h               
co-incubation with motile re-isolate BU05 35364. The very motile E. coli Nissle strain (super 
swimmer) was used as positive control. SN25 is a motile E. coli 83972 re-isolate from a non-
symptomatic episode used in another study. Gene expression was normalized to E. coli 83972 and  
standardized using the GAPDH gene as an internal control.  
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replaced with a cat cassette from the pKD3 plasmid. The antibiotic resistance cassette 
was cured through the plasmid pCP20. PCR and Southern Blot analysis verified the 
deletion (Figure 33). Following this, the deleted gene was replaced with the papGX gene 
from UPEC strain CFT073. First, the gene was amplified from CFT073 and afterwards 
introduced into a region of the pKD3 plasmid upstream of the antibiotic resistance cat 
cassette. Successful incorporation of the gene was verified by PCR and sequencing 
(Figure 34). Next, the papGX gene together with the cat cassette was amplified from the 
plasmid giving a 4-kb product. This was then successfully introduced into the 
chromosome as proven by PCR and DNA sequencing (Figure 35; Table 10). Finally, the 
functional expression of P-fimbria was tested by agglutination with sheep blood where 
the ABU isolate 83972 wt was shown to be incapable of agglutinating the blood cells 
while the constructed mutant (83972∆papGX::CFT073papGX_cat) was able to (Figure 
36). In addition, the papG complemented ABU isolate 83972 strain also adhered better to 
T24 cells compared to wild type. In fact, it adhered to the cells as much as UPEC strain 
CFT073 (See Figure 22, Section 5.2.6). 
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Figure 34. Introduction of papGX gene from CFT073 into the pKD3 plasmid. (A) PCR showing 
that the papGX gene is inserted into the plasmid, (B) PCR showing that papGX is inserted upstream of 
the cat cassette in pKD3.  
 
Figure 33. Reconstitution of a functional papG gene into the E. coli 83972 chromosome. (A)PCR 
screening for deletion of papGX inABU isolate 83972 using primers for the papGX gene, (B) curing of 
cat cassette using pCP20 plasmid, verified by PCR,  (C) PCR screening for cat cassette integration in 
ABU isolate 83972, (D) Southern Blot analysis to verify the integration of cat cassette in ABU isolate 
83972.      
Figure 35. Screening for E. coli 83972 wt complemented with papG gene from CFT073. (A) CFT073, 
(B) ABU isolate 83972∆papGX, (C) ABU isolate 83972∆papGX::CFT073papGX_cat, (D) papGX in 
pKD3 plasmid, (E) pKD3 plasmid. (1) papFG, (2) papG,  (3) papX,  (4) cat,  (5) cat and papX. 
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A B C 
Figure 36. Agglutination assay using sheep blood cells.                
(A) ABU isolate 83972∆papGX::CFT073papGX_cat,                                  
(B) E. coli 83972 wt, (C) E. coli CFT073. 
 
 
 
 
 
 
 
Table 13. Summary of screening for correct reconstitution of the papGX gene from UPEC strain CFT073 
into the E. coli 83972 chromosome 
Bacterial Strain papFG papG papX cat cat_papX 
 E R E R E R E R E R 
CFT073 + + + + + + _ n/a _ n/a 
ABU isolate 
83972∆papGX 
_ _ _ _ + + _ _ _ _ 
ABU isolate 
83972∆papGX:: 
CFT073papGX_cat 
+ + + + + + + + + + 
papGX in pKD3 
plasmid 
_ _ _ _ + + + + + + 
pKD3 plasmid _ n/a _ n/a _ n/a + + _ _ 
   *E- Expected; R- PCR result 
 
Discussion 
 
-101- 
6. Discussion 
 
The main focus of this study was to characterize the various genotypic and phenotypic 
traits and factors associated with E. coli asymptomatic bacteriuria isolates as well as re-
isolates from patients stably colonized with E. coli 83972 for prophylactic treatment.  
 
6.1. Pheno- and genotypic characterization of ABU isolates and fecal 
isolates from healthy individuals  
 
6.1.1. Phylogenetic lineage of ABU isolates differs from commensal fecal isolates 
 
Phylogenetic analyses showed that there are four main phylogenetic groups (A, B1, B2 
and D) in which E. coli strains are classified (Herzer et al., 1990; Selander et al., 1986). 
Virulent extra-intestinal strains belong mainly to group B2 and to a lesser extent, group 
D. On the contrary, many commensal strains belong to group A (Johnson and Stell, 
2000). 
 
ABU patients often carry the strain for long periods of time without producing symptoms, 
resembling commensalism. One would then expect them to be phylogenetically related to 
commensals. However, majority of the ABU isolates included in this study belonged to 
group B2 (Figure 5).  This shows that more than half of all the ABU isolates were related 
to pathogenic E. coli since group B2 is from where pathogenic E. coli strains are chiefly 
derived (Johnson and Stell, 2000). A study by Mabbett et al. (2008) demonstrated that 
many ABU isolates are phylogenetically related to UPEC in that most of them belong to 
group B2. Furthermore, a comparative study between ABU isolates from catheterized 
versus non-catheterized patients by Watts et al. (2010) also showed that the majority of 
all isolates belong to group B2.  
 
The genetic diversity of the isolates was further explored in this study. Multi-locus 
sequence typing (MLST) was carried out to examine if the isolates in the collection were 
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clonally related. MLST showed that ABU isolates belong to multiple clonal groups. In 
addition, ABU and fecal isolates belong to different clonal lineages but that there really is 
no strict delineation as to which clonal group they each belong to since there appears to 
be overlaps in the distribution of ABU and fecal isolates in some clonal complexes 
(Figure 6). This also indicates that ABU isolates represent a phylogenetically 
heterogenous group. Two thirds have most likely evolved from classical uropathogenic 
strains probably by reductive genome evolution while one third resembles commensals 
according to phylogeny (Zdziarski et al., 2008).  
 
In order to substantiate this genetic diversity, one should look at traits which are common 
or different among the isolates. Pathogens differ from commensals in that the former 
have evolved mechanisms that enable them to establish themselves at the site of infection 
and thereafter due to a cascade of virulence traits are recognized by the host. On the other 
hand, commensals may share the virulence properties of their pathogenic variants 
required for initial establishment at the site of infection but lack pathogenicity islands and 
genes that would trigger host response (Godaly et al., 2000; Müller et al., 2006). 
 
6.1.2. Genotypic and phenotypic variations 
 
Virulence is the ability of an organism to cause disease in the host. In E. coli, virulence 
results from the cumulative impact of one or several special properties, or virulence 
factors which serve to distinguish potential pathogens from harmless intestinal strains 
(Johnson, 1991). The expression of these special properties or virulence factors lies in the 
virulence genes carried by the organism. 
 
In this study it was shown that all 30 virulence genes included in the PCR were found 
among the ABU isolates. On the other hand, eight of these genes were not carried by any 
of the fecal isolates. However, phenotypic assays conducted in this study revealed that 
there are cases when even if the gene is present in the isolate, it is not expressed. For 
instance, among ABU isolates, the most predominant gene fimH, which encodes the 
mannose-specific adhesin sub-unit of type 1 fimbriae, is present in most of the isolates, 
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but not functionally expressed by all of them that harbor the gene. The fimH gene is a part 
of the transcriptional unit fimAICDFGH (Korea et al., 2011). It specifically encodes for 
the adhesin sub-unit FimH, which functions for receptor recognition (Krogfelt, 1990).  
 
Uropathogens are believed to originate predominately from the intestinal tract and later 
on ascend into the bladder to cause either symptomatic or asymptomatic bacteriuria. This 
is initially accomplished through bacterial adherence to the host environment (Reid and 
Sobel, 1987). Adherence is a property used by pathogenic organisms to enable them to 
attach to host structures and avoid being swept along by the normal flow of fluids and 
eliminated (Johnson, 1991).  
 
In the case of type 1 fimbriae, successful colonization specifically of the bladder is aided 
by its ability to adhere to host cells. During urinary tract infection, the hydrodynamic 
forces brought about by the flow of urine post a challenge to the bacteria in successfully 
colonizing the bladder and from there establish a niche. It is known that adhesion to 
mucosal surfaces pave the way for the coming together of bacterial colonies to establish 
biofilms. Type 1 fimbriae appear to play a role in inter-bacterial binding and biofilm 
formation in the central parts of the epithelial cell lumen (Melican et al., 2011). The 
FimH adhesin has been shown to be instrumental in biofilm formation by E. coli K-12 
under both static and hydrodynamic growth conditions in vitro (Pratt and Kolter, 1998; 
Schembri and Klemm, 2001). Furthermore, in a fimH deletion mutant, it was also 
demonstrated that biofilm-forming capacity was significantly reduced. 
 
Type 1 fimbriae are expressed by many Gram-negative bacteria. They facilitate 
adherence to mucosal surfaces and inflammatory cells in vitro. Moreover, they were 
shown to increase the virulence of E. coli in the urinary tract by promoting bacterial 
persistence and enhancing the inflammatory response to infection. Thus, they are said to 
contribute to the pathogenesis of E. coli in the urinary tract (Connell et al., 1996). In 
addition, subunits of adhesive structures might act not only as adhesins but also as 
invasins. This is, for example, the case of the FimH adhesin (Bouguénec, 2005). FimH 
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appears to mediate the bacterial invasion of human bladder cells (Martinez et al., 2000; 
Mulvey et al., 2001; Mulvey, 2002).  
 
Type 1 fimbriae are also found to be involved in phase-variation. It has been 
demonstrated that the virulence characteristic imparted by type 1 fimbriae is dependent 
on its switching “on” or “off”. As demonstrated by Gunther et al. (2002), expression of 
type 1 fimbriae is regulated at the transcriptional level by a promoter situated on an 
invertible element, which can exist in one of two different orientations. The orientation of 
the invertible element that allows the expression of type 1 fimbriae is defined as “on,” 
and the opposite orientation, in which no transcription occurs, is defined as “off.” They 
found that UTI strains isolated from cystitis patients switched the invertible element to 
the “on” position where it remained. Meanwhile, strains from pyelonephritis patients 
turned the switch “on” early in infection and then tended to turn the switch “off” later. 
These results suggest that the switching of the invertible element itself contributes 
significantly to virulence in the urinary tract. 
The various abilities conferred by expression of type 1 fimbriae among bacteria then lead 
to the question as to whether type 1 fimbriae are really a virulence factor or not. To shed 
light to this question, one has to look at how these fimbriae actually act upon the host 
cell. Virulence factors are defined as those components of an organism that determine its 
capacity to cause disease but are not required for its viability per se (Davis et al., 1990).  
They are molecules expressed and secreted by pathogens that enable them to colonize a 
niche in the host (which includes adhesion to cells), evade the host's immune response, 
suppress or inhibit the host's immune response, enter into and exit out of cells and obtain 
nutrition from the host. In addition, virulence factors are very often responsible for 
causing disease in the host as they inhibit certain host functions. (Peterson J, 1996; Chen 
et al., 2005). 
In the case of the model ABU organism E. coli 83972, the type 1 fimbriae are non-
functional due to a deletion in the fim region (Klemm et al., 2006).  In the same way, 
more than half of the ABU isolates included in this study also fail to phenotypical express 
type 1 fimbriae. Since type 1 fimbriae enable the bacteria to colonize the host through 
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adhesion, it can be counted as a virulence factor. However, in general, since most ABU 
isolates still fail to express it and use it for this purpose, it probably does not count as a 
means by which ABU increases its virulence. 
 
In addition to type 1 fimbriae, other genes encoding for virulence factors had been found 
present among the ABU isolates. Nevertheless, most of these genes are not 
phenotypically expressed. An earlier study showed that E. coli 83972 carry genes of the 
pap, fim and foc gene clusters, encoding P, type 1 and F1C fimbriae, respectively (Hull et 
al., 1999). However, it was also demonstrated that it is unable to express functional P and 
type 1 fimbriae (Klemm et al., 2006). Moreover, molecular epidemiology has shown that 
>60 % of ABU strains carry virulence genes but fail to express the phenotype (Plos et al., 
1991, 1995). This implies that the virulence genes found in UPEC are also found among 
ABU although most of these genes are not functionally expressed and may thus have 
contributed to the ability of ABU to establish infection but not cause any symptom. The 
fecal isolates, on the other hand, do not possess all these genes with the toxin gene cnf1 
and fimbrial genes (some pap genes, gafD and sfa/focDE), as well as afa/draBC) not 
found in any of the tested isolates. This is in affirmation to the finding that urinary 
isolates including ABU E. coli are found to typically have higher inferred virulence 
compared to fecal isolates from healthy individuals (Blanco et al., 1996; Johanson et al., 
1993). In addition, virulence determinants were rarely detected for fecal isolates and 
those with virulence factors most frequently belonged to phylogenetic group B2, a rare 
group among commensal isolates (Duriez et al., 2001). According to Russo and Johnson 
(2000), commensal isolates of E. coli lack the specialized virulence traits present among 
intestinal and extra-intestinal pathogenic E. coli. Isolates are defined as extra-intestinal 
pathogenic E. coli through the presence of two or more of a specific subset of virulence 
genes which includes papA, papC, sfa/foc, afa/draBC, iutA and kpSMTII (Karisik et al., 
2007). Thus, it can be said that the difference between commensal isolates and extra-
intestinal pathogenic E. coli lies in the virulence genes present. From the results, it can be 
deduced that ABU isolates are more closely related to extra-intestinal pathogenic E. coli 
which includes UPEC with regards to the virulence genes they possess but behave like 
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commensals in the urinary tract being “asymptomatic”, or in other words, carried by the 
host symptom-free.   
 
The inability of ABU isolates to express functional virulence-associated determinants 
may result in successful urinary tract colonization without activation of local and 
systemic inflammatory response pathways. It was suggested that some ABU strains may 
arise by the attenuation of UPEC strains as an adaptation to growth in the urinary tract. 
This implies that the ABU isolates stemmed out from UPEC but due to survival 
mechanisms have adapted commensal lives (Mabbett et al., 2009; Zdziarski et al., 2008).    
 
Bacteria in the urinary tract are said to have originated from the gastrointestinal tract 
(Reid and Sobel, 1987. In the phylogenetic analyses conducted, it was shown that UPEC 
and ABU are derived from the same lineage. One could then deduce from here that there 
appears to be a transition, first of all, from a commensal bacterium in the gastrointestinal 
tract to a uropathogen in the urinary tract or an asymptomatic bacterium. Nonetheless, it 
is also possible that the uropathogen that originated from the gastrointestinal tract 
transformed itself back to a “commensal-like” bacterium in the course of time.  
 
Genome plasticity plays a significant role in persistent infections. Among ABU and other 
persistent infections, prolonged growth in the host is accompanied by genomic alterations 
that result in bacterial attenuation which then contributes to bacterial adapatation to their 
host niche and a reduced activation of immune host responses (Dobrindt et al., 2010). For 
instance, reductive evolution and gene loss are well-known events in persistent UTI 
caused by UPEC. However, this is not only confined to UPEC but described to other 
persistent bacterial pathogens such as Pseudomonas aeruginosa or Helicobacter pylori as 
well.  In the case of P. aeruginosa, long-term persistence in the cystic fibrosis (CF) lung 
is characterized by the selection of a variety of genotypes and phenotypes that typically 
descend from one infecting P. aeruginosa clone, a process known as adaptive radiation 
(Hogardt and Heesemann, 2010). This infection process is associated with extensive 
genetic adaptation and microevolution of the infecting bacteria (Jelsbak, 2007; Smith, 
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2006). A similar event was also observed for H. pylori wherein genes may be lost or 
gained during progression of infection (Oh, 2006). 
 
6.2. Characterization of ABU re-isolates from symptomatic episodes  
 
The eight re-isolates included in this study were taken from patients stably colonized with 
E. coli 83972 wt as prophylactic treatment for recurring UTI who reported episodes of 
symptoms during the inoculation period. This study aimed to compare re-isolates taken 
from patients stably colonized with ABU isolate 83972 who reported symptoms. The 
characterization of phenotypic alterations in E. coli 83972 re-isolates from symptomatic 
episodes may help in the improvement of the use of this strain for prophylaxis of 
symptomatic UTI.  
 
Results demonstrated that out of the eight re-isolates, only two were not ABU isolate 
83972 namely BU05 17629 and BU05 42290 which were found to be Pseudomonas and 
a different E. coli, respectively. This shows that both patients from which BU05 17629 
and BU05 42290 were isolated most probably had a superinfection. Pseudomonas 
abounds in hospitals and the likelihood of an infection is not improbable. A 3-year study 
period documented that Pseudomonas aeruginosa is a common nosocomial pathogen. 
The most common sites for P. aeruginosa infection were the lower respiratory tract, 
urinary tract, blood stream, and surgical wounds. Nosocomial P. aeruginosa lower 
respiratory tract and blood stream infections were significantly associated with exposure 
to certain intensive care units, whereas P. aeruginosa urinary tract infections more 
commonly occurred on the neurology and neurosurgery services (Sherertz and Sarubbi, 
1983). Since the patients enrolled in the deliberate colonization studies have frequent 
hospital visits due to illnesses associated with UTI, it is not unlikely for them to acquire 
nosocomial infections.  
 
Whether the infection with another microorganism besides E. coli 83972 is nosocomial or 
not, however, is beyond the scope of this study. 
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6.2.1 Re-isolates are genetopically identical to parent strain E. coli 83972 but some 
vary in morphology  
 
Even though the re-isolates were samples taken from patients that reported episodes of 
symptoms, their genomic content does not vary from the parent strain ABU isolate 
83972. As revealed by the results of the genotypic tests, all investigated virulence-
associated genes of uropathogenic Escherichia coli (UPEC) found in parent strain 83972 
were also found among the re-isolates confirmed to be ABU isolate 83972 (Section 
5.2.5). Furthermore, the DNA banding patterns of all the re-isolates were identical to 
ABU isolate 83972 (Figure 23) which confirms that there is no alteration at all which 
took place among the re-isolates relative to their parent strain (i.e. that they are still, in 
essence ABU isolate 83972).  
6.2.1.1. Small colony variants (SCV) 
Although the re-isolates showed to be completely identical to ABU isolate 83972 
genotype-wise, deviation of one re-isolate from the typical morphology of ABU isolate 
83972 wt was observed. Five out of 20 colonies from BU04 50907 showed small, 
atypical growth morphology in all media used. They grew transparent on chromogenic 
agar instead of the typical pink color indicating the ability to synthesize β-galactosidase, 
an enzyme produced by E. coli. However, 16S rRNA sequencing identified all five 
colonies to be E. coli. Furthermore, they carry the cryptic plasmid, have the fim deletion 
and showed a 100 % similar restriction pattern as ABU isolate 83972 in the PFGE. They 
also share 100 % of the UPEC-associated genes of ABU isolate 83972 wt. Interestingly, 
the unusual morphological characteristic of these colonies could be likened to small 
colony variants (SCV). SCVs are certain variants of bacteria that grow slowly on routine 
media and yield unexpectedly small colonies in comparison to the normally growing 
parent strains (Roggenkamp et al., 1998). Minute transparent colonies, then referred to as 
“dwarf-colony mutants” were isolated from the urine of a patient with an asymptomatic 
urinary infection (Borderon et al., 1978). Furthermore, 16 metabolically deficient dwarf 
mutants of E. coli were isolated from urine culture and it appeared that the mutants were 
the true cause of urinary tract infection since there was leukocyturia and important 
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bacteriuria were obtained in pure culture (Borderon and Horodniceanu, 1978). It can then 
be deduced that SVCs could be isolated from urine samples of typical UTI patients and 
even those with ABU. However, whether the morphological alteration carries alongside it 
genotypic changes leading to the occurrence of symptoms among patients carrying ABU 
remains unclear.  
6.2.2. Expression of virulence traits and host-response 
Virulence traits in bacteria are known to induce several immune responses in the host that 
aid in bacterial clearance. Although the phenotypic assays showed that there were several 
virulence characteristics expressed by the re-isolates, most of them cannot be taken in the 
general context since they were not commonly expressed among all re-isolates. In fact, 
the only marked virulence factor common in at least three of the re-isolates is motility. 
The question then is whether bacterial factors (i.e. changes in the expression of virulence 
traits) induced the host-response among the patients who reported episodes of symptoms 
or that changes within the hosts themselves prompted the bacteria to undergo certain 
alterations in behavior and expression of virulence traits in order to cope up with the 
changes in their living environment.  
6.2.2.1. Bacterial factors involved in symptomatic episodes 
 
The establishment of symptomatic UTI by UPEC is enhanced by virulence factors such 
as adhesins (e.g. type1 and P fimbriae) and toxins (e.g. hemolysin) (Brzuszkiewicz et al., 
2006; Klemm and Schembri, 2000; Oelschlaeger et al., 2002). The ability of E. coli 
83972, the best characterized ABU E. coli to date, to colonize the host without triggering 
immune response is owed to the fact that its virulence-associated adhesin genes have 
become attenuated giving rise to poor immune detection by the host (Klemm et al., 
2006). In addition, E. coli strains isolated from pyelonephritis show virulence factors 
more frequently than those from cystitis and asymptomatic bacteriuria (Blanco et al., 
1996). Moreover, Zdziarski et al. (2008) suggested that some ABU isolates arise from 
virulent strains by attenuation of virulence genes while others are non-virulent and 
resemble commensal strains.  
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Meanwhile, results of this study showed that the various re-isolates possess various 
virulence characteristics. Based on the PCR conducted, all six re-isolates confirmed to be 
E. coli 83972 share 100 % similarity to ABU isolate 83972 wt with regards to presence of 
UPEC-associated virulence genes. In addition, the genomic restriction pattern did not 
show any difference between the re-isolates and the parent strain. However, the marked 
differences lie in the phenotypic expression of the virulence traits among them.  
 
Primarily, as mentioned previously, assessment of swarming motility revealed three re-
isolates to be motile (Figure 20; Table 12). However, among these three re-isolates, only 
BU05 35364 was completely motile. The other two were a mixture of motile and non-
motile clones. This finding is in agreement with the result of the microarray analysis. 
Among the three re-isolates, upregulation of a cascade of genes involved in flagellar 
assembly and biosynthesis was observed only in re-isolate BU05 35364 (Figure 27). This 
was further confirmed by the results of qRT-PCR wherein only this re-isolate among all 
motile re-isolates showed a significantly high expression of the fliA gene involved in 
flagellar biosynthesis (Figure 29).  
 
It has been suggested that flagella may be required for biofilm formation. Motility 
facilitated by flagella might be necessary to bring cells in close proximity with each other 
and the surface to which they will attach (Dunne, 2002; Pratt and Kolter, 1998). In 
addition, flagella, together with outer membrane proteins and fimbriae are required for 
initial bacterial adhesion during biofilm formation (Landini and Zehnder, 2002). 
However, c-di-GMP also plays a role in the expression of flagella and biofilm formation. 
Intracellular c-di-GMP positively regulates phenotypes such as sessility, biofilm 
formation, and expression of adhesive extracellular matrix (ECM) components. On the 
other hand, it negatively influences phenotypes such as motility and virulence in bacteria 
(Lee et al., 2010). This shows that motility and biofilm formation are diametrically 
affected by c-di-GMP and are thus mutually exclusive. This was observed among the 
motile re-isolates as none of them could form significantly stronger biofilm compared to 
their parent strain.  
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In fact, together with non-motile re-isolates BU04 50907-1 and 11, BU04 68088, motile 
re-isolates BU05 35364 and FIM 636-4 formed even significantly less biofilm compared 
to their parent strain. Biofilms may be important virulence factors (Mendez-Arancibia, 
2008). Hancock et al. (2007) reported that ABU isolate 83972 has the ability to form 
stronger biofilms compared to UPEC and proposed that this is a favorable strategy for a 
successful ABU lifestyle. Biofilms provide a protected environment for survival under 
hostile conditions. They are composed of cells embedded within a complex glycocalyx-
like matrix. Biofilms protect pathogens from attack by the immune system. This 
complicates chronic infections that are difficult to eliminate with antibiotic therapy. 
Bacterial biofilm infections are up to 1000-fold more resistant to antibiotics, biocides and 
hydrodynamic shear forces because sessile bacteria can withstand host immune responses 
more than their planktonic counterparts (Costerton et al., 1995, 1999; Donlan and 
Costerton, 2002).  
 
However, since there is no increased biofilm formation among any of the re-isolates, it 
seems to be the opposite case for the re-isolates. Instead of being protected from 
incurring host response from the host, it is probable that by having a diminished ability to 
form biofilm, these weak biofilm-forming re-isolates may have enabled recognition by 
the host and reduced their fitness.  
 
Secondly, motility is another major role of flagella (Pratt and Kolter, 1998). Although 
flagellar expression was shown in the Western Blot analyses conducted, microarray 
results revealed that only the homogeneously motile re-isolate BU05 35364 have 
upregulated flagella-related genes (Figure 21; Figure 27). In addition to its role in 
motility and biofilm formation, flagella are also considered to be contributors to virulence 
of UPEC (Wright et al., 2005). In 2005, Wright et al. hypothesized that they may 
contribute to UPEC virulence during urinary tract infection since they have putative roles 
in adherence, ascension, biofilm formation and dispersal. Moreover, they concluded that 
flagella enhance the fitness of UPEC throughout the urinary tract. Flagellum-driven 
motility allows bacteria to disseminate to sites more advantageous for colonization 
(Simms and Mobley, 2008). In a study by Lane et al. (2007), it was demonstrated that 
Discussion 
 
-112- 
flagella contribute to efficient colonization of the urinary tract. Hence, it can be deduced 
that increased motility and upregulated flagellar gene expression may have brought about 
an increased fitness quality to re-isolate BU05 35364. 
 
Since flagella are considered virulence factors, they are able to induce host response. It 
has been reported by Zhou et al. (2003) that FliC, the flagellin of enteropathogenic E. coli 
(EPEC) stimulates interleukin-8 (IL8) production and release in T84 cells. Data of pro-
inflammatory cytokine secretion among the re-isolates showed that there was no 
significant increase in expression levels of IL-6 and IL-8 among the motile re-isolates. In 
addition, the motile re-isolates were also not able to adhere better to bladder epithelial 
cells compared to the other re-isolates as well as the parent strain. (Figure 22; Figure 31).  
These results show that the induction of symptoms of UTI in the formerly 
asymptomatically colonized patients cannot be attributed to the presence of flagella in 
that it does not play a role in adhesion, biofilm formation nor increased host response. 
Flagella, however, are not only considered as virulence factors but also fitness factors. 
Since the motile re-isolates were confirmed to be flagellated, the expression of flagella is 
possibly a kind of adaptation to enable them to become more fit in the host environment. 
It was already reported by Zdziarski et al. (2010) that different host appear to personalize 
their microflora in that re-isolates taken from different patients showed a distinct pattern 
of genetic alterations in addition to random changes. In order for the bacteria to survive 
the selective host environment, they use various mechanisms to for adaptation.  
 
It is interesting to note that the re-isolates taken from urine samples of patients were 
heterogeneous specifically when it comes to motility. Among the six re-isolates 
confirmed to be ABU 83972, three showed increased motility compared to the parent 
strain (Figure 20; Figure 21; Tables 8-10). Still, however, there is heterogeneity also 
among clones from the same re-isolate. For instance, re-isolate FIM 636 was observed to 
be a mixture of motile and non-motile clones and the degree of motility observed among 
clones which were motile also varied. This shows that it is not only the patients which 
tend to contribute to the variability of the re-isolates but that the clones within each re-
isolate are in themselves also variable. 
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Third, BU04 63630 (clones 1 and 14) was also observed to be incapable of lysing the K5 
bacteriophage lysate, indicative of inability to express K5 capsule. Capsules inhibit the 
opsonizing activities of complement, decreasing the elimination by phagocytes, or escape 
the immune response by mimicking host molecules thereby increasing bacterial virulence 
(Bayer et al., 1994; Boulnois et al., 1990; Cross et al., 1990). The E. coli K1 and K5 
capsules are frequently found among isolates causing extraintestinal infections. K1 is 
more commonly associated with neonatal septicemia and K5 with sepsis and urinary tract 
infection (Cross et al., 1990). E. coli 83972 harbors the kpsMTK5 genes and is able to 
express K5 capsule which is a group 2 type capsule. In the same way, all the re-isolates 
also do except for BU04 63630 (clones 1 and 14) and BU05 35364. This particular 
change in capsular expression may be contributory to altered and increased host response. 
According to Clarke et al. (2000), expression of a polysaccharide capsule confers 
resistance to host immune defences and other adverse environmental conditions. 
Therefore, the absence of a functional K5 capsule in BU04 63630 (clones 1 and 14) and 
BU05 35364 could have triggered the host immune system to react and produce 
symptoms. The results showing that these two re-isolates do not express K5 capsule is in 
line with the findings of Valle et al. (2006) that group 2 capsules modulate bacterial 
adhesion and prevent biofilm formation in both gram-negative and gram-positive 
bacteria.  Strains that express group 2 capsules exhibit antibiofilm activity. The capsular 
polysaccharide K-antigen, which is a surface-exposed polysaccharide polymer, plays an 
indirect role in biofilms by shielding of bacterial surface adhesin. The physicochemical 
properties displayed by the group 2 capsules might sharply alter bacterial ability to 
interact with surfaces and therefore drastically reduce adhesion. The notion that biofilm 
formation is evident among those that do not form group 2 capsules is true in re-isolate 
BU04 63630 (clones 1 and 14). This re-isolate was found to not express K5 capsule but 
formed biofilm.  
 
Furthermore, a cascade of genes involved in LPS biosynthesis was also upregulated in 
BU05 35364. LPS is a known virulence factor. The connection between flagella and LPS 
was shown in a study by Parker et al. (1992). They found out that flagella formation is 
impaired in LPS-deficient strains which means that in order for flagella formation to 
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occur, LPS should be expressed. In this sense, it is true that there is upregulation of 
several flagella-related genes as well as those involved in LPS biosynthesis in the motile 
re-isolate BU05 35364. However, no increase in the expression of LPS was observed in 
this re-isolate compared to the rest, as well as the parent strain. In addition, genes 
involved in the production of another extracellular polysaccharide, N-acetyl glucosamine, 
were also upregulated in BU05 35364 which was also able to express it based on 
immunoblot assay.  Poly-GlcNAc expression has been hypothesized to correlate with 
urovirulence (Cerca et al., 2007).    
 
It is known that exopolysaccharides such as the polysaccharide poly-N-
acetylglucosamine also known as intercellular adhesin (PIA) play a crucial role in the 
formation of biofilms and biofilm resistance to antimicrobials and innate host defense 
(Vuong and Otto, 2008). The motile re-isolate BU05 35364 was found to be the only re-
isolate capable of expressing PIA. However, even if flagella and PIA are associated with 
biofilm formation, BU05 35364 is not a stronger biofilm former compared to ABU 
isolate 83972 wt. According to Hall-Stoodley et al. (2004), strains with PIA might still 
fail to form biofilms if they are defective in initial adherence. 
 
Finally, an upregulation of six P-fimbrial genes in FIM 636 was observed. ABU isolate 
83972, although expressing P-fimbriae, fails to hemagglutinate human red blood cells 
(RBCs), bind to human uroepithelial cells as well as Galα1-4-Galβ-containing glycolipids 
(Klemm et al., 2006). This means that even if P-fimbriae are expressed, they are non-
functional. Although an increased transcriptional expression of papA, one of the genes in 
the pap operon in re-isolates BU05 35364 and FIM 636 was confirmed by qRT-PCR, the 
fact remains that their P-fimbriae are still non-functional as shown by hemagglutination 
assays.  
 
Bacteria have the ability to adapt to changes in their environment. Dalhoff et al. (1985) 
stated that some characteristics of bacteria growing in an infected host may differ 
markedly from those growing in vitro. It has been shown that when grown under different 
growth conditions (i.e. in vivo and in vitro), Staphylococcus auerus grown in vivo 
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possessed enhanced virulence compared with their counterparts grown in vitro when 
injected intradermally into sheep, intraperitoneally into mice or infused into lactating 
mammary glands of ewes (Watson, 1982).  This implies that bacteria grown in vivo differ 
in their pathogenicity from their counterparts grown in vitro. Dalhoff et al. (1985) further 
stated that bacteria frequently exhibit such a pronounced adaptive plasticity to a changing 
growth environment that the new characteristics acquired during growth in vivo are 
rapidly lost upon subculture in vitro. For instance, E. coli sequentially isolated from 
untreated patients suffering from asymptomatic bacteriuria have shown consecutive 
changes with respect to their serum sensitivity and spontaneous agglutinability (Lindberg, 
et al., 1975). In addition, in another study, Ljungh & Wadstrom (1983) described that 
approximately 20% of the bacteria originally isolated from midstream urine samples were 
not fimbriated whereas after serial transfers under static conditions all isolates expressed 
fimbriae. 
 
It would be good to take note that in this study, the bacterial isolates tested were re-
isolated from urine samples of patients deliberately colonized with the parent isolates E. 
coli 83972 wt. Once they were re-isolated, they were then grown either in pooled human 
urine or LB broth in vitro for all experimental procedures conducted. It is then possible 
that there may be differences in the actual behavior and characteristics of the bacteria 
residing in the bladder of the patients compared to when they were re-isolated and grown 
in vitro for the experiments. 
 
6.2.3.1. Host factors involved in symptomatic episodes 
 
When there is a change in the environment and bacteria undergo stress, they respond by 
changing the pattern of gene expression. They either activate a set of genes necessary for 
survival or turn off genes which are not needed at a certain time. Often, this is 
accompanied by induction of virulence factors (Chowdhury et al., 1996).  
 
An example of stress encountered by bacteria is DNA lesion or damage. If there are 
lesions in the DNA, DNA replication is inhibited. This in turn induces the SOS response. 
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During SOS response, there is an increased expression of about 20 genes aimed at 
restoring the capacity of the chromosome to replicate. The synthesized proteins are 
induced at various time points. For instance, after the expression of lexA, an SOS 
repressor gene, ruvB and dinI, along with some other genes, the recA and recB genes 
which are involved in recombinatorial repair are known to be expressed next. Following 
this, translesion DNA synthesis takes place and umuD encoding an error-prone DNA 
polymerase  as well as sfiA (also known as sulA) encoding a cell division inhibitor are 
two of the genes which are then expressed (Kuzminov, 1999). All aforementioned genes 
were shown to be upregulated in re-isolate BU04 63630 which implies that the re-isolate 
has encountered DNA lesion or damage which brought about the induction of the SOS 
response regulon. 
 
E. coli, a neutrophilic bacterium, can survive extreme acid (pH <2.5) stress for several 
hours (Castanie-Cornet et al., 2010). There are several acid resistance systems in E. coli. 
One acid response system designated as the oxidative or glucose-repressed system was 
reported to require the alternative sigma factor RpOS (Castanie-Cornet et al., 1999). The 
rpoS gene encodes the alternative sigma factor σS, a subunit of RNA polymerase that acts 
as the master regulator of the general stress response in E. coli. In the microarray 
analysis, the rpoS gene was observed to be upregulated together with rpoA and rpoE in 
BU04 63630. It was reported that many gene products regulated by rpoS protect E. coli 
from adverse environmental conditions such as starvation, hyperosmolarity, oxidative 
damage, and UV radiation (Small et al., 1994). In addition to RNA polymerase sigma 
factor genes, the gadA and gadB genes were also shown to be upregulated in BU04 
63630. These genes are involved in another acid resistance system based on glutamate 
decarboxylation by the GadA and GadB decarboxylases and the import of glutamate via 
the GadC membrane protein (Castanie-Cornet et al., 2010; Foster 2004). It is interesting 
to note that aside from these, other genes involved in resistance to low pH such as hdeA 
and hdeB were also upregulated in the same re-isolate. HdeA supports acid resistance in 
pathogenic enteric bacteria (Gajiwala and Burley, 2000). This implies that re-isolate 
BU04 63630 has undergone a drastic change in environmental pH.  
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The normal physiological range of urine pH values ranges from 4.8 to 7.4. In 2003, 
Cahill et al. showed that urine becomes alkalinized in its passage along the lower urinary 
tract. Urine acidification relative to that of arterial blood occurs initially as urine passes 
along the kidney nephron, such that renal pelvic urine is more acidic than that of the 
proximal tubule. Although urine has mainly an acidic pH and E. coli is a neutrophilic 
bacterium, the upregulation of genes for resistance to low pH suggests a change in the 
environmental milieu of the bacterial re-isolate to a more acidic one which it has to cope 
up with.  
 
In addition to coping up with stress in the environment, bacteria also need to defy 
changes in the normally-occurring levels of toxins within the host. The frmRAB operon, 
shown to be upregulated in FIM 636, is induced by formaldehyde. In 2004, Herring and 
Blattner, demonstrated that the level of frmR transcript was induced by formaldehyde 
215-fold over the level of non-induced cells. They suggested that it is most likely that the 
frmRAB operon encodes a complete pathway for degradation of formaldehyde produced 
endogenously as a by-product of demethylation reactions. In addition to these genes, a 
formate dehydrogenase transcript was also upregulated. Formate dehydrogenase 
catalyzes the oxidation of formate, a salt or ester of formic acid, to bicarbonate. Formic 
acid is the oxidizing product of formaldehyde while exposed to air. Formaldehyde can 
occur in very small amounts in the body. However, upregulation of genes related to 
formaldehyde in FIM 636 relative to ABU isolate 83972 suggests that there was probable 
increase in the levels of formaldehyde in the host to which the bacteria had been exposed.   
 
Interestingly, aside from the upregulation of genes related to formic acid metabolism and 
formate dehydrogenase, genes related to nitrate reductase were also upregulated in FIM 
636. Bacterial nitrate reductase reduces nitrates to nitrite (Lundberg et al., 2004). 
According to Stewart (1988), in the absence of oxygen, there is induction of respiratory 
nitrate reductase. E. coli is a member of the family Enterobacteriaceae, of which all 
members are facultative anaerobes (Brenner, 1984. In: Stewart, 1988). Facultative 
anaerobic bacteria use nitrate as an alternative electron acceptor to oxygen under hypoxic 
conditions (Lundberg et al., 2004). That means, they grow well in the absence of oxygen 
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when fermentable substrates are available. Moreover, they also grow with oxidizable 
substrates when environmental conditions allow for respiration. All enteric bacteria 
respire oxygen, nitrate, and fumarate, and most species can use other terminal electron 
acceptors as well (Brenner, 1984. In: Stewart, 1988).  
 
As early as 1962, Itagaki et al. (In: Stewart, 1988) already showed that formate 
dehydrogenase is induced during anaerobic growth on nitrate, reinforcing the idea that 
formate is an important electron donor for nitrate reduction. 
 
Taken together, since there is a unique pattern of phenotypic traits expressed by the re-
isolates as well as the transcriptional profile of the three motile re-isolates, it can be 
speculated that the expression of virulence factors and other factors such as stress-
resistance among the re-isolates could be attributed to the involvement of response 
mechanisms of the hosts and not only on the characteristics of the bacteria. It might very 
well be that the different hosts (i.e. patients included in the colonization studies) have 
different ways of responding to the introduction of ABU isolate 83972 into their system. 
Although ABU are said to be asymptomatic, they are still able to induce host response. 
There appears to be an increased chemokine production as well as neutrophil influx at the 
site of infection in ABU infections (Haraoka et al., 1999; Samuelsson et al., 2004). In this 
study, IL-6 and IL-8 levels were not significantly increased in vitro in A498 kidney cells 
upon inoculation with the motile re-isolates. However, the general trend of increase in the 
levels of these inflammatory markers was observed as incubation time increases (Figure 
32). It can therefore be deduced that the longer time the bacteria remains in the host could 
lead to increased detection and response.  
 
Moreover, even if the colonization studies have been going on for years and the patients 
have been stably colonized with ABU isolate 83972 without triggering any sign of 
infection, there may have been changes in the general-well being of the patients during 
the course of time (i.e. older age and possibly, physical deterioration and decrease in 
potency) which increased their susceptibility to even the slightest environmental stressor 
which aided the immune system to recognize ABU isolate 83972. This in turn, might 
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have paved the way for the bacteria to counter-act the changes in the host by undergoing 
changes in the expression of their own self-protecting factors.   
 
6.3. Functional papG gene in the E. coli 83972 Chromosome 
 
Genes of the P-fimbrial operon of ABU isolate 83972 are highly identical to UPEC strain 
CFT073 with the exception of papA, papE and papG, showing the greatest divergence 
(Klemm et al., 2006). The PapG adhesin, located at the tips of the fimbriae, recognizes 
the α-d-galactopyranosyl-(1-4)-β-d-galactopyranoside receptor epitope in the globoseries 
of glycolipids and mediates binding (Leffler et al., 1980; Lindberg et al., 1987). 
However, in ABU isolate 83972, although P-fimbria is expressed, it fails to 
hemagglutinate human red blood cells (RBCs), bind to human uroepithelial cells as well 
as Galα1-4Galβ-containing glycolipids (Klemm et al., 2006).  
 
In 2004, Bergsten et al. selected a strain that normally causes ABU and transformed it 
with a fully functional pap operon or a mutated, papG-deficient sequence. Their results 
demonstrated that PapG mediated adherence activates a mucosal host response. 
 
In this study, the non-functional papG gene of ABU isolate 83972 wt strain was 
complemented with a functional papG gene from UPEC strain CFT073. Results showed 
that upon complementation, the non-functional P-fimbria of ABU isolate 83972 has 
restored its function. The strain which does not have the ability to hemagglutinate sheep 
blood cells was able to do so upon complementation (Figure 36). In addition, the 
complemented strain could adhere better to T24 bladder cells compared to the wild type 
strain (Figure 22). This just shows the significant role played by the papG gene in the 
functionality of P-fimbria in E. coli 83972.  
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6.4. Implications and Outlook 
 
This study tried to address questions about the virulence traits and mechanisms present in 
ABU isolates. It tried to look at whether ABU isolates which mostly belong to the same 
phylogenetic group as UPEC strain CFT073 but behave like commensals have more 
similarities with commensal E. coli fecal isolates or if they have the tendency to harbor 
and express virulence traits in a similar fashion known among ExPEC strains. Using 
isolates from in vivo growth conditions, results of this study showed that ABU isolates 
generally possess virulence genes typically found among ExPEC strains but that they are 
mostly not expressed in the isolates. This verifies other researches already conducted on 
the virulence properties of ABU isolates (Watts et al., 2010; Mabbett et al., 2008; Hull et 
al., 1998). In these researches, ABU isolates were shown to possess genes, which are 
known to contribute to bacterial virulence. However, in this study, apart from looking at 
the virulence characteristics of ABU isolates alone, we also probed into the fact that since 
ABU isolates do not elicit symptoms on the part of the host, they therefore resemble 
commensals. It was already shown that some ABU strains arise from virulent strains by 
attenuation of virulence genes while others are non-virulent and resemble commensal 
strains. Through this finding it was proposed that virulence attenuation might constitute a 
general mechanism for mucosal pathogens to evolve toward commensalism (Zdziarski et 
al., 2008). We tried to look at the relatedness of ABU isolates to commensal fecal strains 
with regards to virulence properties. As a result, we were able to see that there is indeed 
not much significant difference between ABU and fecal isolates with regards to the 
virulence genes that they harbor and express.  
 
Next, this study was able to show that some of the re-isolates taken from patients stably 
colonized with E. coli 83972 that experienced episodes of symptoms were able to express 
certain virulence-related traits not expressed by their parent strain. The fact that these 
virulence-related strains were expressed variably from one re-isolate to another suggests 
that the changes in the expression of these traits in the bacteria is not dependent on the 
changes that the bacteria could acquire over time from its environment but rather, traits 
acquired through host-driven and host-dependent factors. Changes in the host 
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environment might have required the bacteria to acquire certain traits that will enable 
them to be more fit in thriving within the host environment. Zdziarski et al. (2010) 
already reported that some of the adaptation mechanisms involved in the changes within 
the bacteria appear to be unique for each host, suggesting that the genomic identity of a 
bacterial isolate is flexible and relevant in a given host niche. 
 
Most prominent among the virulence traits in the re-isolates is motility brought about by 
the flagella. It could be deduced that since motility is the only common virulence trait 
expressed in at least three of the re-isolates, the expression of flagella could have 
contributed to the induction of host response. However since the motile re-isolates, 
specifically BU05 35364, failed to adhere to host cells or even increase the levels of 
inflammatory markers secreted and expressed by the host cells show that motility among 
these re-isolates is most probably not a virulence trait at all. In contrast, it a means by 
which the bacteria are able to become more fit for survival in the host environment. 
 
Finally, this study also showed that the reconstitution of the non-functional papG gene of 
E. coli 83972 with the papG gene of UPEC strain CFT073 was able to restore the 
functionality of the P-fimbria in that it was able to agglutinate sheep blood cells and 
adhere better to host cells. This shows that expression of the fimbrial adhesin alone could 
possibly lead to a change from an asymptomatic strain to one that could induce host 
response. 
  
In summary, this work on the characterization of asymptomatic bacteriuria E. coli isolates 
could show the main similarities and differences between ABU and commensal fecal 
isolates, the significance of virulence traits expression and how they impact host-
bacterium interactions, and whether or not these virulence traits are used by the bacterium 
for their benefit or that these may pose a threat to their detection by the host’s immune 
system. 
  
In conclusion, in order to better understand the role played by the host in the changes of 
virulence traits expression and other factors among the re-isolates, it would be useful to 
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do functional gene analysis in the future. In addition, it would be interesting to analyze 
the gene expression pattern initiated by the bacteria in the host (i.e. either in vivo via a 
mouse model or in vitro through cell culture experiments).  
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8.2. Detailed methodological approaches 
 
Appendix 8.2.1. Agarose Gel Electrophoresis 
 
In running PCR products from multiplex reactions, a gel concentration of 2 % was used. 
For other PCRs performed, 1% gel was used. 
 
Procedure: 
 
1. An appropriate amount of agarose was dissolved in 1x TAE buffer by boiling in an 
Erlenmeyer flask in a microwave oven and cooled.  
2. The gel was casted when the Erlenmeyer flask was cool enough to be handled by 
pouring the gel to a gel mold. 
3. When the gel has hardened, it was transferred to an electrophoresis machine. The 
samples were loaded on the slots. 
4. The gel was run at 140 volts for 45 minutes.  
5. After the run, the gel was stained in ethidium bromide after which a photograph 
was taken to visualize the bands. 
 
Appendix 8.2 2. Pulsed Field Gel Electrophoresis 
 
Procedure: 
 
1. 4 ml (2x 2 ml) of an overnight culture was centrifuged at 13000 rpm, 2 min, RT 
2. They were then washed 2x with 1 ml SE buffer (Note: Vortexed after the first 
wash and re-suspended with a pipette upon the second wash.) OD600= 0.6-0.8 
(proper dilutions were made when necessary). 
3. The metal molds for the gel were prepared. (They were cooled at 4 °C prior to 
pouring of the gel). 
4. 900 µl bacterial suspension was mixed with 0.9 ml 2 % low melting agarose gel 
dissolved in LGT Buffer. 
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5. The mixture was pipetted into the metal mould. 
6. Once the cast hardened, half of the whole gel was placed into a 15 ml Greiner 
tube with 2.5 ml NDS solution. The gel was sliced into smaller pieces. 
7. These were incubated overnight in a 50 °C water bath. 
8. The following day, they were washed with TE Buffer every two hours and once a 
day everyday thereafter for 1-2 weeks. 
9. The plugs were stored at 4 °C until use. 
10. Restriction. Two pieces of agar plugs (cut further into about 1-3 mm size) were 
incubated in 1 ml NDE buffer (Vorpuffer) for 1 h at 50 °C. The buffer was 
warmed at the same temperature prior to this because it was stored at -20 °C. 
11. Afterwards, the following components were used for restriction digestion at 37 °C 
for 1 h: 
1 x restriction buffer (Spaltpuffer), 15 µl in a 150 µl reaction mix 
   1 µl enzyme (XbaI or AvrII) 
   134 µl water 
 
12. The agar plugs were loaded on gel and electrophoresis was done for 20h using 0.5 
x TBE + urea (1 M, 100 µl/L) and 1% agarose gel. 
 
   Program: Block 1, Initial time (5), Final time (50), Run time (20)  
        Blocks 2 and 3 must be set at 0 
 
Appendix 8.2.3. Sodium Dodecyl Sulfate- Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
 
SDS-PAGE separates proteins on a gel based on their molecular size. SDS is a detergent 
with a C-12 chain containing an ionogen sulfo-group. When β-mercapthoethanol is added 
to the protein samples and heated, the S=S bonds between sub-units in the proteins are 
broken and the proteins loose their tertiary structures. 
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SDS-PAGE needs the following materials: 
1x Running buffer 
12 % Running gel 
Stacking gel  
Molecular marker 
 
1. Preparation of the Gel 
 
Procedure: 
 
1. Two well-fitted glass plates were cleaned with ethanol to make one gel. The glass 
plates were clamped in place. 
2. The running and stacking gels were prepared using small flasks. For two gels, the 
following amounts and chemicals were used: 
 
 
 
 
 
 
 
 
 
 
3. The APS and the TEMED were added to the rest only when the gel was ready to be 
poured. 
4. The gel was poured in between the two glass plates using a Pasteur pipette. 
Immediately, isopropanol was added to make the gel very straight. 
5. The gel was then left at room temperature to polymerize for 15-30 minutes. 
6. When the gel has set, the top was rinsed with distilled water. Excess water was 
removed by using a Whatmann filter paper. 
Components Running 
Gel (12%) 
Stacking Gel 
30 % Acrylamide Mix 4 ml 330 µl 
Water 3.3 ml 1400 µl 
SDS (10 %) 100 µl 20 µl 
Tris (3 M, pH 8.8 for running gel &  
1 M, pH 6.8 for stacking gel) 
2.5 ml 250 µl 
APS (10 %) 100 µl 20 µl 
TEMED 4 µl 2 µl 
Appendix 
-143- 
7. The comb was inserted just a few centimeters above the level of the smaller glass 
plate to give room for the stacking gel. 
8. The stacking gel was then poured and left for 15 minutes or more until it was set. 
 
2. Running the Gel 
 
Procedure: 
 
1. The glass plates with the gel were transferred to the SDS-PAGE apparatus. 
2. Running buffer was then poured into the tank. The combs were removed and the 
samples (boiled at 94 oC for 10 minutes and centrifuged to spin down) were loaded 
into the slots. 
3. The lid was placed and the voltage set to maximum and amperage to 25 A per gel 
for 1 hour. 
4. The electrophoresis machine was turned off when the gel has run until the end of 
the glass plates. 
 
3. Protein Gel Staining 
 
Procedure: 
 
1. Gel was stained for 20 min in Coomasie Brilliant Blue (0.25 % CBB R-250, 0.25 
% CBB G-250, 40 % methanol and 7 % acetate). 
2. Then, it was destained 2 x 20 min in Destaining solution I (50 % ethanol, 10 % 
acetate). 
3. Gel was further destained 2 x 20 min, also overnight or longer (5 % ethanol, 7.5 
% acetic acid). 
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Appendix 8.2.4. Western Blot Analysis 
 
Western blot is an immunodetection technique that uses antibodies to recognize specific 
proteins. This technique is normally preceded by separation of proteins on a 
polyacrylamide gel. The proteins are blotted on a nitrocellulose membrane followed by 
immunodetection. 
 
1. Semi-dry Blotting 
 
After performing SDS-PAGE, the proteins on the gel were transferred on a nitrocellulose 
membrane by semi-dry blotting. For this, the following materials were needed: 
 
Semi-dry Blotting Buffer 
Methanol 
8 pieces of Whatmann filter paper 
Nitrocellulose membrane (Immobilon-P, Millipore) 
Electrophoresed gel 
 
Procedure: 
 
1. The Whatmann filter papers and nitrocellulose membrane were soaked in semi-dry 
blotting buffer for 5 minutes.  
2. The necessary materials were arranged in the electrode plate of the blotting 
apparatus from top to bottom as follows: 3 pieces of Whatmann filter paper, 
electrophoresed gel, nitrocellulose membrane and 9 pieces of Whatmann filter 
paper. 
3. The amperage was set to 32 mA per gel and blotting was done for 1 hour. After 
which, immunodetection followed. 
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2. Immunodetection of Western Blot 
 
To detect proteins on the blot, specific antibodies are used. The primary antibody is used to 
bind to the antigen and the secondary antibody binds to the primary antibody for detection 
using a series of incubation and washing steps. The secondary antibody is conjugated to an 
enzyme that would react with a specific substrate to determine the presence of the 
antigen/s. 
 
Procedure: 
 
1. After semi dry blotting, the nitrocellulose membrane was blocked for one hour at 
room temperature or overnight at 4 ºC in 5 % skimmed milk in TBS-T. 
2. The blot was then washed for 5 minutes, 3 times in TBS-T.  
3. The blot was incubated with the primary antibody (anti-flaA raised in rabbit against 
Legionella pneumophila) in 2.5 % skimmed in a 1:1000 dilution for one hour. 
4. Then it was washed again 2 times 10 minutes and 2 times 5 minutes in TBS-T. 
5. The blot was incubated with the secondary antibody (anti-rabbit from goat or 
swine) in incubation buffer similarly used in step 3 in a 1:5000 dilution. 
6. The blot was then washed 2 times 15 minutes and 4 times 5 minutes in TBS-T. 
7. After washing, detection followed by staining the membrane with the Membrane 
Staining Solution for a few minutes. Once bands were visible, reaction was stopped 
in water. 
 
Appendix 8.2.5. Extraction of Total RNA  
 
When working with RNA, special care had to be taken in order to prevent contamination 
of the samples with exogenous RNases. Gloves were worn throughout the whole 
experiment and RNase free pipette tips and reaction tubes were used. For all buffers and 
solutions, water was pre-treated overnight with 0.1 % (v/v) diethylpyrocarbonate (DEPC) 
at 37 °C and autoclaved twice to remove remaining DEPC. 
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RNA was isolated using the RNeasy Mini kit (QIAGEN) according to the supplied 
protocol. All steps of the RNeasy protocol were performed at room temperature (RT). 
 
Procedure: 
 
1. Bacteria were grown at 37 °C in 125 ml of pooled human urine until the optical 
density OD600 reached 0.15.  
2. 50 ml of the urine culture was taken and centrifuged at 6000 rpm for 5 min.  
3. The supernatant was removed and pellets were resuspended in 20 ml PBS and 
RNAprotect (Qiagen) 1:1 (v/v).  
4. Samples were incubated at room temperature for 5 min and centrifuged at 6000 
rpm for 10 min.  
5. Bacterial pellets were either stored at -80 °C or bacterial RNA was immediately 
isolated. To continue, bacterial pellets were resuspended thoroughly in 100 µl of 
lysozyme-containing TE buffer (50 mg/ml) and incubated at 37 °C for 5 s with 
vortexing every 2 min.  
Appendix 8.2.6. Removal of contaminating DNA by DNase treatment and RNA cleanup 
 
Contaminating DNA was removed from total RNA preparations by DNase I digestion 
(New England Biolabs).  
 
Procedure: 
 
1. 15 µg RNA in a final volume of 85 µl were mixed with 10 µl 10 x DNase I buffer 
and 10 µl RNase- free DNase I.  
2. Samples were incubated for 1 h at 37 °C, followed by RNA cleanup using the 
RNeasy Mini kit (QIAGEN).  
3. 350 µl RLT buffer supplemented without 10 µl ß-mercaptoethanol and 250 µl 
100 % (v/v) ethanol were added to the DNase-treated RNA samples 
4. They were then loaded into the purification columns.  
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5. After brief centrifugation, the columns were transferred to fresh collection tubes 
and washed twice with 500 µl RPE buffer.  
6. Finally, RNA was eluted from the column in 30 µl nuclease-free water and run on 
Bioanalyzer for analysis of RNA quality and quantity. 
 
Analysis of RNA Stability and Concentration (2100 Bioanalyzer, Agilent 
Technologies) 
 
Procedure: 
 
1. Samples are denatured at 94 °C for 2 min. 
2. Next, 65 µl gel matrix and 1 µl dye are mixed, vortexed and centrifuged at 1000 
rpm for 10 min. 
3. Meanwhile, the Bioanalyzer pins were washed with 350 µl RNAseZap for 1 min 
followed by 350 µl water for 30 seconds. 
4. 9 µl gel matrix is applied to the corresponding slots on the chip. 
5. 5 µl of buffer is then pipetted into every slot on the chip except for the 3 slots for 
the gel matrix.  
6. 1 µl of each sample is then loaded onto the slots. 
7. The chip is vortexed and loaded into the Bioanalayzer. 
Appendix 8.2.7. Reverse Transcription and cDNA labelling 
 
Reverse transcription was performed using SuperScript IIITM reverse transcriptase 
(Invitrogen) and the fluorescently labelled nucleotides Cy3- and Cy5-dCTP (Amersham 
Pharmacia, Freiburg, Germany).  
 
Procedure: 
 
1. For primer annealing, 10 µg total RNA was mixed with 1 µg of hexamer oligos in 
a total volume of 15 µl.  
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2. The annealing mix was heated for 10 minutes at 70 °C, then cooled down to room 
temperature for 5 min followed by brief centrifugation. In the meantime, the 
reaction mix composed of the following was prepared:  
5x first strand buffer   8 µl 
0.1x DTT    4 µl 
Nucleotide mastermix   4 µl 
RNaseOut     1 µl 
SuperScript IIITM (200 U/µl)   1 µl  
RNase free H2O   4 µl 
  
3. Then, 22 µl of the reaction mix was pipetted into a small PCR reaction tube 
together with 15 µl annealing mix  
4. 4 µl Cy3- or Cy5-dCTP (1 mM) was added.  
5. The total mix was incubated for 1h at 46 °C in a thermoblock.  
6. After 25 min, another 1 µl of SuperScript IIITM reverse transcriptase (200 U/µl) 
was added.  
7. The reaction was stopped by addition of 5 µl EDTA (500 mM). 
8. To hydrolyze RNA, 10 µl NaOH (1 M) was added, followed by incubation at 65 
°C for 15 min.  
9. The reaction mixture was cooled down to room temperature. 
10. 25 µl Tris-HCl (1M, pH 7.5) was added. 
11. Labelled targets were purified using the Qiaquick PCR Purification Kit (Qiagen) 
according to the manufacturer’s instructions. 
For generation of cDNA for qRT-PCR, after annealing of primers at 70 °C for 15 
minutes, the tubes were cooled down for 5 min at room temperature. Afterwards, 22 
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µl transcription mix was added to each tube. The reaction mixture was incubated at 
52 °C for 1 h in a thermoblock, followed by 15 min at 70 °C. 
Appendix 8.2.8. Hybridization of Nucleotide Microarrays  
1. Pre-hybridization (OpArray) 
 
1. An appropriate volume of OpArray Pre-hybridization Solution was pre-warmed at 
42°C for 30 min. 
2. Slides were incubated in the pre-warmed solution using an array box (Scienion 
AG) with enough volume of buffer to soak them at 42°C for 1h. 
3. Slides were washed for 5 min in Wash Solution 1 at room temperature. They were 
then transferred to double distilled water and rinsed for 30 seconds. This was 
repeated twice. 
4. The slides were then centrifuged at 1000 rpm for 5 min to dry. 
 
2. Hybridization (OpArray) 
 
1. The slide was placed in the hybridization cassette. 
2. Meanwhile, the labelling target solution was prepared by mixing 2 µl of 40 pmol 
Cy5-labelled targets with 2 µl of 40 pmol Cy3-labelled targets and 36 µl OpArray 
Hybridization Buffer. 
3. The labelling target solution was denatured by incubating in a thermocycler at 65 
°C for 5 minutes. 
4. The solution was applied directly to the slides. 
5. The cassette was then placed inside the hybridization of oven and left to hybridize 
for 14-16 hours.  
 
3. Post-hybridization Washing (OpArray) 
 
1. The post-hybridization washing solutions were prepared as follows: 
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Wash Solution 2: 
 50 ml OpArray Wash A 
 25 ml OpArray Wash B 
 to a final volume of 500 ml with sterile water 
 
Wash Solution 3: 
 50 ml OpArray Wash A 
 to a final volume of 500 ml with sterile water 
 
Wash Solution 4: 
 5 ml OpArray Wash A 
 to a final volume of 500 ml with sterile water 
 
2. Wash Solution 2 was pre-warmed at 42 °C. 
3. After hybridization, the slides were washed in the pre-warmed Wash Solution 2 at 
42 °C for 10 min. 
4. The slides were transferred to Wash Solution 3 and incubated at RT for 10 min. 
5. The slides were transferred to Wash Solution 4 and incubated at RT for 5 min. 
6. The slides were then centrifuged at 1000 rpm for 5 min to dry. 
 
Appendix 8.2.9. Polysaccharide Intercellular Adhesin (PIA) Immuno Dot Blot 
 
Procedure: 
 
1. 20 ml overnight cultures of bacteria were grown statically at 37 °C. RP62A was 
used as positive control and TM 300 as negative control. 
2. Optical density was measured the following day. OD600 was standardized to 6. 
Samples pelleted in 50 µl EDTA (0.5 M, pH8) by centrifugation. 
3. Samples were heated at 100 °C for 5 minutes. 
4. Samples were centrifuged at 13000 rpm for 10 minutes, room temperature. 
5. 40 µl of the supernatant were taken and 5 µl Proteinase K (20 mg/ml) was added. 
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6. They were then incubated at 57 °C for 1 hour. 
7. Samples were inactivated by heating for 5 minutes at 100 °C.  
8. 5 µl each of the samples was gently and carefully pipetted on a nitrocellulose 
membrane.  
9. The membrane was dried very well under the sterile hood. 
10.  The membrane was blocked in 5 % skimmed milk in 1 X TBS for 1 hour while  
 shaking. As alternative, blocking overnight at 4 °C may also be done. 
11.  The membrane was incubated in the primary antibody (PIA), diluted 1:200 in 2.5  
% skimmed milk in 1 x TBS-T for 1hour at room temperature while shaking.   
Alternatively, incubation may be done overnight at 4 °C. 
12.  The primary antibody was decanted and stored at -20 °C for further use (may be  
 re-used up to 3 x). 
13.  The membrane was briefly washed 1x followed by 3x washing for 5 minutes  
 each, in 1x TBS-T. 
14.  The membrane was then incubated in the secondary antibody diluted 1:5000 for 1  
 hour at room temperature. 
15.  The secondary antibody was decanted and store at -20 °C for further use (may be   
 re-used up to 4x). 
16.  The membrane was briefly washed 1x followed by 3x washing for 5 minutes  
    each, in 1x TBS-T. 
17.  For visualization of immunological interaction, the membrane was incubated in    
 the developing solution for 2 minutes and immediately viewed under a  
 chemiluminescence camera. 
18.  In addition, the blot may also be transferred to an X-ray film by incubation of the  
 blot unto the film in the dark room, followed by development in the machine. 
 
Developing Solution: 
1 ml Solution A + 0.3 µl H2O2 (30 %) + 100 µl Solution B 
100 ml Solution A + 3 µl H2O2 + 100 µl Solution B 
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Solutions: 
Solution A: 200 ml 0.1 M Tris-HCl pH 8.6 + 50 mg Luminol (Sigma A4685) (stored 
at 4°C) 
Solution B: 11 mg para-Hydroxycomarine acid (Sigma C9008) in 10 ml DMSO 
(stored in the dark at room temperature) 
 
Appendix 8.2.10. LPS Isolation 
 
Procedure: 
 
1. Strains were grown on plate. Next, they were scraped off from the agar and 
transferred to an Eppendorf tube. 
2. The cells were weighed and resuspended in water to a concentration of 1 mg cells/ 
30 µl suspension. 
3. 30 µl of sample (1 mg cells) was mixed with 10 µl 4x SDS sample buffer and 
incubated at 100 °C for 10 min. 
4. This was then cooled briefly. 
5. Afterwards, 100 µg proteinase K was dissolved in 1x SDS sample buffer. 20 µl of 
this was added into the samples and incubated at 60 °C for 1 h. 
6. 30 µl of the LPS prep was used for electrophoresis in a 20 x 20 cm 15 % gel. The 
gel was run overnight (O/N) at 8 mA, RT. 
 
Staining with AgNO3 
  
Procedure: 
 
1. The gel was fixed O/N in 100 ml 1X fixation solution. 
2. Next day, the fixation solution was replaced with 100 ml 1x periodate solution 
where the gel was incubated for 5 min. 
3. The gel was washed 3x, 30 min each, with dH2O. 
4. Next, the gel was incubated for 10 min in AgNO3. 
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5. The gel was washed 3x, 10 min each, with dH2O. 
6. Meanwhile, the developing solution was pre-heated to 60 °C. The gel was 
developed in this solution. 
7. When bands appeared intense enough, the reaction was stopped by incubating in 
50 mM EDTA solution for 10 min. 
8. Finally, the gel was scanned. 
 
Appendix 8.2.11. PCR Product Purification 
 
PCR products were directly purified either using the QIAquick PCR Product Purification 
Kit (Qiagen™) or gel-purified by the Gel Extraction Kit (Qiagen™). 
 
QIAquick PCR Product Purification 
 
Procedure: 
 
1. 5 volumes of Buffer PB were added to 1 volume of PCR sample and mixed. 
2. DNA was bound into a QIAquick spin column by pipetting the sample into the 
column and centrifuging at 13000 rpm for 1 min. 
3. The flow-through was discarded and the sample was washed with 0.75 ml Buffer 
PE and centrifuged at 13000 rpm for 1 min. 
4. The flow-through was discarded and the column was dried by centrifugation at 
13000 rpm for 1 min. 
5. The column was placed in a clean 1.5 ml eppendorf tube. The DNA was eluted 
with 30 µl of water by centrifugation at 13000 rpm for 1 min.  
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Gel Extraction  
 
Procedure: 
 
1. The gel fragment was excised using a clean sharp scalpel and the gel slice was 
weighed. 
2. 3 volumes of Buffer QG were added to 1 volume of gel. 
3. This was then incubated at 50°C for 10 min or until it was completely dissolved. 
4. 1 gel volume of isopropanol was then added to the sample and mixed. 
5. DNA was bound into a QIAquick column by applying 800 µl of sample followed 
by centrifugation. 
6. The flow-through was discarded and 0.5 ml of Buffer QG was given to the 
column then centrifuged at 13000 rpm for 1 min. 
7. The sample was washed with 0.75 ml Buffer PE and centrifuged at 13000 rpm for 
1 min. 
8. The column was again centrifuged at 13000 rpm for 1 min to dry. 
9. The sample was eluted with 40 µl of water by centrifugation at 13000 rpm for 1 
min. 
 
Appendix 8.2.12. Southern Blot Analysis 
 
Procedure: 
 
1. 10 µg chromosomal DNA was subjected to restriction digestion with the proper 
enzyme then 
2. Run on agarose gel. 
3. The blotting apparatus consisting of a white tray (height should be sufficient just 
to hold enough solution but must not be too deep), plus a glass, a stack of gray 
tissue paper (about 10 cm and of equal size as gel) was prepared. 
4. The gel was placed in denaturation solution (0.5 NaOH; 1.5 M NaCl) for 20 min, 
2x with shaking. 
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5. Afterwards, it was transferred into neutralizing solution (0.5 M Tris-HCl, pH 7.5; 
1.5 M NaCl) for 20 min, 2x with shaking. 
6. Meanwhile, the following: 5x Whatmann paper (exactly the same size as gel), 1x 
Nytran Super Charge membrane were prepared. 
7. The “Blotting Machinery” was constructed as follows: 
 
 
 
 
 
 
 
 
 
 
 
 
 
8. Over the Whatman paper over the glass, 2x pre-wetted Whatman (remove air 
bubbles by rolling a Pasteur/glass pipette over it), the agarose gel (upside down), 
membrane, 3x Whatman and a stack of tissue paper (10 cm) were stacked on top 
of each other. A weight was put on top to facilitate transfer. 
9. This was left to stand overnight. 
10. The following day, the blot was marked with pencil by tracing through the holes 
of the gel (to serve as guide). 
11.  The blot was then washed 1x in 6x SSC for 5 min, with shaking. 
12.  Next, it is dried in Whatman paper until ready to use. 
 
Note! Probe should be made ready. At least 3x of 50 µl of PCR volume for both 
strains of interest and a control should be available. 
 
Tray with 20x SSC (0.3 M 
Na citrate, pH 7.0; 3M 
NaCl) which could be re-
used 
Glass with big Whatman paper on top 
(will provide capillary action for 
blotting) 
= must be completely wet; thus, 
pipette some 20 x SSC over it 
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13.  For cross-linking of the DNA into the membrane, 1 µl of probe was pipetted into 
the membrane. For example,  
 
  
 
 
 
 
       Then, in the UV chamber, C3 (for cross-linking through exposure to UV) was  
       used for cross-linking. 
 
             Meanwhile, the hybridization buffer was prepared by thawing at 42 °C. 
 
14.  The membrane was transferred into two short shaking glass tubes (one part only   
       with the DNA ruler and another with the samples to be probed). 25 ml of the   
       thawed hybridization buffer was put into each. 
15.  This was then put in shaking incubator (set at 42 °C) and incubated while shaking  
       for 1 hour. This is called pre-hybridization. 
16.  Next step was to label the probe. 100 ng DNA per ml of hybridization buffer in a   
       final volume of 10 µl in dH2O was denatured for 5 min at 94 °C and cooled    
       immediately on ice for another 5 min. Then, 10 µl of labelling reagent and 10 µl  
       gluteraldehyde were added. The mixture was incubated for 15 min at 37 °C and  
       added to the hybridization reaction. This was incubated overnight at 42 °C. 
17.  The membrane was washed 2x for 20 min at 42 °C with wash solution I (0.5 x   
       SSC; 0.4 % (w/v) SDS). 
18.  Then again, it was washed 2x for 10 min, RT, with wash solution II (2x SSC). 
19.  A bit of the remaining wash solution was removed by tapping the membrane on   
       Whatman paper (Note! It should not be very dry though). 
20.  The membrane was incubated for 2 min in 2-3 ml each (depends on the size of  
       the membrane) of detection solution I and detection solution II (ECL Kit). The  
       two must be mixed well (1:1). 
For example, put 
here 
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21. The membrane was dried a bit on Whatman paper and covered in a Saran wrap 
(avoid air bubbles). 
 
Chemoluminescence was detected by exposure of the membrane to an X-ray film, 
developed in the dark room. 
 
Appendix 8.2.13. Plasmid Isolation  
 
Procedure: 
 
1. Bacterial cultures were grown overnight at 37 °C.  
2. 4 ml (2 x 2 ml) of the cultures were centrifuged for 2 min at 13000 rpm, room 
temperature (RT). 
3. Pellets were resuspended with 150 µl Buffer 1 by vortexing. 30 µl lysozyme was 
added and incubated for 10 min, RT. 
4. 300 µl Buffer 2 was added. The mixture was inverted 2x and incubated for 5 min, 
RT. 
5. 225 µl Buffer 3 was added. The mixture was inverted 2x and incubated for 10 min 
on ice. 
6. 200 µl Phenol-chloroform was added into the mixture followed by vortexing. 
7. Mixture was centrifuged for 10 min, RT. 
8. Supernatant was transfered into a new 1.5 ml Eppendorf tube. 100 % ethanol was 
added up to the brim of the tube. 
9. It was then centrifuged for 30 min at 13000 rpm, RT. Supernatant was decanted. 
10. 70 % ethanol was added up to the brim of the tube. This was followed by 
centrifugation for 10 min at 13000 rpm, RT. Supernatant was decanted. 
11. The tube was spun for 1 min at 13000 rpm, RT to facilitate complete drying. 
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Appendix 8.2.14. Chromosomal DNA Isolation (using Phenol) 
 
Procedure: 
 
1. Overnight bacterial culture was grown in LB.  
2. The sample was centrifuged for 15 minutes, 13000 rpm. 
3. Pellet was resuspended in 500 µl Buffer 1 (50 mM Tris-HCl; 50 mM EDTA; pH 
8.0) and 
4. Incubated for 1 h or longer (-20 °C). 
5. 50 µl lysozyme solution (freshly prepared: 10 mg/ml lysozyme in 0.25 M Tris-
HCl, pH 7.5) was added into the cells and inverted. 
6. Samples were incubated for 45 minutes on ice. 
7. 100 µl step-solution was added while inverting. 
Step-solution:  0.5 % SDS 
  50 mM Tris-HCl, pH 7.5 
  0.4 M EDTA  
8. The samples were incubated for 1-2 h in 50 °C water bath. 15 µl Proteinase K was 
added and then another 10 µl if it was still not clear. 
9. Water was added up to the 1.5 ml mark (in a 2 ml microfuge tube) and inverted. 
10.  Phenol (equilibrated in Tris-HCl) was added up to the 2 ml mark and vortexed. 
11.  Samples were centrifuged for 15 minutes, 13000 rpm, RT. 
12.  The upper phase was removed using a blue pipette tip cut at the edge to widen    
       the hole. (Only the thread-like part was taken and transferred to an eppendorf   
       tube). 
13.  0.1 volume 3 M Na acetate, pH 5.2 was added. 
14. Next, 2.5 volume ethanol was added and this was mixed until clear then 
transfered into a white plastic tube. 
15.  Samples were washed 1 x in 100% ethanol, 1 x in 70 %. (Just inverted and  
       removed).  
16. They were then dissolved in 200 ml water.  
 
+ 1 mg/ml 
Proteinase K 
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Figure 37. Motility of 20 colonies of BU05 35364 on LB swarm agar plates. 
8.3. Appendix Figures 
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Figure 38. Motility of 20 colonies of BU04 63630 on LB swarm agar plates. 
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Figure 39. Motility of 20 colonies of FIM 636 on LB swarm agar plates.   
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Figure  40. Motility of 20 colonies of BU05 35364 on urine swarm agar plates. 
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Figure   41. Motility of 20 colonies of BU04 63630 on urine swarm agar plates. 
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Figure   42. Motility of 20 colonies of FIM 636 on urine swarm agar plates. 
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Figure 43. Host parameters of Patient 1 from which re-isolate BU 04 41631 
was taken. Sampling Time Points (Number of days post-inoculation):  1- 0, 2- 11, 
3- 40, 4- 76, 5- 111, 6- 140, 7- 185, 8- 192.  BU 04 41631 was taken at time point 
8. Data kindly provided by Dr. B. Wullt, Lund, Sweden.  
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Figure 44. Host parameters of Patient 2 from which re-isolate BU 04 68088 
was taken. Sampling Time Points (Number of days post-inoculation):  1- 0, 2- 25, 
3- 53, 4- 88, 5- 104.  BU 04 68088 was taken at time point 5. No data available for 
PMN influx for time point 5. Data kindly provided by Dr. B. Wullt, Lund, 
Sweden.  
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Figure 45. Host parameters of Patient 3 from which re-isolate BU 04 50907 
was taken. Sampling Time Points (Number of days post-inoculation):  1- 0, 2- 3,       
3- 20.  BU 04 50907 was taken at time point 3. Data kindly provided by Dr. B. 
Wullt, Lund, Sweden.  
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Figure 46. Host parameters of Patient 4 from which re-isolate BU 04 63630 
was taken. Sampling Time Points (Number of days post-inoculation):  1- 0, 2- 1, 
3- 19.  BU 04 63630 was taken at time point 3. Data kindly provided by Dr. B. 
Wullt, Lund, Sweden.  
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Figure 47. Host parameters of Patient 5 from which re-isolate BU 05 35364 
was taken. Sampling Time Points (Number of days post-inoculation):  1- 0,    
2- 12, 3- 40, 4- 63, 5- 67. BU 05 35364 was taken at time point 5. Data kindly 
provided by Dr. B. Wullt, Lund, Sweden.  
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Figure 48. Host parameters of Patient 6 from which re-isolate FIM 636 
was taken. Sampling Time Points (Number of days post-inoculation):  1- 0,    
2- 1, 3- 2, 4- 7, 5- 14, 6- 28, 7- 49, 8- 59.5. FIM 636 was taken at time point 8. 
Data kindly provided by Dr. B. Wullt, Lund, Sweden.  
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8.4. Expression Profiling Data 
 
Table 14. Upregulated genes in re-isolate BU04 63630 
Gene Function Ratio p-value 
gadA Acid resistance 1.012 0.016821 
gadB Acid resistance 1 0.018224 
hdeA Acid resistance 1.248 0.002506 
hdeB Acid resistance 1.062 0.006815 
slp Acid stress 1.182 0.008119 
rpoA RNA Polymerase, sigma factor 1.055 0.008119 
rpoE RNA Polymerase, sigma factor 1.046 0.005747 
rpoS RNA Polymerase, sigma factor 0.915 0.000314 
recA SOS response to DNA damage 3.196 0.001533 
recN SOS response to DNA damage 1.932 0.00274 
lexA SOS response to DNA damage 1.536 0.00932 
yebG SOS response to DNA damage 1.837 0.080393 
sulA SOS response to DNA damage 1.839 0.006357 
dinB SOS response to DNA damage 1.524 0.003321 
dinI SOS response to DNA damage 2.125 0.005379 
ruvB SOS response to DNA damage 1.197 0.001149 
umuD Response to DNA damage 1.67 0.007761 
yphE ABC Transporter 0.979 0.003161 
yphF ABC Transporter 1.12 0.013532 
kdpA Potassium Transport 0.932 0.002286 
kdpB Potassium Transport 1.136 0.001215 
rpmC 50S ribosomal protein 1.115 0.000042 
rpmD 50S ribosomal protein 1.029 0.017251 
rpmI 50S ribosomal protein 0.911 0.00241 
c1524  Unknown function 1.528 0.006826 
c1525  Unknown function 1.472 0.001486 
c1527  Unknown function 1.641 0.003696 
c1528  Unknown function 1.607 0.003131 
c1530  | c5144  | c3607  Unknown function 2.034 0.002908 
c1531  Unknown function 1.362 0.004536 
Z2360 | Z2135 Phage-related 2.027 0.004327 
Z2361 | Z2134 Phage-related 1.502 0.001511 
Z2362 | Z2133 Phage-related 1.407 0.007946 
c1536  Phage-related 2.159 0.001151 
c1538  Phage-related 1.95 0.007709 
c1539  Phage-related 1.571 0.03906 
c1541  Phage-related 1.214 0.001956 
c1547  Phage-related 2.26 0.009778 
c1550  Phage-related 1.581 0.007511 
c1555  Phage-related 1.821 0.004958 
c1570  | c1446  Phage-related 1.324 0.008774 
c1571  | c1447  Phage-related 1.26 0.00663 
c1574  Phage-related 2.027 0.00198 
c1575  | c1451  Phage-related 1.697 0.004709 
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c1578  Phage-related 1.466 0.011361 
c1584  | c3161  Phage-related 1.534 0.08459 
c3162  | c1583  Phage-related 2.081 0.042295 
c3163  Phage-related 1.48 0.000738 
 
 
Table 15. Upregulated genes in re-isolate BU05 35364 
Gene Function Ratio p-value 
groES Chaperonin. heat-shock proteins 0.959 0.006171 
flgA Flagellar assembly and biosynthesis 1.481 0.031897 
flgD Flagellar assembly and biosynthesis 1.847 0.042864 
flgE Flagellar assembly and biosynthesis 1.413 0.018316 
flgF Flagellar assembly and biosynthesis 1.379 0.090894 
flgG Flagellar assembly and biosynthesis 1.716 0.046086 
flhA Flagellar assembly and biosynthesis 1.301 0.057089 
fliA Flagellar assembly and biosynthesis 3.55 0.067707 
fliG Flagellar assembly and biosynthesis 1.334 0.078135 
fliO Flagellar assembly and biosynthesis 1.068 0.000531 
rfaG Lipopolysaccharide 1.101 0.003292 
rfaI Lipopolysaccharide 1.311 0.003868 
rfaJ Lipopolysaccharide 1.249 0.015306 
rfaP Lipopolysaccharide 1.16 0.015306 
rfaY Lipopolysaccharide 1.368 0.00051 
waaV Lipopolysaccharide 1.191 0.010939 
waaW Lipopolysaccharide 1.31 0.002182 
glmS N-acetyl glucosamine 1.628 0.000975 
glmU N-acetyl glucosamine 1 0.002555 
lpxA N-acetyl glucosamine 1.407 0.009802 
lpxB N-acetyl glucosamine 0.952 0.003486 
chuA Heme 1.485 0.004442 
chuT Heme 1.26 0.016839 
chuU Heme 1.249 0.007451 
chuW Heme 1.277 0.011657 
chuX Heme 1.168 0.0219 
chuY Heme 1.162 0.017643 
entC Enterochelin biosynthetic pathway 1.021 0.000406 
entA Enterochelin biosynthetic pathway 1.049 0.018279 
cvpA Colicin production 3.492 0.000656 
cirA 
Colicin receptor, iron-siderophore complex uptake 
receptor 1.72 0.009339 
malE Maltose transporter 2.349 0.011769 
malF Maltose transporter 1.183 0.080574 
malK Maltose transporter 0.927 0.00219 
malM Maltose transporter 2.188 0.026 
malP Maltose transporter 2.141 0.013584 
malQ Maltose transporter 1.867 0.01209 
malZ Maltose transporter 0.976 0.058784 
ompF Outer membrane protein 1.663 0.001972 
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fabA Dehydaratase 1.175 0.004356 
fabZ Dehydaratase 1.021 0.001472 
fabB Dehydaratase 1.107 0.000234 
speA Decarboxylase 1.288 0.00237 
speB Decarboxylase 0.9 0.000083 
yqjG Transferase 1.285 0.016022 
yqjF Oxidase 1.769 0.005481 
proA Amino acid biosynthesis 1.029 0.017441 
proP Amino acid biosynthesis 1.286 0.018709 
proS Amino acid biosynthesis 1.089 0.000408 
proY Amino acid biosynthesis 1.242 0.001179 
glnA Amino acid biosynthesis 0.992 0.00056 
glnK Amino acid biosynthesis 1.382 0.001173 
glnL Amino acid biosynthesis 1.014 0.007842 
glnP Amino acid biosynthesis 0.92 0.008164 
glnQ Amino acid biosynthesis 1.045 0.002131 
thrA Amino acid biosynthesis 1.176 0.025932 
thrB Amino acid biosynthesis 0.979 0.016287 
thrL Amino acid biosynthesis 0.889 0.076079 
yhhW Pirin homolog  1.201 0.013399 
c4310  Unknown function 1.937 0.006885 
 
 
Table 16. Upregulated genes in re-isolate FIM 636 
Gene Function Ratio p-value 
frmA Formic acid metabolism 2.653 0.027601 
frmB Formic acid metabolism 2.206 0.045425 
frmR Formic acid metabolism 1.942 0.026269 
fdnG Formate dehydrogenase 0.942 0.00034 
fdnH Formate dehydrogenase 1.283 0.008418 
fdnI Formate dehydrogenase 1.405 0.036096 
narH Nitrate reductase. reduces nitrate to nitrite 0.957 0.007741 
narI Forms a respiratory chain with formate dehydrogenase 1.318 0.028437 
narJ Forms a respiratory chain with formate dehydrogenase 1.159 0.000942 
napA Nitrate reductase 1.066 0.002103 
napB Nitrate reductase 1.071 0.002724 
napC Nitrate reductase 0.921 0.013884 
napG Nitrate reductase 1.121 0.002918 
nirB Reduces nitrite to ammonia 1.236 0.001582 
nirC Reduces nitrite to ammonia 0.898 0.003501 
nirD Reduces nitrite to ammonia 1.04 0.018341 
hcp Scavenger of toxic by-products of nitrogen metabolism 1.11 0.000099 
hcr Scavenger of toxic by-products of nitrogen metabolism 1.131 0.00182 
yagU Acid resistance 1.272 0.001399 
uspA Induced in response to a variety of stresses 1.254 0.002062 
yfiA Cold shock protein related to 30S 1.37 0.007329 
frdB Fumarate reductase, flagellar motility 1.118 0.003225 
frdC Fumarate reductase, flagellar motility 1.012 0.001462 
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papC_2 | papC P fimbria 1.125 0.003409 
papD_2 P fimbria 0.99 0.070153 
PapE P fimbria 1.434 0.082258 
papK_2 | papK P fimbria 1.233 0.019907 
focA F1C fimbria 1.455 0.00342 
focC F1C fimbria 1.016 0.007778 
sfaB F1C fimbria 1.09 0.004029 
sfaD F1C fimbria 1.034 0.006438 
oppA Oligopeptide transporter 1.197 0.000418 
oppB Oligopeptide transporter 0.952 0.00577 
oppD Oligopeptide transporter 0.957 0.000882 
oppF Oligopeptide transporter 1.003 0.000224 
ompC Outer membrane protein 1.296 0.000324 
deoB Phosphopentomutase  0.997 0.00036 
deoD Phosphopentomutase  0.957 0.007274 
manX Phosphotransferase system (PTS), mannose 0.912 0.030577 
manY Phosphotransferase system (PTS), mannose 0.924 0.006227 
manZ Phosphotransferase system (PTS), mannose 1.007 0.018686 
leuB Amino acid biosynthesis 1.361 0.000511 
leuC Amino acid biosynthesis 1.314 0.002602 
leuD Amino acid biosynthesis 1.261 0.000873 
ilvC Amino acid biosynthesis 1.008 0.000492 
ilvH Amino acid biosynthesis 0.999 0.001171 
ilvN Amino acid biosynthesis 0.965 0.006679 
ilvY Amino acid biosynthesis 0.815 0.001236 
 
 
Table 17. Commonly upregulated genes in re-isolates BU04 63630 and BU05 35364 
Gene Function Ratio Ratio p-value p-value 
     BU05 BU04   BU05 BU04  
    35364 63630 35364 63630 
osmB Osmotic stress, lipoprotein 1.996 1.92 0.021315 0.011682 
groEL Chaperonin, heat-shock proteins 1.205 1.212 0.029904 0.007058 
cnf1 Cytotoxic necrotizing factor  1.364 0.944 0.049088 0.008995 
ydhA Lysozyme inhibitor, predicted lipoprotein 1.106 1.017 0.004189 0.011748 
rpmB 50S ribosomal protein 1.43 1.299 0.014022 0.001217 
rpmG 50S ribosomal protein 1.482 1.344 0.012841 0.001111 
yohN Unknown function 1.337 1.154 0.01608 0.004048 
ypeC Unknown function 1.332 1.609 0.027133 0.007874 
 
 
Table 18. Commonly upregulated genes in re-isolates BU04 63630 and FIM 636 
Gene Function Ratio Ratio p-value p-value 
    BU04  FIM BU04  FIM 
    63630 636 63630 636 
yjbE Biofilm Formation 1.277 1.064 0.001571 0.000489 
yqjD Biofilm Formation 0.994 0.864 0.000166 0.010177 
papH P fimbria 1.021 1.936 0.002403 0.002768 
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gudD Lyase and transferase 1.073 0.801 0.000271 0.004584 
gudP Lyase and transferase 1.293 0.906 0.000394 0.001035 
rplF 50S ribosomal protein 0.964 0.881 0.001304 0.000326 
rplO 50S ribosomal protein 1.208 0.974 0.001304 0.000326 
rplQ 50S ribosomal protein 1.029 0.884 0.006106 0.002628 
rplR 50S ribosomal protein 1.032 0.927 0.003437 0.000848 
rplV 50S ribosomal protein 0.979 0.908 0.000892 0.001226 
rplX 50S ribosomal protein 0.871 0.976 0.001673 0.007648 
rpsC 30S ribosomal protein 0.981 0.948 0.000118 0.005782 
rpsE 30S ribosomal protein 0.993 0.919 0.011663 0.001632 
rpsH 30S ribosomal protein 0.965 0.887 0.008411 0.001092 
rpsI 30S ribosomal protein 0.917 0.811 0.010743 0.000347 
rpsN 30S ribosomal protein 0.976 0.96 0.00271 0.004157 
 
  
Table 19. Commonly upregulated genes in re-isolates BU05 35364 and FIM 636 
Gene Function Ratio Ratio p-value p-value 
     BU05 FIM  BU05 FIM 
    35364 636 35364 636 
dppA Dipeptide transporter 0.801 1.103 0.012405 0.001699 
dppB Dipeptide transporter 0.901 0.805 0.05888 0.002997 
yrdA Transferase. hypothetical 1.076 1.208 0.031021 0.000603 
eno Phosphopyruvate hydratase  1.198 1.356 0.018329 0.003002 
papF P fimbria 1.243 1.752 0.018911 0.000383 
 
 
Table 20. Commonly upregulated genes in re-isolates BU04 63630. BU05 35364 and FIM 636     
Gene Function Ratio Ratio Ratio 
   p-
value p-value p-value 
    
 
BU05 BU04  FIM  BU05 BU04  FIM 
    35364 63630 636 35364 63630 636 
yjgb 
Alcohol dehydrogenase, RpoS 
regulon 1.094 1.036 1.426 0.0043 0.00085 0.000005 
degP Survival at high temperatures 0.876 1.382 0.835 0.0091 0.00445 0.015322 
bipA GTP-binding. colanic acid synthesis 1.501 1 1.019 0.0112 0.00891 0.000646 
ECP_0113 Colicin production 1.558 1.015 1.059 0.0381 0.00424 0.02762 
papA P fimbria 0.918 1.556 2.056 0.0069 0.00119 0.002195 
c0391  Integrase 1.315 1.226 1.207 0.0788 0.00007 0.002303 
UTI89_C3360 Unknown function 1.239 1.019 1.071 0.0171 0.03126 0.000793 
ytjA Unknown function 1.041 1.413 1.147 0.0087 0.00026 0.003503 
 
 
Table 21. Downregulated genes in re-isolates BU04 63630 
Gene Function Ratio p-value 
dctA dicarboxylate transport -1.446 0.0282 
mglA galactose ABC transporter -2.171 0.08096 
mglB galactose ABC transporter -1.762 0.08532 
malT MalT-Maltotriose-ATP transcriptional activator -1.765 0.01577 
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ygeV putative transcriptional regulator -1.586 0.05885 
nrfA formate-dependent nitrite reductase -1.903 0.00841 
nrfB formate-dependent reduction of nitrite to ammonia -1.326 0.0641 
nrfC 
enables formate dehydrogenase H to transfer electrons into an electrogenic 
electron-transfer chain -1.182 0.08167 
nmpC Phage-related -4.011 0.04418 
ychH Inner membrane protein  -1.881 0.06059 
 
 
Table 22. Downregulated genes in re-isolates BU05 35364 
Gene Function Ratio p-value 
agaB Phosphotransferase System -1.414 0.05281 
agaV Phosphotransferase System -1.337 0.01381 
agaW Phosphotransferase System -1.356 0.04572 
srlE_1 Phosphotransferase System -1.623 0.00907 
srlR Phosphotransferase System -1.037 0.01128 
gutM transport and utilization of glucitol -1.268 0.04317 
yadD predicted transposase  -1.575 0.00041 
dgoD galactonate dehydratase  -1.17 0.00075 
dgoT functions as a galactonate/proton symporter -1.537 0.00075 
 
 
Table 23. Downregulated genes in re-isolates FIM 636 
Gene Function Ratio p-value 
ybiP predicted hydrolase, inner membrane  -1.57 0.02598 
 
 
Table 24. Commonly downregulated genes in re-isolates BU05 35364 and BU04 63630  
     BU05 BU04   BU05 BU04  
    35364 63630 35364 63630 
Gene Function Ratio Ratio p-value p-value 
lysU lysine tRNA synthetase, inducible  -0.945 -1.342 0.036 0.0129 
kbaZ tagatose 6-phosphate aldolase 1, kbaZ subunit  -2.066 -1.026 0.09981 0.0106 
ykgC pyridine nucleotide-disulfide oxidoreductase  -1.042 -1.324 0.01502 0.0177 
rbsA ribose ABC transporter -1.784 -1.024 0.00599 0.0003 
rbsD ribose ABC transporter -1.45 -1.206 0.00359 0.0157 
ybhD predicted DNA-binding transcriptional regulator -1.538 -1.474 0.0028 0.0418 
 
 
Table 25. Commonly downregulated genes in re-isolates BU05 35364 and FIM 636 
     BU05 FIM  BU05 FIM 
    35364 636 35364 636 
Gene Function Ratio Ratio p-value p-value 
cspG cold shock. response to stress 0.81 -1.677 0.0263 0.0006 
 
 
Appendix 
-177- 
Figure 49. Plasmid construct pKD3 with papGX from CFT073 inserted upstream of 
cat. Primer binding sites are shown. 
Figure 50. ABU 83972 with reconstituted papGX from CFT073. Primer binding sites are shown. 
fliC locus 83972 rc
4266 bp
fliA fliDcat
fliC DW cat-ff
flic DW cat-revfliC Ktr ff
fliC Ktr rev
Figure 51. Flagellin gene (fliC) deleted from ABU 83972. Primer binding sites are shown. 
8.5. Maps of Plasmids and Constructs 
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8.8. Abbreviations 
 
 
µg  microgram 
µl  microliter 
ABU  asymptomatic bacteruria 
Amp  ampicillin 
APS  ammonium persulfate 
bp  base pairs 
BSA  bovine serum albumin 
CFU  colony forming unit 
Cm  chloramphenicol 
del  deletion 
DEPC  diethyl pyrocarbinate 
DNA  desoxyribonucleic acid 
DNase  desoxyribonuclease 
dNTP deoxyribonucleotide phosphate 
DTT dithiothreitol 
ECOR E. coli group of reference 
strains 
EDTA  ethylendiamine tetra-acetate 
et al.  et altera (and others) 
EtOH  ethanol 
ExPEC extra-intestinal pathogenic  
E. coli 
Fim  type 1 fmbriae 
g  gram 
h  hour 
ID  identification 
i.e.  id est (this means) 
IL 6  Interleukin 6 
IL 8  Interleukin 8 
Kan  kanamycin 
kb  kilo bases 
kDa  kilo Dalton 
l  liter 
LB  lysogeny broth 
LPS  lipopolysaccharide acid 
M  molar 
 
 
 
 
 
 
 
 
 
 
 
mA  milliampere 
mg  milligram  
min  minute 
ml  milliliter 
MLST  Multi Locus Sequence Typing 
mm  millimeter 
mM  millimolar 
ng  nanogram 
nt  nucleotides 
OD  optical density 
ORF  open reading frame 
PAI  pathogenicity island 
PAGE polyacrylamide gel 
electrophoresis 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
PFGE  pulsed field gel electrophoresis 
PIA polysaccharide intercellular 
adhesin 
PMN  polymorphonuclear cell 
RNA  ribonucleic acid 
RNase  ribonuclease 
rpm  rounds per minute 
RT  room temperature 
qRT-PCR real time PCR 
SD  standard deviation 
SDS  sodium dodecyl sulfate 
s  second 
TBS  Tris buffered saline 
TAE  Tris-acetate-EDTA 
TLR  toll like receptor 
U  unit 
UPEC  uropathogenic E.coli 
UTI  urinary tract infection 
wt  wild type 
